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The natural genetic code is largely shared amongst all terrestrial life, though 
variations do exist that provide evidence of genetic code evolution. The field of synthetic 
biology has developed methods to augment and modify the genetic code, by reassigning 
codons and genetically incorporating noncanonical amino acids (NCAAs). Most 
commonly, amino-acyl tRNA synthetases and their cognate tRNAs are engineered to 
recognize (NCAAs), the tRNA charged with an NCAA is then used during translation to 
decode the amber stop codon. Using this method, over 200 unique NCAAs have been 
added to the genetic code, allowing for the site-specific incorporation of useful 
chemistries, including covalent bond formation and fluorescence. NCAAs have been 
implemented in biological research and protein engineering. The second chapter of this 
dissertation explores the biophysical parameters that allow efficient crosslinking with a 
NCAA. We investigated several environmental factors which could impact crosslinking 
between two interacting proteins. We define a set of parameters that permit efficient 
crosslinking.  
Noncanonical amino acids are a potentially powerful tool in understanding 
genetic code evolution. Evolutionary experiments using NCAAs have already been used 
to explore proposed theories on codon evolution, including codon capture and ambiguous 
intermediate theories. Though several studies have explored the implications of NCAAs 
 vii 
in evolution, significant obstacles have prevented the long-term evolution of wild-type 
organisms with expanded genetic codes. In chapter three of this dissertation we 
demonstrate that a single essential enzyme can be engineered to be structurally dependent 
on a genetically encoded NCAA. This confers a functional addiction to the NCAA and 
the addiction can be transferred to new bacterial hosts using a DNA plasmid. Chapter 
four expands on this idea, attempting to use the chemistries bestowed by the NCAA for 
active site chemistry. Finally, in chapter five we demonstrate that a protein-conferred 
cellular NCAA addiction is sufficient for the long-term evolution of bacteria with a 
recoded amber codon. We investigated the genetic and phenotypic impact of evolution 
with an expanded genetic code. 
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Chapter 1: The Genetic Code: Structure, Plasticity, and Evolution 
The genetic code is nearly universal, with all known lifeforms relying upon the 
same five nucleotides and 22 proteinogenic amino acids. Yet natural variations exist 
which provide evidence of the evolutionary history of the genetic code. While several 
theories have been proposed on the evolution of the genetic code and the arrangement of 
the codon table, experimental exploration of these theories has largely been limited to 
computational modeling and other in silico approaches. Over the last few decades, 
advances in synthetic biology have allowed for the augmentation of the genetic code, 
through the reassignment of codons and the addition of noncanonical amino acids into the 
proteome. These advances should provide insights into genetic code evolution, as well as 
enable the evolution of organisms that utilize expanded genetic codes throughout their 
proteome. While progress has been made towards these goals, barriers still exist which 
inhibit the full implementation of expanded genetic codes in biology.   
The genetic encoding of the components necessary to maintain life are held in 
polymeric nucleic acids and stably stored in genomic DNA, the biomolecule responsible 
for heritability (Avery et al., 1944). The nucleotide sequence of genomic DNA is used as 
a template to transcribe a copy using the chemically similar RNA backbone, which in 
turn is translated by the ribosome though the RNA-sequence defined assembly of amino 
acids, coded for by triplet nucleotide codons. This general idea was hypothesized more 
than half a century ago, (Crick, 1958) and the then-imminent elucidation of the genetic 
code and decoding of triplet codons verified this hypothesis (Matthaei et al., 1962).  
The triplet nature of codons paired with the four available genetic nucleotides 
allows for 64 possible codons (4x4x4=64) in the genetic code (Figure 1-1 and Figure 1-
2). Typically, 61 codons code for 20 standard amino acids which are decoded using 
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transfer RNA (tRNA), and the remaining three used to signal the termination of protein 
synthesis. Before being used in translation, tRNAs are charged with the appropriate 
amino acid by their amino-acyl tRNA synthetase (aaRS), which ligates the correct amino 
acid onto its corresponding tRNA. The charged tRNA is then recognized by an 
elongation factor (EF-Tu in bacteria) and is delivered to the ribosome where it participate 
in the translation of an mRNA codon. The remaining three codons, amber (UAG), ochre 
(UAA), and opal (UGA), code for the termination of protein synthesis, accomplished in 
the ribosomal A-site by protein release factors which recognize these stop codons and 
release the translated peptide from the ribosome (Scolnick et al., 1968). This arrangement 
of the codons was thought to be universal, and famously hypothesized to be a “frozen 
accident” (Crick, 1968). This conjures images of a primordia ooze, with a milieu of 
diverse organisms containing the foundation of the genetic code; DNA, RNA, and 
proteins, but with different arrangements of codons, or an alternate set of amino acids in 
each organism. Yet our single arrangement of 20 amino acids somehow persisted, by 
chance or merit, and life is now constrained to operate within any limitations of the code. 
But how frozen is the genetic code? Is life forever confined to this, perhaps 
suboptimal, code? Or is it evolving even now, and it always has been? Evolution of 
something so fundamental as the genetic code would likely require enormous time 
periods, making observation and experimentation difficult. In this era of biotech, can we 
augment the foundation of life, and peak into mechanisms of genetic code evolution? Can 
we evolve new genetic codes, either through rational engineering or directed evolution of 
whole organisms? This dissertation focuses on using stop codon reassignment, and 
adding additional noncanonical amino acids to the genome, as a method to explore the 
evolutionary impact of expanded genetic codes.  
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1.1 EXPANDING THE GENETIC CODE 
Since the elucidation of the genetic code, the dogma that it is a frozen artifact of 
evolution; ridged, unalterable, and inflexible, has slowly thawed. In the era of 
bioinformatics, natural variations to the code have been discovered with additional 
proteinogenic amino acids, demonstrating natural variations among extant life. While 
simultaneously, biotechnological advances have made it possible to engineer the genetic 
code, altering it to fit specific needs. Together, the once untouchable central dogma of 
biology is proving to be flexible and engineerable.  
1.1.1 Natural Expansion of the Code 
For nearly 30 years the frozen accident hypothesis seemed to fully describe life. 
The 20 standard proteinogenic amino acids were considered the entirety of the genetic 
code, and contained all information that was necessary for survival of Earth’s diverse 
biome. Recently, however, examples have been identified that demonstrate that life has 
evolved beyond the 20 standard proteinogenic amino acids (Figure 1-1). Nature has 
devised mechanisms to use two additional amino acids which provide unique chemistries 
beyond the standard genetic code. The noncanonical amino acids selenocysteine and 
pyrrolysine are evidence that the genetic code is not entirely frozen, and nature itself has 
evolved to use new amino acids. Further demonstrating the flexibility of the code, both of 
these amino acids use stop codons as signals for incorporation, defying the canonical 
translation scheme. Importantly, these examples of natural variation to the standard 
genetic code demonstrate that nature can use new amino acids to accomplish new 
functions, and thus can reach higher fitness peaks with additional amino acid chemistries.  
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1.1.1.1 Selenocysteine  
In the late 1980s, the discover of selenocysteine, and is often called the 21st amino 
acid, was the first example of natural expansion of the genetic code. Selenocysteine is 
biosynthesized by modifying a serine-charged opal (UGA) stop codon suppressor tRNA, 
and is encoded site-selectively with signaling from an mRNA structural element and a 
specialized elongation factor (Berry et al., 1991). Selenocysteine is used across all 
domains of life; it is essential in some, and nonessential in others, and is an ancient 
component of the genetic code (Allmang and Krol, 2006; Atkinson et al., 2011; Böck et 
al., 1991; Kaiser et al., 2005; Kryukov et al., 1999). Selenocysteine brings unique 
chemistry to the code that cannot be achieved with canonical amino acids. It is one of two 
proteinogenic amino acids with side chains readily capable of forming covalent bonds, 
the other being cysteine, though no structural diselenide bonds have been discovered in 
nature. The discovery of selenocysteine was irrefutable evidence that the universal 
genetic code was not so universal, and that variations could arise.  
1.1.1.2 Pyrrolysine 
More recently, pyrrolysine was identified as the 22nd proteinogenic amino acid. 
Unlike selenocysteine, pyrrolysine has only been identified in methanogenic archaea and 
a single eubacterium, Desulfitobacterium hafniense (Herring et al., 2007), likely 
indicating an evolutionary appearance after selenocysteine. Like selenocysteine, 
pyrrolysine is inserted at a stop codon, though a different codon, using amber (UAG) 
suppression instead of opal suppression, as selenocysteine does. Pyrrolysine is 
biosynthesized in the cell, then charged on a tRNA using a pyrrolysine specific aaRS 
(Atkins and Gesteland, 2002; Gaston et al., 2011; Hao et al., 2002). Like selenocysteine, 
pyrrolysine performs a chemical function which cannot be accomplished by any of the 20 
standard proteinogenic amino acids, and is essential for enzymatic function of 
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methyltransferases in some archea (Hao et al., 2002), again demonstrating nature can 
evolve new chemistries to reach higher fitness peaks.  
1.1.1.3 Implications of selenocysteine and pyrrolysine 
For nearly 30 years, the universal genetic code was considered all that was 
necessary for life. Since then, two exceptions to the universal code have been discovered 
in nature. Each of these expanded amino acids provide unique functions that cannot be 
accomplished with the universal code. It’s likely that selenocysteine and pyrrolysine 
evolved at different periods in history, as selenocysteine is used among all domains of 
life, while pyrrolysine is limited to a specific branch of archaea. Additionally, both amino 
acids use ambiguous codons for incorporation, each utilizing a stop codon, selenocysteine 
using the UGA codon, and pyrrolysine utilizing UAG codon. We are now in an era where 
genome sequencing is relatively easy, and bioinformatics is a major focus. It’s possible 
that other variations to the code exist, and have yet to be identified. But certainly, these 
two natural expansions demonstrate that the genetic code is far from frozen, and is, like 
all things, amenable to evolution.  
1.1.2 Demonstrations of code plasticity in vitro 
1.1.2.1 In vitro incorporation of NCAAs at cognate codons 
After the elucidation of the genetic code and the underlying mechanisms of 
protein translation, it was apparent that aaRSs played an important role in maintaining = 
translation fidelity. Each aaRS required specificity toward both cognate tRNA and 
appropriate amino acid. Other translational machinery, including the ribosome and 
elongation factors, is generally shared amongst amino acids and tRNAs. Since the aaRS 
was largely responsible for amino acid recognition, circumventing the aaRS might allow 
incorporation of NCAAs by the ribosome and elongation factors. This was first 
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demonstrated when synthetically acylated tRNAs charged with L-4’-[3-(trifluoromethyl)-
3H-diazirin-3-yl]phenylalanine were readily used by the ribosome in an in vitro assay 
using rabbit reticulocyte lysate (Baldini et al., 1988). The tRNA was read as a 
phenylalanine, and encoded into translating proteins at phenylalanine codons.  
1.1.2.2 In vitro incorporation of NCAAs at stop codons 
With NCAAs readily incorporated by cellular translation machinery, a codon was 
needed to signal for site specific NCAA incorporation. While 61 of the 64 possible 
codons are already occupied by natural amino acids, it was well known that some 
organisms used suppressor tRNAs complementary to stop codons as alternatives for 
typical release factor mediated translational termination (Murgola, 1985), and that some 
aaRSs would recognize their tRNA even if mutated to complement a stop codon (Bruce 
et al., 1982). As such, stop codons were identified as possible sites for NCAA 
incorporation. Using this approach, two groups reported that the UAG codon could be 
used as a signal for NCAA incorporation in vitro, one using a biologically produced 
tRNA which was chemically charged with a NCAA (Noren et al., 1989), and another 
which used a synthetic tRNA (Bain et al., 1989) charged with an NCAA. This 
demonstrated that the core genetic code was amenable not only to NCAA incorporation, 
but to the conversion of a stop codon to a cognate NCAA incorporation site. While 
laborious, using synthetically charged tRNAs for in vitro NCAA incorporation had 
demonstrated uses in exploring protein structure, elucidating pathways, and 
understanding protein mechanisms, as was demonstrated in elucidating the role of a 
glutamate thought to be responsible for enzymatic activity in staphylococcal nuclease (D 
Mendel et al., 1995). 
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While in vitro methods for NCAA incorporation have largely been superseded by 
efforts towards in vivo methods (Chapter 1.1.3), the flexibility of in vitro systems allows 
for NCAA incorporation at multiple codons, or incorporation of NCAAs that are largely 
rejected by incorporation machinery in vivo. A benefit to in vitro translation is that each 
component of translation can be individually added or removed for the translation 
mixture, including release factors, tRNAs, aaRSs, and even canonical amino acids 
(Forster et al., 2003; Goto et al., 2011; Shimizu et al., 2001). In fact, in vitro translational 
systems have been developed which function in an entirely different fashion than natural 
translational properties, with de novo ribozymes that can charge tRNAs with NCAAs that 
are difficult to incorporate using in vivo methods described below, including D-amino 
acids (Goto et al., 2011; Ohuchi et al., 2007), without engineering aaRS specificity for 
each desired NCAA.  
1.1.3 Methods for in vivo Incorporation of NCAAs 
While expansion of the code had successfully been demonstrated in vitro, the 
process was laborious, and synthetically charged tRNAs could only be used for a single 
codon translation event, severely limiting production of proteins. Ideally, aaRSs could be 
used to charge tRNAs with an NCAA in vivo, allowing for unlimited turnover and 
continuous production of protein. As such, several approaches have been developed to 
incorporate NCAAs into proteins in vivo.  
1.1.3.1 Using aaRS Promiscuity for NCAA incorporation in vivo  
AaRS fidelity is crucial to translation and thus biological function. Despite this, it 
has long been known that certain amino acid analogs could be recognized by aaRSs and 
would be charged to the corresponding tRNA. The tRNA could then be used by the 
ribosome for the translation of its natural codon complement. This was first demonstrated 
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when methionine was replaced with the ethionine in rat proteins (Levine and Tarver, 
1951), and subsequent studies showed similar aaRS flexibility (Cowie and Cohen, 1957; 
Richmond, 1962). An exploration of the promiscuity of the E. coli methionyl-synthetase 
demonstrated that a number of methionine analogs, including chemically reactive, 
terminally unsaturated amino acids could be charged to the methionyl-tRNA and would 
be used during translation at ATG codons by the ribosome (van Hest et al., 2000). 
Analysis of translated proteins revealed that ATG codons were read ambiguously during 
translation and contained either methionine, the natural metRS substrate, or the 
methionine analog supplemented to the host.  
Using the promiscuity of aaRSs has allowed for the introduction of chemically 
reactive amino acids, including several capable of forming covalent bonds, such as 
azidohomoalanine (Dieterich et al., 2007). This methodology requires no changes to the 
genome, providing a facile method to monitor in vivo protein synthesis (Ngo and Tirrell, 
2011) and detailed proteomic analysis of individual cells in complex multicellular 
organisms (Yuet et al., 2015). This same general process has also been used to force the 
tolerance of toxic amino acids into the genome of growing cells (Lemeignan et al., 1993).  
1.1.3.2 Engineering host aaRSs for relaxed substrate specificity 
While aaRS promiscuity allows for in vivo incorporation of NCAAs, nature has 
evolved aaRSs for specificity, and the range of NCAAs that can be used as a substrate is 
limited. Expanding the number of NCAAs which can be encoded required engineering 
aaRSs for relaxed or changed amino acid specificity. As recombinant DNA technology 
and protein structural information became available, engineering aaRSs became feasible. 
The first demonstration of relaxed aaRS fidelity used a single amino acid substitution in 
E. coli phenylalanyl-synthetase (A294G) (Ibba et al., 1994). This single mutation allowed 
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for tRNA charging with the NCAA p-chlorophenylalanine (PCFA). Follow up work 
demonstrated that the tRNA charged with PCFA was used in protein synthesis in vivo by 
the host organism (Ibba and Hennecke, 1995). This same mutation, as well as this 
mutation paired with a secondary mutation (T251G), later showed the ability to 
incorporate a number of tyrosine analogs, including chemically reactive amino acids p-
cyano-, p-azido-, and p-keto- phenylalanine (Datta et al., 2002; Kirshenbaum et al., 
2002), and photoreactive amino acids including benzofuranylalanine (Bentin et al., 2004).  
1.1.3.3 Assigning a Codon for NCAAs 
While successfully demonstrating aaRSs could be engineered to incorporate 
NCAAs in vivo, there were detrimental fitness effects to the host when incorporating the 
NCAA. Fitness effects were later identified as a consequence of global NCAA 
incorporation at cognate codons throughout the genome (Ibba and Hennecke, 1995). 
Beyond fitness cost, commandeering a cognate codon for NCAA incorporation results in 
a mixture of amino acids at a given codon. For efficient incorporation, and to maintain 
cellular viability, a designated codon was needed to signal NCAA incorporation. 
Preferably, the NCAA would be the sole amino acid coded by the codon, which 
significantly reduced the codon options to stop codons.  The UAG stop codon had been 
used for NCAA incorporation in vitro (Noren et al., 1989), and was followed by a 
demonstration of in vivo suppression, when an E. coli UAG suppressor tRNA and 
corresponding tyrRS were heterologously expressed and shown to function in S. 
cerevisiae (Edwards and Schimmel, 1990). UAG is the rarest codon throughout the 
genome, and signals for termination, and so assignment to an NCAA meant only 
translational competition between the NCAA and termination (Figure 1-3) 
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1.1.3.4 Engineering orthogonal translational machinery 
The semi-rational engineering of an aaRS for the improved mis-incorporation of 
NCAAs at cognate codons throughout a genome demonstrated the plasticity of the 
genetic code translational machinery (Chapter 1.1.3.2). As high resolution structural 
information became available, and methods to generate large libraries of protein variants 
were perfected, it became possible to generate aaRSs which were NCAA specific as 
opposed to amino acid generalists. This requires the genetic encoding a new aaRS into an 
organism, and engineering the aaRS for NCAA specificity, as well as the tRNA. For high 
fidelity incorporation of an NCAA into the genome, the supplemented aaRS and tRNA 
must function in the new host, while simultaneously not interacting with host tRNAs or 
aaRSs. A number of these orthogonal translation systems, comprised of an aaRS and 
tRNA from a genetically distinct lineage from the host, have been developed for use in a 
variety of model organisms.  
The original, and still most common, OTS engineered for NCAA incorporation is 
the Methanocaldococcus jannaschii tyrosyl-tRNA synthetase and corresponding tRNA. 
The Mj tyrRS/tRNA pair is optimal because the cognate codons for tyrosine (TAT/TAC) 
are similar to the amber codon (TAG) that is often used for NCAA incorporation, and the 
Mj tyrRS has a minimal anticodon recognition domain (Steer and Schimmel, 1999). This 
meant that the Mj-tyrRS would still recognize and charge the tRNA even if the anticodon 
of the tRNA was mutated to complement the UAG stop codon. Furthermore, an ideal 
OTS would function without interfering with, or interference from the host translational 
machinery (Figure 1-4). Since most NCAA incorporation experiments are performed in 
E. coli, it was essential to use an aaRS/tRNA pair which was orthogonal to the E. coli 
translational machinery. The archaeon M. jannaschii is a genetically distinct and far 
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removed from E. coli, and the tyrRS/tRNA pair has been shown to be orthogonal in E. 
coli.  
The structure of the wild type Mj tyrRS:tRNA complex has been solved 
(Kobayashi et al., 2003) (Figure 1-5), providing insight into the orthogonality of the pair 
in E. coli, but also informing attempts to engineer the MjOTS. In fact, many of the 
MjOTSs engineered for NCAA incorporation have been selected by randomizing the 
same residues, those responsible for amino acid binding and recognition, including 
Tyr32, His70, Asp158, Ile159, and Leu162. Many of these engineered versions of the 
MjOTS that are specific for NCAAs have been crystallized and the structures solved. 
These structures have further shed insight into the functionality of the synthetase in 
amino acid and tRNA recognition (Cooley et al., 2014; Sakamoto et al., 2009) (Figure 1-
5).  
While the Mj tyrRS/tRNA pair has been successfully engineered to incorporate a 
range of diverse NCAAs (see Chapter 1.2.2), the ability to successfully evolve an aaRS 
for NCAA recognition depends on the structural limitations of the aaRS active site. As 
such, several other aaRSs, based on many of the existing natural amino acids, have been 
engineered to orthogonally incorporate NCAAs in model organisms. Like the Mjtyr OTS, 
a number of OTSs have been derived from archaea, including the pyrrolysine synthetase 
from the methanogenic archaea Methanosarcinaceae, which naturally recognized the 
amber stop codon, has been demonstrated to introduce a number of NCAAs with minimal 
engineering (Tuley et al., 2014). Other archaeal OTSs include the Glutamyl-RS from 
Methanosarcina mazei, and the Lysyl-RS from Pyrococcus horkoshii, both of which have 
been further engineered to recognized quadruplet codons (Anderson and Schultz, 2003; 
Anderson et al., 2004). The Saccharomyces cerevisiae tryptophanyl-tRNA synthetase has 
been engineered for orthogonal NCAA incorporation in E. coli (Ellefson et al., 2014; 
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Hughes and Ellington, 2010). Other S. cerevisiae OTSs have been used for NCAA 
incorporation, including the aspartyl-RS, glutamyl-RS, tyrosyl-RS (Furter, 1998; Liu et 
al., 1997; Ohno et al., 1998; Pastrnak et al., 2000). And the E. coli leucyl- and tyrosyl-
synthetases has been engineered for NCAA incorporation into yeast and mammalian cells 
(Brustad et al., 2008).  
While the aaRS is often the focus of engineering, as the gate responsible for both 
amino acid and tRNA recognition, the corresponding orthogonal tRNA can also exert  
significant influence on translation. Foreign tRNAs can have interplay with host aaRS, 
resulting in charging with undesired natural amino acids, as was seen when an E. coli 
tRNA was charged with lysine when expressed in S. cerevisiae (Furter, 1998). Harboring 
an OTS carries a significant burden on the host, and work toward engineering the Mj-
tyrtRNA showed that it was possible to decrease misacylation by native aaRSs while still 
retaining NCAA charging by the Mj-tyrRS (Wang and Schultz, 2001). Somewhat 
surprisingly, later work revealed that the tRNA was important in NCAA recognition, and 
could be evolved to increase NCAA specificity (Guo et al., 2009; Maranhao and 
Ellington, 2016) and decrease fitness effects typically associated with harboring an OTS 
(Maranhao and Ellington, 2016). 
1.1.5 Conclusions 
The universal genetic code was, for several decades, considered frozen and 
immovable. Since then, a series of natural discovers as well as engineering breakthroughs 
have demonstrated that the genetic code is not entirely ridge. Nature itself provides 
examples of expanded codes, having evolved pathways for the addition of at least two 
noncanonical amino acids. Beyond that, aaRSs have some amino acid promiscuity, and 
can incorporate chemically reactive NCAAs that are structurally similar to the natural 
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amino acid. Furthermore, aaRSs can be engineered at the amino acid binding pocket for 
NCAA recognition and specificity, and can be introduced from distant organisms into 
host cells with minimal reactivity with host translational machinery. The tRNA is also 
important in NCAA incorporation, and can be used to further tune NCAA specificity and 
reduce the fitness cost of harboring an OTS.  
1.2 EXPANDING THE CHEMISTRIES OF PROTEINS 
Chemical modification of proteins has been a powerful tool in elucidating 
biological interactions and metabolic pathways, as well as in biochemical engineering. 
The development of amino-acid specific crosslinkers has been a boon in interactome 
studies, the most prominent include protein surface labeling with N-hydroxysuccinimide 
(NHS) or Sulfo-NHS, targeting proteinogenic amines or carboxylic acids (Staros et al., 
1986), and succinimidyl 4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC), 
which reacts selectively with nucleophilic amines and thiols (Brinkley, 1992). Other 
forms of protein modification include enzymatic modification of proteins (Hwang et al., 
2004), and the encoding of biochemically unique proteins or protein domains to the 
protein of interest, including GFP (Hanson et al., 2004; Wilson et al., 2004) and SNAP 
tag (Keppler et al., 2003), which provides a unique physiochemical environment for the 
generalized labeling of proteins (Gautier et al., 2008; Juillerat et al., 2003). Nature has 
even evolved sequence specific modifications, which can be used to label proteins 
(Dierks et al., 1999; Rush and Bertozzi, 2008). Yet, the development of site specific 
NCAA incorporation has superseded these technologies, allowing the incorporation of 
amino acids which can accomplish each of these tasks, and more, with the replacement of 
a single amino acid.  
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1.2.1 Noncanonical amino acids for protein modification 
The addition of noncanonical amino acids (NCAAs) to the genetic code allows for 
the incorporation of novel and useful chemistries not available through the standard 
proteinogenic amino acids. While a series of approaches have been used to modulate 
protein structure and function, NCAAs allow for site specific modification of proteins 
with minimal changes to the target protein sequence and overall structure. NCAAs 
provide site specificity, orthogonal reactivities, and scarless insertion. The utility of an 
augmented code was recognized over 50 years ago as a way to study protein function by 
inserting amino acid analogs with chemical synthesis of proteins (Hofmann and Bohn, 
1966), and was later recognized as a tool for use in peptide and protein design and 
engineering (Balaram, 1992; Link et al., 2003). Since then, a series of progressive 
advancements have led to the in vivo site specific incorporation of an NCAAs with 
unique and useful chemistries.  
1.2.2.1 Crosslinking 
 The chemical labeling of proteins has been a powerful tool for understanding and 
engineering biology. Historically, proteins have been chemically modified after 
translation at specific reactive groups present in the natural genetic code, or with the 
addition of large protein tags. Historical methods are nonspecific – they react with all 
surface exposed amino acids containing the target chemistry (i.e. every cysteine, every 
lysine, or every glutamate and aspartate, etc.). Site specific crosslinking is a highly 
desirable characteristic, but is difficult to accomplish in most proteins using these 
traditional labeling methods. Several systems to incorporate NCAAs with crosslinking 
chemistry have been engineered. Crosslinking NCAAs have distinct advantages over 
traditional methods; many are bioorthogonal, a number have been incorporated that can 
be crosslinked at physiologically relevant pH and temperatures, preserving protein 
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structure and function, and they can be incorporated in vivo, and several can be activated 
for crosslinking in vivo.  
 Ketones and aldehydes are chemically reactive functional groups that are often 
used as reaction sites in organic chemistry. The reactivity of carbonyls is largely outside 
the realm of biomolecules, allowing covalent bond formation in biological conditions 
with minimal interference from proteins and nucleic acids. Additionally, their small size 
has made them amenable to incorporation using NCAAs. p-acetyl-L-phenylalanine has 
been incorporated into proteins using engineered OTSs, and has facilitated protein 
complex assembly using alkoxyamine- or hydrazide- crosslinking functional groups, in 
slightly acidic conditions (Kim et al., 2012). These requirements ensure crosslinking does 
not occur in vivo, but when initiated by protein treatments and the presence of the 
associated crosslinkers.  
 Possibly one of the most common crosslinking systems used with NCAAs is 
azide- and alkyne- reactions. At least two sets of OTSs have been developed for each of 
these functional groups, using the M. jannaschii OTS, and the pyrrolysine OTS (Chin et 
al., 2002a; Deiters and Schultz, 2005; Tuley et al., 2014; Wang et al., 2012, 2013). Azide- 
and alkyne- NCAAs are attractive because they can interact with each other in a 
bioorthogonal manner, through 3+2 cycloadditions. 
 The NCAA p-benzophenone (pBpa) has been incorporated using an engineered 
OTS and is chemically inert in low light conditions. Upon UV irradiation, pBpa 
crosslinks preferentially with inactivated C-H bonds, which are common in the proteome 
(Chin et al., 2002b; Galardy et al., 1973). Because UV irradiation can induce crosslinking 
in living cells, pBpa has been used to map protein-protein interactions in vivo (Pham et 
al., 2013; Shiota et al., 2013). In addition to amino acid crosslinking, pBpa is also capable 
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of crosslinking with DNA, expanding the potential interaction mapping capabilities 
beyond protein interactions (Lee et al., 2009a).  
Alternatively, the NCAA L-DOPA can be oxidized and crosslinks with reactive 
nucleophiles, including the amino acids cysteine, lysine, and histidine (Liu et al., 2006). 
The crosslinking of L-DOPA to canonical amino acids not only provides protein 
interaction information, but also sequence information as well, as it reacts with a limited 
set of natural amino acids. L-DOPA has been used to determine the binding site of a 
peptide-protein complex in vitro, using oxidation as the crosslinking trigger (Burdine et 
al., 2004). 
1.2.2.2 Post-translational modifications 
Nature uses chemical modifications through post-translational modification 
(PTM) of proteins for the activation or deactivation of enzymes and cellular signaling 
pathways, and for controlling transcription, and gene expression (Wold, 1981). Studying 
and understanding PTMs is essential for drug discovery, understanding disease states, 
and a general understanding of protein structure and function. PTMs are tightly 
controlled in cellular environments, and controlling the PTM state of proteins can be 
difficult, as reproducing the conditions that induce PTMs can be impossible, or 
purification of the protein in its natural modified condition can be prohibitive. The utility 
of NCAAs in studying PTMs has been realized for quite some time (Hortin and Boime, 
1983), and in this vein, NCAAs provide a facile method to introduce PTMs into proteins 
using bacteria, simplifying protein expression and purification.  
OTSs have been engineered to incorporate PTM or PTM analogs during 
translation, which have helped researchers understand the role a PTM has on protein 
activity or interactions. A number of different demonstrations have shown phosphoserine, 
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as well as analogs of phosphoserine and phosphotyrosine can be incorporated in vivo 
(Lee et al., 2013; Park et al., 2011; Rogerson et al., 2015; Xie et al., 2007)). Additional 
engineering of translational machinery, specifically engineering EF-Tu to recognize a 
tRNA charged with phosphoserine and improve phosphoserine utilization in the 
ribosome, substantially increased NCAA incorporation (Rogerson et al., 2015).  
A number of other PTMs have been genetically encoded using NCAAs, including 
Nε-acetyllysine (Neumann et al., 2008a) which was used for histone regulation (Struhl, 
1998), and nitrotyrosine, an oxidation product of tyrosine, which may be a biomarker, but 
has been proposed as a PTM to alter function (Cooley et al., 2014; Neumann et al., 
2008b; Ng et al., 2013; Siles et al., 2005). Additionally, complex PTMs, such as 
glycosylation or ubiquitination, can be added using crosslinking NCAAs (van Kasteren et 
al., 2007). 
1.2.2.3 Fluorescence 
 The development of biologically relevant fluorescent trackers, largely based on 
GFP has revolutionized in vivo protein monitoring, allowing for protein localization 
analysis (Feilmeier et al., 2000), protein-protein interaction mapping (Cabantous et al., 
2013; Kamiyama et al., 2016), and chemical environment indicators (Cannon and 
Remington, 2006; Hanson et al., 2004). GFP requires the encoding of a ~25 kDa protein 
onto the proteins being studied. To remove the large protein tag necessary for 
fluorescence, a series of fluorescent amino acids have been developed of in vitro and in 
vivo incorporation. Early attempts at genetic encoding of fluorescence used host 
translational machinery, but required chemical acylation of the tRNA (Pantoja et al., 
2009). Other methods have used crosslinking amino acids to conjugate with fluorophores, 
this requires chemical modification after translation, but has the benefit of the NCAA 
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sidechain and the pre-fluorophore being nonfluorescent, but becoming fluorescent upon 
conjugation (Song et al., 2008). Since these, in vivo incorporation of several different 
fluorescent amino acids has been accomplished using engineered OTSs, and been used in 
protein localization studies and NCAA environmental determination (Charbon et al., 
2011; Chatterjee et al., 2013; Summerer et al., 2006).  
1.2.2.4 Additional NCAA properties 
 Other useful chemistries have been engineered into the genetic code using 
NCAAs, including the incorporation of heavy atom containing amino acids, which have 
been used to solve the phase problem of proteins structure elucidation (Lee et al., 2009b; 
Sakamoto et al., 2009), and metal chelation (Lee et al., 2009b; Luo et al., 2016), which 
has been used to stabilize protein motifs.  
1.2.3 Conclusions 
Noncanonical amino acids allow for the incorporation of many useful chemistries 
into proteins as they are synthesize in vivo. While many NCAAs accomplish the same 
tasks as tradition protein modification techniques, NCAAs provide the combined benefits 
of being site specific, small, and efficient. As protein design and engineering becomes 
easier, the number of chemistries that can be engineered into the proteome will likely 
continue to expand. It may be possible to incorporate glycosylation without downstream 
chemistry, or FAD or NADH analogs, or even nucleobase amino acids. The limits of 
translational machinery are just beginning to be understood, and it’s possible even the 
current limitations can be overcome as computer modeling and additional OTS structural 
information data is collected from the many diverse life forms on earth.  
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1.3 EVOLUTION OF THE GENETIC CODE 
 Once deciphered, it was quickly realized that the genetic code is largely shared 
among all life (Hinegardner and Engelberg, 1963; Woese, 1964), though examples of 
minor modifications exists, including eukaryotic organelles (Barrell et al., 1979), and 
some fungi and bacteria (Fitzpatrick et al., 2006; Santos and Tuite, 1995; Yamao et al., 
1985). The universal genetic code is nonrandom, with spatially adjacent codons typically 
coding for the same or chemically similar amino acids. This has been hypothesized as an 
evolutionary mechanism to reduce the effects of translational errors or genomic 
mutations, and computational analysis has supported this hypothesis (Freeland and Hurst; 
Haig and Hurst, 1991). Despite the nonrandom nature of the code, computational 
modeling has identified further optimized table arrangements that could theoretically be 
achieved. Despite this, the code remains as it is, likely because mechanisms of codon 
reassignment make the evolutionary transition to these optimized codes prohibitory 
(Koonin and Novozhilov, 2009; Santos and Monteagudo, 2011). 
 While further optimized codes have been proposed, optimality is condition 
dependent, as can be seen through diverse phenotypes throughout biology. The 
conditions that existed and were responsible for shaping genetic code evolution are far 
different than those that exist today. Yet, the code suffices to maintain life in today’s 
environments. Understanding the level of code optimization in its current form requires a 
set of parameters that objectively define optimality.  Probably the most important feature 
is adoption of mutations. While mutation is the driving force behind evolution and 
required for changing organismal characteristics, most mutations are detrimental or lethal 
to the host. Adopting a code tolerant to mutation was likely a driving force in the 
arrangement of the code. A second feature to consider is translation errors, which is 
closely related to genomic mutations. Translation has evolved to be somewhat 
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ambiguous, with wobble pairing (Crick, 1966; Varani and McClain, 2000), and 
frameshift codons allowing alternate translations of the same mRNA sequence. These 
features appear counterintuitive or costly to the natural code yet they have persisted 
during evolution and are likely beneficial. Tolerance of these translational anomalies 
must play some role in the formation of the code.  
1.3.1 Amino acid evolution 
Understanding the evolution of the genetic code is simplified by considering the 
20 standard proteinogenic amino acids, as well as two sets of base-pairing nucleotides 
(adenine-thymine, and guanine-cytosine), and that codons are composed of triplet 
nucleotide sequences. Though a number of exceptions to these rules exist, and are 
addressed in this work, they can be viewed as evidence for evolutionary processes instead 
of complications of code evolution analysis. Early discussion on the evolution of the 
genetic code largely concluded that the code was frozen, and incapable of further 
changes. The freezing of the code happened after settling on the current 20 amino acid 
system and corresponding assignment of codons. Three theories have been proposed to 
describe the evolutionary processes that led to the current set of amino acids.  
1.3.1.1 Stereochemical theory 
One of the earliest hypotheses used to explain the evolution of genetic code was 
the stereochemical theory. The stereochemical theory proposes that the triplet codons 
have an inherent affinity for the amino acids they code for in the codon table. This is a 
satisfying theory when considering evolution in a ‘primordial ooze’, where a preliminary 
propensity for binding would allow the evolution of the two parts, anticodon and amino 
acid, in close physical proximity to each other. Significant efforts were made to explore 
this possibility, even with some potentially encouraging results showing anticodons were 
 21 
attracted to their associated amino acid (Pelc, 1965; Pelc and Welton, 1966; Saxinger et 
al., 1971). The discovery that DNA and RNA sequences could have structurally based 
specific binding to ligands (Ellington and Szostak, 1990, 1992) led credence to the idea 
that anticodons could have been early aptamers for amino acids, and some work showed 
aptamers against amino acids did enrich for sequences containing the anticodon coding 
for the amino acid (Knight and Landweber, 1998). Preliminary statistical analysis showed 
it unlikely that these occurred at random, through a more comprehensive analysis, 
considering features of the code as it exists, showed that these enrichments were likely 
just coincidence. The stereochemical theory, as proposed, has little evidence supporting it 
today.  
1.3.1.2 Adaptive theory 
 The vast increases in computational power over the last few decades have allowed 
for analysis of the genetic code in comparison to other codes which could have evolved. 
Quantitative features are required to compare the fitness levels of hypothetical codes 
against the standard code, and a number of approaches have been taken to examine the 
fitness of the code. Typically, physiochemical similarity of amino acids is used as a 
parameter, although the exact definition of physiochemical properties is unclear. While 
phylogenetic analysis, looking at which amino acids replace generally conserved residues 
is a protein, has been used to determine which amino acids are physiochemically similar. 
The utility of this method for characterizing amino acid similarity is dubious at best, as 
these mutations and substitutions are a product of the code, and thus are a poor way to 
define physiochemical similarity. Other approaches, including hydrophobicity index, and 
polar requirement scale have been used to characterize amino acids, though a precise, 
objective description of amino acid relatively has yet to be accepted. 
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 There is no doubt that the code is special. Compared to other randomized codes, 
the standard code has been estimated to have a one in a million odds of randomly settling 
in its current layout (Freeland and Hurst). This is largely because, despite the lack of a 
strict definition of physiochemical properties, generally similar amino acids share similar 
codons. Interestingly, the most important indicator of the physiochemical property of the 
coded amino acid is the central nucleotide of a codon, which has also been shown to be 
translated with the highest fidelity. Mistranslations of both the third and first nucleotides 
are more likely to mis-pair during translation (Kramer and Farabaugh, 2007; Parker, 
1989). This reduces the number of ‘crucial’ nucleotides in the codon from three to one, 
and would favor amino acids of similar properties to flow ‘down’ the codon table.  
 1.3.1.3 Coevolutionary theory 
Finally, the coevolutionary theory postulates that a prerequisite to amino acids 
adoption into the genetic code was the biosynthesis of the amino acid. It is probable that 
amino acids appeared in the genetic code in some temporal sequence, and did not all 
appear simultaneously. A number of amino acids are known to occur naturally under 
conditions that could have existed early in terrestrial history (Kobayashi et al.). While 
several amino acids could have been chemically synthesized in a prebiotic environment, 
many proteinogenic amino acids seen today likely required biosynthesis for existence at 
concentrations high enough for utility in biology. While it’s difficult to imagine that both 
biosynthesis of an amino acid and its use in the genetic code would occur simultaneously 
there are a few possibilities that could describe the evolutionary path. 
First, today there exist a number of nonproteinogenic amino acids that are 
biosynthesized and used as neurotransmitters (Misu et al., 2002), pigments (Roffler-
Tarlov et al., 2013), pheromones (Yambe et al., 2006), and defense mechanisms (Yeung 
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et al., 2002). The possibility that amino acids perhaps served alternative functions in pre-
code life, and were then coopted during evolution of the code is a clear possibility. In this 
instance, biosynthesis of an amino acid, (e.g. cysteine) would evolve, and free cysteine 
might be useful in some function in the proto-cell or cell (reducing agent). A second 
possibility would be the evolution of amino acid biosynthesis and the hijacking of a 
promiscuous aaRS would allow immediate incorporation into the code, and over time, 
differentiation between the two amino acids, and codons which code for each, could 
evolve. A third possibility postulates that new amino acids could be synthesized by 
modified, pre-charged tRNAs. This is seen extensively in nature (Sheppard et al., 2008), 
and some evidence suggests it as a mechanism during genetic code evolution (Francklyn, 
2003; Roy et al., 2003).  
1.3.2 Codon assignment evolution 
Once the extant amino acids were established as part of the code, rearrangement 
of the codon table itself could be used to optimize the code through mutational tolerance 
and misincorporation during translation. It has been postulated that codon reassignment 
with a new or existing amino acid would result in global replacement of an amino acid 
throughout a host genome and would be expected to severely compromise fitness or 
likely be lethal to the host organism (Crick, 1968; Hinegardner and Engelberg, 1963). 
While the basic structure of the genetic code is shared among all life, examples of 
alternate codes provide evidence of previous evolution, and even the current transitioning 
of codon assignment. Three theories attempt to explain codon assignment and evolution.  
1.3.2.1 Codon capture, or the disappearing codon 
 A prominent theory on codon reassignment is codon capture, which proposes that 
during evolution a codon can disappear entirely from a genome (Osawa and Jukes) 
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(Figure 1-7). Once the codon is extinct, the complementary tRNA is no longer necessary 
and may also be removed from the hosts genome. The codon can then reappear, along 
with the near simultaneous mutation of a tRNA, resulting in a complementary anticodon 
to the renewed codon, and the codon now codes for a different amino acid. This process 
is facilitated at small genome sizes, which makes extinction of a codon statistically more 
favorable. Evidence for codon capture includes the alternate assignment of UGA codons 
to signal tryptophan incorporation in the bacterial genus Mycoplasma, which have small 
genomes. The capture of UGA is largely facilitated by the existence of two alternative 
stop codons (UAG and UAA) which provide mutational destinations for any genomic 
UGA codons used for translational termination. In fact, Mycoplasma have no ORFs 
which terminate in UGA (Yamao et al., 1985). The UGA to UAA mutation requires a 
single, transitional mutation, which is a relatively favorable (Collins and Jukes, 1994). 
The result would be UGA to UAA, and would terminate protein synthesis in the same 
fashion as UGA codons, having little to no effect on translation or translated products. 
Once UGA was removed from the genome, a duplicated tryptophanyl-tRNA could 
acquire an anticodon mutation complementary to the UGA codon, which could still 
translate UGG tryptophan codons with wobble pairing. Any mutations which then 
introduced UGA codons to the genome would result in tryptophan incorporation, and 
evolution would occur with this redefined codon. Besides Mycoplasma, a number of 
other examples exist to provide evidence for the codon capture hypothesis, including 
mitochondrial genomes of animals and yeast (Inagaki et al., 1998; Macino et al., 1979). 
1.3.2.2 Ambiguous intermediate hypothesis 
 Another proposed mechanism to explain genetic code evolution is the ambiguous 
intermediate hypothesis. This explanation proposes that a tRNA mutation would provide 
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an alternate translational solution to a codon, in addition to its natural translation (Figure 
1-8). The codon would be read as either the traditional or the new amino acid each time it 
reached in the ribosome. Over time, the new tRNA could become the prominent 
translator, or the primary tRNA could be deactivated or removed from the genome, 
giving an alternative reading of the codon exclusively. Again, this example could occur 
with stop codons, which are not read by tRNAs, but with release factors. In this instance, 
an encountered stop codon could be read by the tRNA, or code for termination by a 
release factor, similar to NCAA incorporation methodologies. Evidence for the 
ambiguous intermediate hypothesis includes suppressor tRNAs. In E. coli, a number of 
UAG, UGA, and UAA complementary tRNAs are known to incorporate amino acids at 
canonical stop codons (Murgola, 1985). Additionally, in some Candida, CUG codons are 
read as leucine (the canonical translation) at low levels, but most often codes for serine, 
an alternative decoding of CUG (Suzuki et al., 1997). It’s possible that Candida could 
evolve to a strict serine translation over time. An ambiguous intermediate could also be 
used to explain the conversion of UGA codons in Mycoplasma.  
1.3.2.3 Genome streamlining 
 A third hypothesis in evolution of the arrangement of the genetic code is genome 
streamlining, which suggests there that genomes are under a pressure to reduce to a 
minimal necessary set of tools for survival (Giovannoni et al., 2005; Lynch, 2006; 
Massey and Garey, 2007). With the current code, reducing the number of degenerate 
codons and tRNAs is a simple, straightforward approach to genome streamlining. The 
clearest examples of genome streamlining include small genome bacteria and eukaryotic 
organelles including mitochondria and chloroplasts, which have greatly reduced the 
genetic code material in their genome.  
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1.3.3 Conclusions 
The genetic code evolved into its current form and likely went through 
transitional codes that contained a reduced number of amino acids and varied codon 
assignments. Multiple mechanisms have been theorized for the evolution of the genetic 
code, but evidence for them is limited to snapshots provided by the extant variations to 
the genetic code, and actual code evolution has been difficult monitor, either in situ or in 
the laboratory. It is likely that all proposed theories described above played roles in 
evolution. The extent that each affected, and currently affects genetic code evolution is 
unknown. Exploration of these theories is largely limited to computer modeling, as 
recoding the genetic code is onerous. Though, advancements in genetic code expansion, 
as well as evolutionary approaches are beginning to open the door to thorough 
investigations of genetic code evolution.  
1.4 EVOLUTION AND EXPANDED CODES 
Nature has evolved at least two different expansions to the standard genetic code, 
with stop codon incorporation of selenocysteine and pyrrolysine. Selenocysteine 
incorporation has evolved with a complex regulatory pathway, establishing two unique 
conditions for the possible decoding of UGA codons: selenocysteine incorporation of 
termination. Selenocysteine is used throughout all domains of life, and has found uses in 
a number of biological functions. Alternatively no regulatory elements have been 
discovered for pyrrolysine, and so UAG codons are read ambiguously (Théobald‐Dietrich 
et al., 2004). Despite this, pyrrolysine has a single known purpose, and UAG codons have 
not appeared throughout the genome of pyrrolysine encoding archaea or bacteria, in fact, 
most in-frame UAG codons in archaea are followed closely by UGA or UAA codons 
(Zhang et al., 2005). So, with two available translations of UAG, pyrrolysine 
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incorporating archaea appear to have eliminated UAG suppression necessity, if not actual 
termination. 
Evolution with expanded or altered genetic codes using NCAAs has not been 
greatly explored, with most examples having been accomplished very recently. 
Experimental evaluation of the proposed evolutionary theories is the ideal tool to explore 
methods of evolution. Expanded genetic codes, and NCAAs in general, provide a toolkit 
for the exploration of genetic code evolution. Two general methodologies have been 
proposed to explore evolution using an expanded genetic code as defined by (Bacher et 
al., 2004): a top-down method, where an organism is required to evolve in order to 
survive in an altered or expanded amino acid environment, and the bottom-up method, 
using rational engineering of the genetic code.  
1.4.1 Top-down genetic code evolution 
Biology has evolved exclusively using the standard genetic code, generally 
limited to the 20 standard proteinogenic amino acids, with exceptions to reach 22. These 
amino acids are sufficient for the rapid adaption to a range of unfavorable conditions. 
Short and long term evolutionary experiments have found that bacteria quickly evolve 
when they encounter non-ideal growth conditions. Examples include the evolution of 
ethanol tolerance (Goodarzi et al., 2010), butanol tolerance (Smith and Liao, 2011), 
thermal tolerance (Rudolph et al., 2010), and antibiotic resistance (Petrosino et al., 1998). 
When faced with challenges nature evolves, and thus evolutionary pressure with an 
altered amino acid pool is a reasonable approach to study the adoption of altered genetic 
codes.  
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1.4.1.1 Evolution with an altered set of amino acids 
While the genetic code was considered frozen, an early test of genetic code 
flexibility demonstrated that the eubacteria Bacillus subtilis rapidly adapted to an 
alternate genetic code (Wong, 1983). By simply excluding tryptophan and including of 4-
fluoro-tryptophan (4FW) in growth media, and providing a means to increase the rate of 
genomic mutation, cells coopted the new amino acid into their genome. Cells not only 
tolerated the new amino acid, but became dependent on 4FW for growth and survival, 
eventually preferring 4FW to tryptophan. To some extent, the adoption of 4FW does not 
seem surprising, as 4FW and tryptophan vary only by the replacement of a hydrogen with 
a tryptophan, with minimal effect on structure, shape, or size. Yet, the polarity is altered 
significantly, and 4FW is insufficient for sustaining growth of wild-type B. subtilis, and 
reduces some enzymatic activity by greater than 90% (Pratt and Ho, 1975). The 4FW 
dependent B. subtilis has recently been genome sequenced and characterized, in an 
attempt to understand mechanisms for the adoption of augmented genetic codes. 
Surprisingly, few mutations were needed to replace genomic tryptophan with 4FW (Yu et 
al., 2014). Hence, the 14600 predicted tryptophan incorporation sites were generally 
amenable to 4FW replacement, demonstrating the malleability of the genetic code in a 
natural organism; the entire code rapidly adapted to a new amino acid environment.  
A similar undertaking using E. coli seems to demonstrate that the code is not . 
Rounds of selection on 4FW resulted in a strain that could largely tolerate 4FW 
throughout the genome, but still grew significantly better with tryptophan. Despite a lack 
of complete acceptance, the strain still began adopting to the new code, with genomic 
modifications in tryptophan transporters and the tryptophanyl-synthetase contained 
mutations presumably to build a tolerance for the new amino acid. The resistance to 
adopt the new amino acid in E. coli was surprising, given the rapid acceptance in the 
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genome of B. subtilis. Evolutionary adoption of new amino acids is perhaps dependent on 
the overall growth environment (Bacher et al., 2004), selection conditions, and the 
organism itself.  
A third attempt at adopting new amino acids into the genome by evolution using 
the bacteriophage Qβ showed that the phage rapidly adapted to 6-fluorotryptophan in 
place of tryptophan (Bacher et al., 2003a). A number of mutations that were found did 
not alter the ratio of tryptophan codons throughout the genome, but were adaptations to 
the replace of tryptophan with the analog 6-FW throughout the genome. Mapped 
mutations were largely involved the metabolism of tryptophan. Characterization of the 
proteome revealed 6FW incorporation, along with tryptophan, throughout the genome. 
These results again supported the hypothesis of ambiguously read intermediate codons 
during evolution.  
1.4.2 Conclusions 
While only a limited data exists, the experimental evidence discussed above 
supports the ambiguous intermediate hypothesis of codon evolution. B. subtilis and the 
bacteriophage Qβ rapidly adapted to new amino acids, altering the genome to tolerate 
these NCAAs were possible over relatively short evolutionary timeframes. These 
examples required no engineering of translational machinery, but instead demonstrate the 
ability of nature to adapt to new genetic codes without any rational engineering.  
1.4.2 Bottom-Up genetic code design and evolution 
Biotechnological advances in genetic engineering have led to site specific 
incorporation of unique chemistries in vivo using NCAAs. The OTSs used for NCAA 
incorporation are engineered for minimal interference with the host genome and are 
specific for the desired NCAA. While OTSs allow the incorporation of additional amino 
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acids, usually at amber stop codons, further attempts to engineer the genetic code involve 
the removal of release factor mediated termination, as well as the removal of entire 
codons throughout a genome. These efforts mirror the theory of the codon capture 
hypothesis of evolution. 
1.4.2.1 OTS engineering 
The simplest form of bottom-up genetic code evolution is engineering OTSs. The 
recoding of UAG codons for NCAA incorporation has been discussed in detail above. 
But, briefly, as the top-down approaches represent ambiguous intermediate hypothesis, 
OTS incorporation of NCAAs represent the codon capture hypothesis, using a codon 
unassigned for translation (UAG), and repurposing it for NCAA incorporation. While 
technically still ambiguous, as the codon can be read as ‘stop’ or NCAA, further genomic 
engineering made the full transition to codon capture possible.  
1.4.2.2 Removing codon competition at UAG 
In E. coli, the competition between release factor one and suppressor tRNAs 
results in reduced translational efficiency of UAG codons by complementary tRNAs. The 
simplest solution is deletion of prfA, the gene encoding release factor one. Release factor 
one is responsible for recognition of UAG codons in the ribosome, and completing 
translational termination. Temperature sensitive versions of prfA demonstrated that stop 
codon suppression could be substantially increased by release factor one inactivation 
(Rydén and Isaksson, 1984), but failed attempts to fully remove prfA from the genome 
suggested that prfA was essential in wild-type E. (Baba et al., 2006; Gerdes et al., 2003). 
Since these initial attempts, several elegant solutions have been found to circumvent this 
essentiality of prfA, allowing genomic knockouts and near cognate translation of UAG 
codons in the ribosome.  
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The first successful prfA knockout required the encoding of seven essential genes 
which terminate with amber codons in genome to be given the alternative termination 
codon TAA on a bacterial artificial chromosome (Mukai et al., 2010). While the 
remainder of the genomic TAG codons did not require recoding or supplementation, the 
strain required UAG suppression to survive. It is hypothesized that secondary stop 
codons, often found within 3 to 10 triplets of genomic TAG codons terminate most 
translating genes, allowing them to retain protein function. Subsequent investigation 
showed that only one of the seven BAC supplemented genes was necessary for cellular 
viability (Mukai et al., 2010). Removal of prfA allowed for greatly improved NCAA 
incorporation at UAG codons (Figure 1-6). 
Later attempts to knockout prfA used a particular feature of release factor two 
(prfB) (Johnson et al., 2011). In E. coli, release factor one is responsible for recognition 
and termination and amber (UAG) and ochre (UAA) codons, while release factor two 
recognizes and terminates at ochre (UAA) and opal (UGA) stop codons. Using a E. coli 
strain with a minimalized genome (Pósfai et al., 2006), and “fixing” prfB, the prfA gene 
could be excised successfully. Fixing of prfB required only the removal of an in-frame 
UAG codon, used as an autoregulatory element, and introducing a T246A mutation, 
which together increased prfB expression and allowing enhanced recognition of ochre 
codon and likely prevented amber codon stalling in the ribosome. This demonstration 
was largely recapitulated in full genome of E. coli by simply using a B strain E. coli, 
which code for A246 naturally (Johnson et al., 2012). Even though these strains were 
capable of survival and reproduction, the fitness of these release factor one knockouts 
was severely compromised. 
More recently, radical engineering of an E. coli BL21 genome allowed for the 
deletion of release factor one with the reassignment of 95 genomic amber codons to 
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alternative stop codons, while leaving the remaining 178 TAG codons in the genome. 
This allowed for the simple knockout of prfB with minimal growth effects (Mukai et al., 
2015).  
1.4.2.3 Engineering genomes for unassigned codons 
While near cognate decoding of the amber codon can be accomplished with prfA 
knockout strains, the remaining genomic UAG codons must be suppressed with NCAAs, 
reducing the site specificity and possibly impacting general fitness of the organism. The 
solution to these issues is the recoding of an entire genome to remove all UAG codons. 
This was largely made possible by the degeneracy of the codon table, the presence of 
alternative stop codons, and multiplexed automated genome engineering (MAGE), which 
streamlines the editing of multiple targets across a genome (Wang et al., 2009). By 
systematically removing UAG codons from the genome, prfA could be removed without 
the requirement for an externally supplemented OTS or UAG suppressor tRNAs (Lajoie 
et al., 2013). This strain (C321.ΔA) is largely unaffected by encoded OTSs or NCAA 
incorporation. 
The generation of the genetically recoded genome of E. coli C321.Δ has 
demonstrated that redundant codons can be removed from the genome with minimal 
effect. While 64 codons are available in the codon table, they code only for 20 standard 
amino acids. The degeneracy of the codon table suggests that other codons could be 
recoded to synonymous codons with little effect on the host. In theory, the total number 
of codons could be reduced to as few as 21, 20 coding for the standard amino acids (one 
for each amino acid), and one signaling termination, although this is complicated with 
wobble pairing. This would allow multiple NCAAs to be incorporated at unique sites 
throughout the genome, providing a platform for in the incorporation of interacting 
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NCAAs (i.e. alkyl/alkyne NCAAs to perform click chemistry in vitro) while being 
bioorthogonal to all natural host chemistries. While a number of methods have been 
demonstrated to incorporate multiple unique NCAAs in vivo, they often require 
inefficient methodologies including quadruplet codon and rare codon suppression 
(Neumann et al., 2010). As the number of available NCAAs increases, the need for more 
codons for NCAA incorporation increases. More recently, progress has been made 
towards entirely removing seven rare codons from the genome of E. coli, opening 
translational space for the site specific incorporation of multiple amino acids in a single 
host (Ostrov et al., 2016).  
1.4.2.4 Evolutionary studies with unassigned codons 
The first real demonstration of genetic code evolution with an unassigned codon 
use a prfA knockout strain of E. coli and the T7 bacteriophage phage. Despite the 
removal of prfA from the genome, and the requirement for UAG suppression for survival, 
incorporated OTSs lose activity in hosts relatively quickly. A simply method to ensure an 
OTS remains functional over evolutionary timepoints is to ‘refresh’ the OTS. While most 
cellular life is not amenable to genetic ‘refreshing,’ phage function with the genetic code 
of the host, and switch to new hosts often. By harboring the OTS in the phage host, (E. 
coli), the phage has a continuously active OTS after each transfection, and thus always 
has a functioning OTS. Using this, T7 bacteriophage utilized an expanded genetic code to 
reach new fitness peaks (Hammerling et al., 2014). This was conducted with the 
relatively inert amino acid 3-iodo-tyrosine, but was still found to provide distinct 
advantages that was not be accomplished with the standard amino acids.  
 In another recent study using C321.Δ, it was demonstrated that expanded codes 
can provide new methods to rifampicin resistance, a phenotypic trait which is 
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representative of a potential beneficial trait in nature. By evolving E. coli with an 
expanded genetic code, using the UAG codon as a cognate codon, the code landscape 
was altered, which provided a new mutational path rifampicin resistance (Hammerling et 
al., 2016).  
 The full implications of expanded genetic codes, both of biological function and 
exploration of genetic code evolution, have yet to be realized. Few examples exist, all of 
them reviewed above, that use NCAAs to explore evolution, and more information is 
needed to fully understand the mechanisms nature uses to evolve new codes, or how it 
adopts new codes once they exist.  
1.4.3 Center-out evolution 
A significant portion of this dissertation (Chapter 3, Chapter 4, and Chapter 5) 
focuses on an intermediate between top-down and bottom-up evolutionary approaches to 
expanded genetic codes. The approach described here, which I’ve labeled as ‘center-out,’ 
uses an engineered genetic element to enforce and OTS into the genome of a host cell 
indefinitely. Engineering the OTS and tool to enforce the OTS falls squarely in the 
‘bottom-up’ camp, yet these tools provide a means to explore evolution from the ‘top-
down’ by evolving the organism with its newly expanded genetic code, providing a 






Figure 1-1: Canonical proteinogenic amino acids  
The 20 canonical proteinogenic amino acids shared among all life, as well as the two rare 






Figure 1-2: The standard codon table with variations  
The standard codon table, with start codons marked in green, and stop codons marked in 
red. Pyrrolysine (Pyl) and selenocysteine (Sec) codons are marked in blue, and are 
incorporated at stop codons. Mycoplasma have inverted codon assignments in the yellow 





Figure 1-3: NCAA incorporation by the ribosome  
The simplest method to expand the genetic code in vivo involves the expressions of 
heterologous aaRS/tRNA pairs in a host cell. The NCAA is charged to a tRNA that 
complements the amber (UAG) stop codon by the engineered aaRS (Figure 1-4). When 
the ribosome encounters the UAG codon, two different translational events can occur: a) 
(top pathway) the NCAA charged tRNA is used to translate UAG and the NCAA is 
inserted into the peptide and translation continues, or b) the traditional reading of the 
UAG codon (bottom pathway), release factor 1 (RF1) terminates translation, and the 






Figure 1-4: Engineering orthogonal translation systems 
A heterologous aaRS expressed in a host cell is engineered for specificity to its 
corresponding tRNA, as well as the desired NCAA. The aaRS should not interact with 
host tRNAs. Endogenous aaRSs do not charge the heterologous tRNA, or the 
supplemented NCAA. A lack of interaction between the translation systems 
(heterologous translational machinery and endogenous translational machinery), are 






Figure 1-5: Structure of M. jannaschii tyrosyl-synthetases  
The crystal structure of the M. jannaschii tyrosyl-tRNA synthetase (pink), aligned with 
the same synthetase engineered for specific recognition of the NCAAs 3-nitro-L-tyrosine 
(green), and 3-iodo-L-tyrosine (teal). The amino acid binding pockets of the synthetases 






Figure 1-6: Release factor 1 knockouts improve NCAA incorporation efficiency 
Over the last 10 years, methods to knockout prfA from the E. coli genome have greatly 
increase NCAA incorporation efficiency. With prfA removed, UAG codons are only 
recognized by OTS suppressor tRNAs. This results in ~100% incorporation efficiency of 







Figure 1-7: Codon capture of amber codons 
Codon capture has been theorized as a method for genetic code evolution. Codon capture 
has been synthetically accomplished with genetically recoded organisms, specifically 
C321.Δ. During codon capture, a codon, the TAG stop codon in this example, becomes 
removed from the genome during evolution or through genome engineering. Its 
translational machinery is no longer necessary and is removed from the genome, release 
factor one in this example (a tRNA could be removed if a cognate codon went extinct). A 
new translator for the codon, here an OTS, appears and evolution TAG codons appear in 





Figure 1-8: Ambiguous intermediate transition of amber codons 
Ambiguous intermediate codons have been proposed as a mechanism in genetic code 
evolution. In this example a cell acquires an OTS, and UAG codons are translated 
ambiguously as termination codons, recognized by release factor one, or as cognate 
codons for NCAA incorporation. Over evolutionary time periods, either the OTS or 
release factor one are removed from the genome, and UAG codons are exclusively 




CHAPTER 2: Structure-based noncanonical amino acid design to 
covalently crosslink an antibody–antigen complex1 
Engineering antibodies to utilize non-canonical amino acids (NCAAs) should 
greatly expand the utility of an already important biological reagent. In particular, 
introducing crosslinking reagents into antibody complementarity determining regions 
(CDRs) should provide a means to covalently crosslink residues at the antibody–antigen 
interface. Unfortunately, finding the optimum position for crosslinking two proteins is 
often a matter of iterative guessing, even when the interface is known in atomic detail. 
Computer-aided antibody design can potentially restrict the number of variants that must 
be explored in order to identify successful crosslinking sites. We have therefore used 
Rosetta to guide the introduction of an oxidizable crosslinking NCAA, L-3,4-
dihydroxyphenylalanine (L-DOPA), into the CDRs of the anti-protective antigen scFv 
antibody M18, and have measured crosslinking to its cognate antigen, domain 4 of the 
anthrax protective antigen. Computed crosslinking distance, solvent accessibility, and 
interface energetics were three factors considered that could impact the efficiency of 
DOPA-mediated crosslinking. In the end, 10 variants were synthesized, and crosslinking 
efficiencies were generally 10% or higher, with the best variant crosslinking to 52% of 
the available antigen. The results suggest that computational analysis can be used in a 
pipeline for engineering crosslinking antibodies. the rules learned from DOPA 
crosslinking of antibodies may also be generalizable to the formation of other crosslinked 
interfaces and complexes. 
                                                 
1 Xu, J., Tack, D., Hughes, R.A., Ellington, A.D., Gray, J.J. (2014). Structure-based non-canonical amino 
acid design to covalently crosslink an antibody-antigen complex. J Struct Biol. 185(2): 215-222. I, Drew 
Tack, was responsible for experimental design and execution in this chapter, I also contributed to writing 
the manuscript.   
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2.1 INTRODUCTION 
2.1.1 Background and Rationale 
2.1.1.1 Computational improvement of antibodies 
Antibodies are key components of the immune system with broad diversity to 
recognize a variety of antigens. Antibody-based therapeutic, diagnostic, and industrial 
applications frequently require antibodies having high stability and strong binding 
affinity. With the development of computational techniques and a number of successful 
experiences in protein modeling and design (Lippow and Tidor, 2007; Mandell and 
Kortemme, 2009), computational antibody design has begun to play an important role in 
predicting improvements to antibody function. Computational design of antibodies has 
been used to enhance binding affinity (Barderas et al., 2008; Clark et al., 2006; Lippow et 
al., 2007), to improve stability by improvement of thermal tolerance or aggregation 
resistance (Chennamsetty et al., 2009; Miklos et al., 2012), to alter binding specificity 
(Farady et al., 2009), and others (A. Caravella et al., 2010; Kuroda et al., 2012; Midelfort 
et al., 2004; Pantazes and Maranas, 2010).  
To date, most computational design methods have focused on manipulating the 
twenty natural proteinogenic amino acids to modify molecular forces such as 
electrostatics (Lippow et al., 2007), hydrophobic interactions (Chennamsetty et al., 2009), 
hydrogen bonds (Clark et al., 2006), and salt bridges (Miklos et al., 2012). However, 
recent advances in engineering the translation system have now allowed for the site-
specific insertion of non-canonical amino acids (NCAAs) with a variety of functionalities 
into proteins with good efficiency (Wang et al., 2006b; Xie and Schultz, 2006). Such 
NCAAs can be used to improve the stability and pharmacokinetics of therapeutic proteins 
(Cho et al., 2011), to augment binding (Liu et al., 2009), and to provide a myriad of 
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chemical handles to study protein structure and function (Jones et al., 2009; Tsao et al., 
2006; Zhang et al., 2002). 
2.1.1.2 The Potential of NCAAs in antibody design 
The generation of protein-protein crosslinks by inserting NCAAs into proteins 
could prove useful for a variety of applications. To this end, a number of crosslinking-
capable NCAAs have been incorporated into proteins in a site-specific manner utilizing 
an array of functionalized amino acids. These crosslinking functionalities include photo-
crosslinkable aryl-azides (Chin et al., 2002a), benzophenones (Chin et al., 2002b) and 
diazirines (Ai et al., 2011) as well as the oxidizable crosslinker, L-DOPA (Alfonta et al., 
2003). While any of the crosslinkers might benefit from a quantitative placement 
methodology, we chose L-DOPA because the periodate induced oxidation would allow 
for more control over the crosslinking conditions compared to the photo-inducible 
crosslinkers which could spuriously crosslink during sample handling (Chin et al., 
2002b). In addition, the nucleophile-driven cross-linking mechanism of L-DOPA has 
been extensively characterized with every available proteinaceous nucleophile (Liu et al., 
2006).  
2.1.1.3 Utility of L-DOPA crosslinking  
L-DOPA has previously been used to successfully crosslink the monomeric 
domains of a dimeric sortase A for structural studies (Umeda et al., 2009), to enhance the 
affinity of low-affinity peptide probes for a kinase SH3 bioassay (Umeda et al., 2010), 
and to site-specifically label proteins with polysaccharides (Ayyadurai et al., 2011). 
While previously reported use of L-DOPA as a site-specific crosslinker has yielded 
examples of effective crosslinking (as shown on SDS-PAGE gels or Western blots), the 
quantization of the efficiencies of these crosslinking events have not been reported 
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(Burdine et al., 2004; Umeda et al., 2009, 2010). These previous reports indicated that it 
is possible to place L-DOPA by intuition, but the placement parameters as they relate to 
crosslinking efficiency are unknown (Umeda et al., 2009, 2010). 
L-DOPA crosslinking to map the antibody-antigen interface 
In this paper, we explore using the Rosetta suite of computational protein design 
tools to predict the site-specific incorporation of L-DOPA into an antibody-antigen 
complex. A better understanding of where and how to insert crosslinking moieties into an 
antibody CDRs could lead to the development of tools for validating antibody-antigen 
structural models and reagents capable of binding analytes with extremely high affinities 
and specificities. As a proof-of principle demonstration, we chose a complex with a 
known structure, the anti-anthrax antibody M18 bound to anthrax protective antigen (PA) 
(Leysath et al., 2009). PA is a component of the tripartite toxin secreted by Bacillus 
anthracis. It binds to cellular receptors and assists host cellular targeting and transport of 
the lethal factor (LF) and edema factor (EF) into cytoplasm (Moayeri and Leppla, 2004; 
Young and Collier, 2007). M18 is an affinity-improved neutralizing antibody (Leysath et 
al., 2009) engineered from monoclonal antibody 14B7 (Harvey et al., 2004; Little et al., 
1988), which binds to the fourth domain of PA (PAD4) and effectively blocks PA 
binding to cellular receptors such as CMG2 to mitigate anthrax toxicity. The success of 
the computational predictions for the L-DOPA mediated crosslinking of M18-PAD4 is 
not only useful for the design of better antibody therapeutics, but also helpful to improve 
antibody-based biosensors for anthrax detection (Kim and Yoon, 2010) and beneficial to 
the development of better antibody epitope mapping techniques via chemical crosslinking 
and mass spectrometry (Pimenova et al., 2008).  
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2.2 APPROACH 
We wished to test whether we could use computational design for the precise 
placement of crosslinks between antibodies and antigens. Our general approach was to 
use simple criteria and the Rosetta suite of software (Kaufmann et al., 2010; Leaver-Fay 
et al., 2011) to identify where we might place the NCAA L-DOPA, which is activated 
when oxidized by periodate to form the ortho-quinone. (Burdine et al., 2004; Liu et al., 
2006) The ortho-quinone is susceptible to nucleophilic attack, and can crosslink to a 
variety of nucleophilic, proteinogenic amino acids, in particular the histidine imidazole 
and the ϵ-amine of lysine. Thus, we first used Rosetta to build structural models of the 
antibody-antigen complex with candidate L-DOPA mutations, using energy parameters 
and rotamer libraries recently developed for NCAAs (Renfrew et al., 2012). For each L-
DOPA position on the antibody, we evaluated various biophysical measurements that 
might affect crosslinking to an adjacent histidine or lysine on the bound antigen. The 
incorporation of L-DOPA into proteins was accomplished using an evolved tRNA 
synthetase from Methanacoccus jannaschii that when expressed in E. coli can 
specifically charge a suppressor tRNA with L-DOPA (Alfonta et al., 2003) . In the 
following sections we detail each of these steps. 
2.2.1 Biophysical Criteria for Rational Design 
2.2.1.1 Initial Choice of Residues for L-DOPA Substitution 
The X-ray structure of the M18-PAD4 complex, solved at 3.8 Å resolution (PDB 
ID 3ETB), reveals a binding interface of ~1700 Å2, with roughly equal contributions 
from the M18 light and heavy chains. All M18 antibody CDR loops except L3 contact the 
antigen, and CDR loops H3 and L2 appear to have the strongest interaction with PAD4 
(Leysath et al., 2009). Histidine and lysine residues are the only nucleophiles present on 
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the antigen surface, however only lysine residues are near the epitope (Figure 2-1). To 
identify candidate positions, we selected all pairs of antigen nucleophilic residues and 
antibody residues that have atoms within 10 Å. Thus, we considered three nucleophilic 
lysines, PAD4 residues K684, K679 and K653, as crosslinking targets for sixteen 
possible L-DOPA locations on the antibody (thirteen on the heavy chain and three on the 
light chain).  
Several biophysical parameters can be suggested as criteria for the evaluation and 
prediction of sites for L-DOPA insertion. First, the distance between the L-DOPA mutant 
and the reactive antigen nucleophilic residue should be close enough for them to react. 
Second, L-DOPA should be introduced to the antibody position where it is exposed to the 
solvent, so that periodate anions can access the reaction pair and trigger the reaction. 
Third, the original binding of M18/PAD4 should not be affected by the introduction of L-
DOPA, meaning the interface must be compatible with it, or the change of interface 
energy should be moderate. Each of these criteria will be examined in turn as the basis 
for design.  
2.2.1.2 Crosslinking Distance between L-DOPA and Nucleophile 
The most obvious structural criterion for L-DOPA crosslinking is that the residue 
must be close enough to a nucleophile to crosslink. To assess this criterion, we took those 
L-DOPA atoms that were already within 10 Å of a lysine, as measured from Cβ to Cβ, and 
further calculated the distance between C2, C5, and C6 on the ring and the lysine Nϵ 
atom. In preliminary calculations, Rosetta tended to extend both L-DOPA and lysine 
residues into solution, and thus the calculated distances would exclude the possibility of 
crosslinking. To bring the reactive atoms closer, we optimized side-chain conformations 
using an energy function augmented with a constraint potential (see Methods). The 
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crosslinking distance thus obtained, dXL, varied from 2.9 to 9.8 Å (Table 2-1). For 
comparison, we also analyzed one L-DOPA substitution at position far from the interface 
(L_D17, dXL = 32.1 Å). 
2.2.1.3 Solvent Accessibility of L-DOPA 
A second hypothesis is that a good crosslinking site needs access to the solvent so 
that the L-DOPA can be easily oxidized by periodate anions. In the presence of periodate, 
the hydroxyl groups on the phenolic ring of the encoded L-DOPA on M18 are oxidized to 
form the quinone intermediate, which activates the ring for potential nucleophilic attack 
by a neighboring lysine nucleophile on PAD4. We chose two methods to quantify the 
degree of solvent exposure. First, a simple metric was to count of the number of 
neighboring antibody and antigen atoms within 3 Å of the L-DOPA side chain. Mutants 
predicted to have fewer neighboring atoms were expected to have better chances for 
effective crosslinking. Second, the solvent-accessible surface area was calculated using a 
1.4 Å probe. Both calculations were performed on the structure of antibody-antigen 
complex in which the L-DOPA and neighboring residue side chains were optimized by 
packing from a rotamer library using standard Rosetta “fixbb” protocol to find an 
energetically favorable conformation (see Computational Methods). We ultimately 
sought to test whether there was a minimal solvent accessibility or whether crosslinking 
would improve as solvent accessibility increased (Table 2-1). 
2.2.1.4 Mutant Interface Compatibility 
While it is difficult to computationally determine the impact of L-DOPA 
substitution on antigen binding, we tested whether Rosetta’s estimated energetics of the 
substituted interface would be helpful. Two energy measures were tested. First, we 
hypothesized that a successful crosslink would require that the introduced L-DOPA 
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would not disrupt the favorable energy of interaction between the antigen and antibody. 
We therefore calculated the interface score, Isc, a measure used in docking calculations to 
approximate a binding energy (see Methods) (Chaudhury and Gray, 2008; Chaudhury et 
al., 2011). Data from docking 116 complexes (Chaudhury et al., 2011) indicate that most 
protein-protein complexes have negative interface scores in the range of -4 to -12 Rosetta 
Energy Units (REU), and comparisons to experimental alanine mutants suggest that 
changes in interface scores above +1 REU are likely to characterize mutations that will 
significantly reduce binding affinity (Kortemme and Baker, 2002). One complication is 
that NCAAs necessitate use of a Rosetta force field variation. In the case of the M18-
PAD4 complex, the predicted interface score was -21.6 with the Rosetta’s (standard) 
score12 and +2.7 with the NCAA score function, mm_std. The mm_std interface scores 
of the L-DOPA substituted variants ranged from -1.4 to 4.8 REU, with most interface 
scores being slightly positive, indicating that the L-DOPA mutated M18-PAD4 complex 
may be slightly disfavored.  
A second energetic hypothesis is that an activated conformation with proximity 
between L-DOPA and the target lysine should be energetically accessible. Thus, we 
evaluated the interface score for the structure we generated with the crosslinking 
constraint that brought the reacting atoms together (I_sc^constr; see Methods). Table 2-1 
shows that these values vary from -0.6 to over 150 kcal/mol, showing that some cases 
exhibit significant energetic perturbations (e.g. H_D56) and even atomic clashes (H_R99 
or H_D54) when the L-DOPA/Lys pair is constrained. 
2.2.2 Crosslinking Studies 
As the generation of a large series of point mutants for crosslinking studies is 
impractical, we selectively tested candidate mutations based on their predicted placement 
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within the protein-protein interface. We anticipated that the distance between the L-
DOPA and a lysine nucleophile was likely to be the most critical parameter for successful 
crosslinking. Therefore, we made the closest eight substitutions within M18 (Table 2-1) 
(crosslinking distance of between 2.9 and 8.3Å), excluding only H_R99 because the high 
constrained interface energy (I_sc^constr) suggested that it would bind antigen poorly. 
As controls for the crosslinking distance, two additional mutants were made by placing 
L-DOPA at two distance-extended locations at H_I51 (9.8 Å, solvent excluded) and 
L_D17 (32.1 Å, solvent exposed) within the antibody structure.  
The recombinant M18 antibodies were expressed in the periplasm of E. coli as a 
28.9kDa single-chain variable fragment (scFv) with a N-terminal FLAG epitope tag and a 
C-terminal His tag to enable purification via immobilized metal affinity chromatography 
(IMAC). The FLAG tag allows ready detection of the antibody via Western blot analysis. 
Similarly, the PAD4 antigen was expressed as a 17.5kDa protein with a C-terminal His 
tag to enable purification of the antigen via IMAC. L-DOPA was introduced site-
specifically into the chosen sites in the CDRs of M18 by changing the codon for the 
naturally occurring amino acid at these positions to an Amber (TAG) stop codon. The 
M18 amber variants were then co-expressed with an orthogonal tRNA suppressor and 
tRNA synthetase pair that had previously been evolved to be specific for L-DOPA 
(Alfonta et al., 2003). Each M18 variant was incubated with PAD4, and crosslinking was 
catalyzed by the addition of sodium periodate. Crosslinking between predicted L-DOPA-
containing M18 variants and PAD4 was probed and quantitated using a Western blot 
assay specific to the FLAG epitope tag (Figure 2-2). A covalent crosslink between 
antibody and antigen was apparent by a shift in the molecular mass of the antibody. The 
efficiency of crosslinking was determined by the percentage of antibody that underwent a 
mass shift. Each variant was tested a minimum of two times. The long-distance 
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crosslinking controls (H_I51 and L_D17) showed no appreciable crosslinking (< 3%), 
and eight of the substitutions exhibited crosslinking values ranging from 5% to 55% 
(Table 2-1). 
2.2.3 Correlations between Rosetta criteria and crosslinking 
We can inspect the biophysical criteria and determine whether and how they 
impact crosslinking efficiency. Figure 2-3 shows the plots of each of the five biophysical 
criteria described above versus the experimentally observed crosslinking extent. 
Crosslinking efficiency drops off appreciably (< 3%) at distances greater than 7 Å [e.g. 
variants H_G55 (8.3Å), H_I51 (9.8Å), and L_D17 (32.1 Å)] relative to L-DOPA 
substitutions that are predicted to lie closer to lysines (Figure 2-3a). There is no 
correlation between solvent accessibility measures and crosslink efficiency when all data 
are considered (Figure 3b and Figure 2-3c). However, when the points representing 
mutants with high crosslinking distance are excluded (black in Figure 2-3b and Figure 
2-3c), both the number of residues that surround an L-DOPA substitution and solvent 
accessible surface area (SASA) are show a relationship to crosslinking efficiency (Figure 
2-3c). In particular, variants H_Y52 and H_W33, with SASA of only 25.1 and 14.1 Å 
respectively, have the lowest crosslinking efficiencies (19.7% and 13.9%, respectively) 
among all variants with dXL under 7 Å. 
The energetic parameters do not provide clear trends for the analysis (or 
prediction) of crosslinking efficiency even after filtering for distance and solvent 
accessibility (Figure 3d and Figure 3e). However, it is notable that the two most 
efficient crosslinking sites (H_S31 and H_G53) have low energies (I_sc and I_sc^constr 
of 1 REU or less in both cases). At best, we can say that by also choosing positions that 
pass the energy filter, we, in general, identify variants that exhibit efficient crosslinking. 
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Overall, these plots emphasize the key importance of distance, followed by solvent 
accessibility, in identifying positions capable of significant crosslinking.  
2.2.4 Interface Structure of a successful crosslinking case 
Figure 2-4 shows a detail of the structural model of the best crosslinking case 
with the L-DOPA mutant at position H_S31 targeting the lysine at position 679. This 
mutant exhibits 52% crosslinking (standard deviation 12%). The crosslinking distance is 
a moderate 5.7 Å, and the SASA of 132 Å2 shows good solvent accessibility. The 
calculated interface energies of Isc = 0.7 REU and I_sc^constr = -0.6 REU suggest that 
both the unconstrained and constrained conformations are energetically favorable in the 
context of the bound antibody-antigen complex. As seen in Figure 2-4, the aromatic 
carbon atoms C2, C5, and C6 are all positioned for nucleophilic attack by the amine. 
2.3 DISCUSSION 
The insertion of new, functional amino acids into proteins, even proteins of 
known structure, remains an enterprise that is fraught with uncertainty. While there have 
been several successful demonstrations of the rational placement of crosslinking amino 
acids into proteins (Alfonta et al., 2003; Forné et al., 2012; Sato et al., 2011; Umeda et 
al., 2009, 2010), to date there has not been a thorough analysis of how a detailed 
structural modeling might be used to guide the placement of amino acids that would 
crosslink efficiently. Currently, placement of an NCAA into a protein is based on 
intuition and no computational tools exist to guide the design of crosslinks. A set of 
computational tools that can streamline the design process while preserving the target 
protein function and enhancing the functionality of the introduced NCAA would be 
extremely desirable for the engineering of proteins and protein based materials.  
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As a first step towards the development of tools for the engineering of proteins 
containing abiotic functionalities, we sought to develop a rational rules-based approach 
for the placement of a novel NCAA within a protein-protein complex. To do this, the 
parameters affecting the placement of a functionalized NCAA (L-DOPA) and its ability 
to effectively perform its function (i.e. crosslinking) within a protein-protein interface 
were explored. While this approach entailed the making and testing of a number of 
different mutants that positioned L-DOPA in various locations of the antibody CDRs, it 
allowed us to elucidate the biophysical parameters which govern productive placement of 
an NCAA into a protein-protein interface.  
In the case of antibody M18 and PAD, one may think that positions H_D54, 
H_D56, or H_Y52 on the antibody are the best locations for L-DOPA since they appear 
close to a lysine in the complex structure. While L-DOPA mutants at all three of these 
positions showed crosslinking (19.7-36.2%), the most efficient crosslinking (40.3% and 
51.9%) occurred at H_S31 and H_R99, positions that scored well by all three biophysical 
criteria. 
Typical crosslinking reactions observed for rationally placed variants in the 
literature have been reported to suffer from a lack of specificity, low yield, and 
uncharacterized side reactions (Fancy and Kodadek, 1999; Fancy et al., 1996; Sinz, 
2006). Additionally, several commercially available ‘random’ crosslinkers have been 
reported as inefficient and hardly detectable by MS analysis (Dihazi and Sinz, 2003). In 
our study, we found that adjacency is an excellent primary criterion for success, and 
additionally, that greater solvent accessibility increases crosslinking efficiency for 
proximal residues. Although energetic calculations are noisy, the best two positions for 
crosslinking L-DOPA moieties showed a low interface energy, both when free and when 
constrained to be near the nucleophile. In the end, we were able to obtain an antibody that 
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could crosslink with very high efficiency (55%) with little to no observable side 
reactions.  
Direct comparison of the crosslinking efficiencies to previously published use of 
L-DOPA as a site-specific crosslinker is difficult because the crosslinking efficiency was 
not considered or reported in these previous works (Burdine et al., 2004; Umeda et al., 
2009, 2010). Instead simple (gel or blot based) demonstrations of conditional L-DOPA 
mediated crosslinking were reported to demonstrate the crosslinking capabilities of 
periodate oxidized L-DOPA. Data reported in our study was collected using a fixed set of 
reaction conditions to effectively evaluate the contributions of various placement 
parameters on overall crosslinking efficiency. Additional optimization of crosslinking 
conditions independent of placement parameters such as buffer conditions and periodate 
concentrations may lead to further enhancements of crosslinking efficiency.  
As this study used a single antibody-antigen target and a known crystal structure 
of the complex, one must interpret the conclusions with caution. Nonetheless, exploration 
of the M18-PAD4 case suggests a general strategy for identifying high-probability 
antibody-antigen crosslinking positions that consists of a three-part filter that requires: (i) 
crosslinking distance under 7 Å; (ii) sufficient solvent-accessibility (SASA over 90 Å2 or 
fewer than ten neighboring atoms); and (iii) compatible interface energies (Isc under 2.5 
REU and I_sc^constr under 10 REU). Application of these filters in this case led to the 
quick and accurate prediction of a small set of substitutions from which generally 
excellent crosslinking antibodies were derived. This differs from previous attempts where 
iterations of insertion and crosslinking conditions had to be considered in order to 
identify the same levels of crosslinking.  
This study employed a crystal structure of the antibody-antigen complex as a 
starting point, but the effort to determine the complex structure can outweigh the effort of 
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a blind scan of potential crosslinking sites. Further studies are needed to test the utility of 
these approaches with antibody homology models (e.g. (Marcatili et al., 2008; Pantazes 
and Maranas, 2010; Sivasubramanian et al., 2009)) or docked structures (e.g. (Sircar and 
Gray, 2010)); certainly accurate complex models will be required. It is our hope that the 
application of a parametric analysis will lead to the computational prediction of a one-hit 
prediction for the functional placement of NCAAs into a protein scaffold, given only 
basic structural information or even structural models. 
2.4 EXPERIMENTAL METHODS 
2.4.1 Plasmid Construction 
The pMB1 origin of replication in the dual aminoacyl tRNA synthetase/tRNA 
expression vector, pRST.11B (Hughes and Ellington, 2010), was replaced by the p15 
origin of replication from vector pACYC184 by amplification of the p15 origin from 
pACYC184 using primers p15AA.1, and p15A0.2 (Supplementary Material). The 
pRST.11B vector was amplified with primers VSP.2 and VSP.3 to generate a ~6kbp 
fragment that lacks the original origin of replication and is flanked by the unique SpeI 
and XmaI restriction endonuclease sites. The 1.2kbp PCR product containing the p15A 
orgin and the 6kbp vector fragment was digested with SpeI and XmaI and ligated 
together to yield vector pRST.11C. The Nap1 mutant Methanococcus jannaschii tyrosyl 
amber suppressor tRNA (Guo et al., 2009) was assembled via PCR from the four 
overlapping oligonucleotides Nap.1, Nap.2, Nap.3 and Nap.4 (Supplemental Material). 
The assembled tRNA gene was digested with KpnI and BsrGI restriction enzymes and 
ligated into a similarly digested pRST.11C vector to yield vector pRST.11C-Nap1. A 
redundant XbaI site in pRST.11C-NapI was removed by quick change mutagenesis using 
primers, Qcxbaprstc.1 and Qcxbaprstc.2. The gene for the evolved L-DOPA utilizing 
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aminoacyl tRNA synthetase (Alfonta et al., 2003) was assembled from overlapping 
oligonucleotides in-house using automated protein fabrication gene assembly process 
(Cox et al., 2007). The assembled gene was digested with XbaI and XhoI and ligated into 
a similarly digested pRST.11C vector to yield the L-DOPA incorporating tRNA 
synthetase/tRNA vector, pDopa.  
The pAK400-M18 scFv antibody and pAK400-pAD4 expression vectors (Leysath 
et al., 2009) were obtained from George Georgiou’s group at the University of Texas at 
Austin. Amber (TAG) codons were introduced into the coding sequence of the M18 
antibody via quick change mutagenesis or Gibson Assembly PCR.  
2.4.2 Expression and Purification of M18 variants with NCAAs 
The M18 antibody variants were expressed using a condensed culture labeling 
method (Liu et al., 2010) in the presence (or absence) of supplemented L-DOPA. Briefly, 
the M18 antibody and variants were expressed by inoculating 900 mls of 2xYT media 
containing 35 µg ml-1 chloramphenicol and 100 µg ml-1 ampicillin with 1 ml of a 
saturated overnight culture. Expression cultures were grown at 37°C to OD600 ~0.8. 
Cultures were centrifuged at 3500g for 10 minutes, and resuspended in 100 ml 2xYT 
containing 5 mM DTT, 1.5 mM L-DOPA, and 1.5 mM IPTG. Condensed cultures were 
grown at 26°C for 12 hours. The PAD4 antigen was grown in Terrific Broth, induced at 
OD600 = 1.0 with 1 mM IPTG, and allowed to grow at 30°C for 12 hours.  
Expression cultures were centrifuged at 3500g for 15 minutes, and resuspended in 
PBS with 1 µg ml-1 lysozyme and 0.25 U ml-1 benzonase, and incubated on ice for 30 
minutes. Cells were then sonicated for 4 minutes to further lyse the cells. Lysates were 
centrifuged at 35,000g for 45 minutes, after which the liquid fraction was poured over a 
1.5 ml Ni-NTA agarose column. The resin was washed with 45 ml wash buffer (60 mM 
 58 
imidazole, 200 mM NaCl, 50 mM Phosphate at pH 8), and the protein was eluted with 
elution buffer (400 mM imidazole, 200 mM NaCl, 50 mM phosphate at pH 8). The 
Proteins were concentrated using an Amicon cellulose based centrifugal concentrators. 
Concentrations of the proteins were determined using Abs280 measurements. DOPA 
incorporation was verified via blue tetrazolium staining of nitrocellulose transferred SDS-
page purified protein samples (Gieseg et al., 1993).  
2.4.3 Crosslinking Assays 
81 pmol (2.7μM) PAD4 and 81 pmol (2.7μM) of the M18 scFv variant were 
mixed in assay buffer (200 mM NaCl, 50 mM Phosphate at pH 8.5). Crosslinking was 
accomplished by adding sodium periodate to 3.3 mM. Samples were incubated at room 
temperature for 30 minutes. Periodate was quenched with addition of DTT to 100 mM 
and 5x SDS loading dye. Samples were denatured by heating to 98 °C for ten minutes.  
Samples were then run on Novex 4-12% Bis-tris SDS gels using MES-SDS 
running buffer at 200 V for 35 minutes. Proteins were transferred to nitrocellulose at 25 
V for 1 hour, using Invitrogen XCell II Blot Module. Nitrocellulose was blocked at room 
temperature for 30 minutes using Superblock in PBS (Thermo) (for α-His antibody) or 
Superblock in TBS (Thermo) (for α-Flag antibody). Nitrocellulose was rinsed three times 
with PBS or TBS. Nitrocellulose was immersed in 50 ml of PBS or TBS with 10 µL of α-
His or α-Flag for 1 hour at room temperature. Nitrocellulose was rinsed with PBS or TBS 
three times, and resolved with Promega Western Blue Stabilized AP substrate for α-His-
AP conjugate, or with Promega ECL western blotting substrate for luminescent detection 
using the α-Flag-HRP conjugate.  
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M18 variants were resolved at ~30 kDa, PAD4 resolves at 14 kDa. Crosslinked 
product appears at ~45 kDa. Luminescence of western bands were quantified using 
ImageJ (Schneider et al., 2012). 
2.5 COMPUTATIONAL METHODS 
 Rosetta computational modeling and calculations were a contribution from the Dr. 
Jeffrey J. Gray lab, from the Johns Hopkins University Department of Chemical and 
Biomolecular Engineering. Dr. Jianqing Xu was the primary collaborator from the Gray 
lab.  
2.5.1 L-DOPA surface-interface models 
Models for various mutants of the antibody–antigen complex were created using 
Rosetta (Leaver-Fay et al., 2011) with l-DOPA placed in various positions within the 
antibody paratope. Coordinates for the wild-type M18-PAD4 complex were downloaded 
from the Protein Data Bank (Berman et al., 2000) (PDB ID 3ETB). To remove crystal 
packing effects and obtain a Rosetta-minimized reference structure, fixed-backbone side-
chain packing and minimization (1000 decoys) on the entire protein complex was 
performed using Rosetta's score12. The lowest-scoring structure was used for the 
calculations for the predictive introduction of l-DOPA into the CDRs of M18. The 
Rosetta 3.4 (revision 51671, available at www.rosettacommons.org) command line used 
to run the “fix_bb” protocol was: 




 -packing:repack_only -ex1 -ex2aro 
For each interface Lys on the antigen, neighboring antibody residues within 10 Å 
(Cβ–Cβ distance) were selected as potential mutation sites. Each antibody residue within 
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the cutoff distance was substituted to L-DOPA individually, followed by fixed-backbone 
side-chain packing (20 decoys) of the nearby residues (<10 Å) to accommodate the local 
changes. For these and any further calculations where L-DOPA is present, Rosetta uses 
the molecular mechanics-based scoring function (mm_std) and associated NCAA rotamer 
library (Renfrew et al., 2012). 
To carry out these calculations, the position of the l-DOPA mutation and the 
positions of the neighboring residues were specified in a “resfile”, and the same “fixbb” 
protocol read the “resfile” and substituted the target residue to l-DOPA, followed by side 
chain repacking including all the neighboring residues. A Rosetta 3.4 (revision 51671) 
command line example is: 
fixbb.linuxgccrelease -s Best_Prepacked.pdb 
 -nstruct 20 -use_input_sc 
 -resfile 315_LYS_J_679–139_SER_H_31.resfile 
 -score:weights mm_std 
 -minimize_sidechains -ex1 –ex2 
2.5.2 Model relaxation with crosslink constraint 
Some measures are performed on a structure where the L-DOPA is artificially 
constrained to be proximal to the target lysine residue. For these calculations, we 
employed an empirically-determined linear constraint potential, Econstr=-100+400*|dXL-
3.5|, where dXL is the distance in Ångstroms between Cγ atom on the l-DOPA ring (the 
atom bound to the Cβatom) and the Lys Nε and Econstr is the constraint energy in Rosetta 
Energy Units (REU). The constraint weights were chosen to bring the l-DOPA and Lys 
into proximity, in order to evaluate interface compatibility. This constraint energy was 
not included in the final calculated interface score. All the neighboring residues within 10 
Å (Cβ–Cβ distance) of the L-DOPA/Lys pair were repacked to accommodate the 
constraint. The constrained conformation was generated using a custom PyRosetta script 
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with PyRosetta 2.012, revision 51671 (PyRosetta available at www.rosettacommons.org, 
script available upon request). 
2.5.3 Crosslinking distance 
After selecting the L-DOPA position and the target Lys, all the distances of 
potential crosslinking atom pairs (lysine Nε atom and L-DOPA atoms C2, C5, and C6) 
were evaluated, and the one with the minimum value represented the crosslinking 
distance (dXL). 
2.5.4 Solvent-accessibility measures 
As a proxy for solvent accessibility, the number of atoms within 3 Å of the L-
DOPA side-chain atoms was computed (Simons et al., 1999). All non-l-DOPA atoms 
were considered, both from the antibody and antigen, and including hydrogens (as placed 
by Rosetta). A second solvent accessibility measure is the solvent accessible surface area 
(SASA) (Le Grand and Merz, 1993), calculated using an embedded function in PyRosetta 
2.012 using a probe radius of 1.4 Å. 
2.5.5 Rosetta energy calculations 
ISC is defined as Isc=Sbound-Sunbound where Sbound and Sunbound represent the total 
scores of the antibody-antigen complex in bound and unbound form, respectively. The 
unbound form was scored after separating the antibody and antigen to a very large 
distance without additional side chain repacking. Scores are given in Rosetta Energy 
Units (REU), which approximate kcal mol-1. 
After repacking side chains under a constraint on the L-DOPA/Lys pair, the new 
pose of the M18/PAD4 complex was saved in a separate file. The constrained interface 
score, Iconstrsc, was then obtained by rescoring the new conformations both as a complex 






unbound, where the superscript indicates that the constrained 
conformations are used. 
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J_K684 H_D54 2.9 4 124.9 0.8 52.0 30.4% (15.8%) 
J_K684 H_D56 3.0 2 120.3 1.1 28.9 36.2% (5.0%) 
J_K684 H_Y52 3.0 14 25.1 1.3 15.6 19.7% (4.4%) 
J_K684 H_W33 3.4 9 14.1 4.8 8.4 13.9% (8.4%) 
J_K684 H_N58 5.5 6 111.3 3.7 6.1 24.4% (3.3%) 
J_K679 H_S31 5.7 1 132.3 0.7 -0.6 51.9% (11.5%) 
J_K679 H_G53 6.1 8 124.8 1.0 0.2 40.3% (13.8%) 
J_K684 H_R99 6.6 8 28.2 0.2 151.1 not tested 
J_K684 H_G55 8.3 1 161.6 2.8 1.8 5.1% (1.3%) 
J_K653 L_N31 8.6 9 75.3 1.2 -1.1 not tested 
J_K684 H_S57 8.8 2 122.7 2.7 12.7 not tested 
J_K684 H_S32 8.9 18 42.9 1.3 12.2 not tested 
J_K653 L_Y50 9.0 11 10.5 2.8 0.1 not tested 
J_K684 H_G96 9.3 11 56.8 -1.4 11.5 not tested 
J_K684 H_I51 9.8 22 0.5 2.8 13.4 2.7% (0.14%) 
J_K653 L_D17 32.1 4 139.9 2.7 0.2 1.5% (0.49%) 
Table 2-1: Crosslinking rates and biophysical parameters of selected residues  
Candidate crosslink residue pairs, calculated biophysical properties, and experimental 
crosslinking of the M18/PAD4 interface with an L-DOPA substitution. Antigen residue 
nucleophile residues paired with antibody positions for placement of L-DOPA. The 
calculated values of factors (accessible distance, number of neighbors, interface score) 
after L-DOPA mutation that can affect L-DOPA-Lys crosslinking. Mutants are sorted by 
accessible distance. Grey shading indicates poor conditions that may reduce or prevent 
crosslinking (dXL > 7 Å, over ten neighbors, SASA < 90 Å2, Isc > 2.5 REU, or Iscconstr 
> 10 REU). For the two cases where antibody positions have multiple candidate crosslink 
targets, only one is shown in the table (Position H_G53’s second target is J_K684 at dXL 
= 4.1 Å with Isc = 1.0 REU and Iscconstr = 11.5 REU, and position H_S31’s second 
target is J_K684 at dXL = 8.6 Å with Isc = 0.7 REU and I_sc^constr = 4.7 REU.) 
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Figure 2-1: The M18/PAD4 antibody-antigen complex  
The M18/PAD4 antibody-antigen complex structure from PDB 3ETB highlighting the 










Figure 2-2: Western blot gel shift assay. 
A western blot of M18 and variants treated with periodate in the absence and presence of 
antigen PAD4. α-Flag-HRP was used to detect a Flag-tag on the M18 variants. The shift 
in mass in the presence of PAD4 corresponds to the mass of PAD4 antigen (~14 kDa), 
signaling covalent crosslinking between antibody and antigen. Bands were quantified 
using ImageJ to determine crosslinking efficiencies, which were listed in Table 1. D17L 






Figure 2-3: Cross efficiency against biophysical criteria. 
Plots relating the biophysical criteria to experimental crosslinking efficiency. Error bars 
display the standard deviations obtained from multiple trials in experiments. (a). Effect of 
crosslinking distance. (b,c). Effect of solvent accessibility by (b) L-DOPA neighboring 
atoms or (c) solvent-accessible surface area. Black circles represent positions with dXL 
over 7 Å (H_G55, H_I51, and L_D17). (d,e). Effect of interface energetics by (d) 
interface energy or (e) crosslink fluctuation energy. Again black circles represent 
positions with d_XL over 7 Å, and additionally red circles represent positions with 






Figure 2-4: Structural modeling of crosslinking residue K679.  
Structural detail of the successfully crosslinking L-DOPA mutant at position H_S31 with 
its targeted Lys at position 679. Crosslinking distance of 5.7 Å, 132 Å2 of solvent-
accessible surface area, and calculated interface energies of Isc = 0.7 REU and Isc
constr = -
0.6 REU. Aromatic carbon atoms C2, C5, and C6 are all positioned for nucleophilic attack 











Chapter 3: Addicting Diverse Bacteria to a Noncanonical Amino Acid2 
Engineered orthogonal translation systems (OTSs) comprised of tRNA and 
aminoacyl-tRNA synthetase (aaRS) pairs have greatly enabled the expansion of the 
genetic code using non-canonical amino acids (NCAAs), typically added across from the 
amber (UAG) stop codon (Liu and Schultz, 2010). However, the biological, biochemical, 
and biophysical impact of NCAAs on organismal evolution remains unclear, in part 
because it is difficult to force the adoption of new genetic codes in organisms; orthogonal 
translation machinery is often lost or inactivated, even when UAG suppression is 
required (Wang et al., 2014). To overcome this limitation, we have reengineered the 
structure of TEM-1 β-lactamase to generate an antibiotic resistance marker that depends 
on the incorporation of the tyrosine analogues 3-nitro- and 3-iodo- tyrosine. Using the 
engineered NCAA dependent beta-lactamase variant, we maintained a functional OTS 
and concomitant NCAA dependence in E. coli cells for more than 250 generations 
without detectable escape. In addition, our engineered β-lactamase allowed the rapid 
introduction and retention of the OTS across a range of different bacterial species 
(Shigella flexneri, Salmonella enterica, Yersinia ruckeri, and Acinetobacter baylyi ). 
3.1 INTRODUCTION 
3.1.1 Previous NCAA evolutionary studies 
Life on Earth has been shaped by the universal and almost static genetic code set 
early in evolutionary history. Life's proteome has been confined to 20 canonical amino 
acids, as well as selenocysteine and pyrrolysine, two rare, naturally occurring non-
                                                 
2 Tack, D.S., Ellefson, J.W., Thyer, R., Wang, B., Gollihar, J., Forster, M.T., Ellington, A.D. (2016). 
Addicting diverse bacteria to a noncanonical amino acid. Nature Chemical Biology. 12, 138-140. I, Drew 
Tack, was responsible for all components of this paper, including experimental design and execution, as 
well as manuscript preparation and submission. 
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canonical amino acids (NCAAs). Attempts to modify or expand this code have required 
significant reworking of the genome, either randomly (Wong, 1983) or rationally 
(Mandell, 2015; Rovner, 2015). Examples include generation of a Bacillus subtilis strain 
via untargeted mutagenesis which preferentially incorporated 4-fluorotryptophan (Wong, 
1983), and an Escherichia coli strain which required azaleucine incorporation to maintain 
thymidylate synthase activity via rational replacement of an active site arginine 
(Lemeignan et al., 1993). In recent years, the development of orthogonal translation 
systems (OTSs), comprised of aminoacyl-tRNA synthetase (aaRS)/tRNA pairs 
orthogonal to the host translation machinery, has expanded the genetic code to add new 
amino acid chemistries and created the potential for new biological functionality 
including crosslinking (Chin et al., 2002a), fluorescence (Wang et al., 2006a) and 
mimicking post-translational modifications (Xie et al., 2007). Reengineering the binding 
pocket of aaRSs to accommodate a wider variety of NCAAs has allowed the limited 
insertion of new amino acids, typically across from the UAG amber stop codon, resulting 
in 21 letter amino acid alphabets in a range of model organisms (Liu and Schultz, 2010). 
However, the ability to expand the use of NCAAs across a proteome will require 
additional engineering and more likely directed evolution that requires or utilizes the 
functionality of the new amino acid. For example, we have previously evolved both Qβ 
and T7 bacteriophages with novel genetic codes (Bacher et al., 2003b; Hammerling et al., 
2014). Directed evolution of the genetic code to even larger genomes has been attempted 
(Bacher and Ellington, 2001), but widespread adoption of a 21st amino acid across the 
proteome of a whole bacteria has not yet been observed. We believe that this is in part 
due to the fact that the proteome is not functionally ‘addicted’ to the new amino acid, and 
thus there are many paths to fitness that do not rely upon it, even in engineered NCAA 
systems (Kato, 2015; Wang et al., 2014). 
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3.1.2 Enforcing genetic codes 
One way to enforce the maintenance of an OTS has been to engineer a number of 
essential genes with UAG codons, either at permissive locations or through 
computational design (Mandell, 2015; Rovner, 2015). This approach has only been 
applied to E. coli, since it requires some foreknowledge of the genome of an organism 
and the relative orthogonality of its extant translation system. In order to extend this 
approach to a more diverse set of organisms, we have instead chosen to engineer an 
antibiotic resistance marker that is dependent on 3-nitro-tyrosine (3nY) or 3-iodo-tyrosine 
(3iY), NCAAs for which highly active and selective OTSs were available, and which 
have been shown to be useful in conferring unique and beneficial phenotypes in 
engineered and evolved proteins (Cooley et al., 2014; Ohtake, 2015; Sakamoto et al., 
2009). The resistance marker thus makes the NCAA part of its functional genetic code 
and, because it is essential for survival, the host is required to maintain an active OTS. 
3.2 APPROACH 
3.2.1 Selection of NCAA insertion sites 
To engineer NCAA dependence we chose to addict TEM-1 β-lactamase, which is 
known to confer high level β-lactam resistance across many Gram-negative bacteria 
(Bradford, 2001), and for which high resolution structural data is available (Fonze, 1995). 
To facilitate the production of an addicted protein, we first needed to identify inner-core 
amino acids in TEM-1 β-lactamase that abolish β-lactamase activity when replaced with 
3nY and 3iY. Potential substitutions were identified by inspecting the structure of TEM1 
β-lactamase (PDB: 1XPB) (Fonze, 1995), focusing on solvent shielded amino acids with 
side chains located in or pointing towards the interior of the protein. Residues involved in 
catalysis or substrate binding were excluded. We identified three residues that we 
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hypothesized would be good candidates for NCAA substitution: F66, L162, and T189. 
TEM-1 variants with single UAG codons were constructed, and introduced into E. coli 
cells containing tyrosyl-tRNA synthetase:tRNA (MjYRS/tRNACUA) pairs derived from 
Methanocaldococcus jannaschii that were capable of incorporating either the natural 
amino acid tyrosine, or the 3-substituted tyrosine analogues 3nY and 3iY (Cooley et al., 
2014; Sakamoto et al., 2009) (Figure 3-1). Substitutions at positions L162 and T189 
abolished β-lactamase activity with all three amino acids, while F66 retained some 
activity with tyrosine (Table 3-1).  
3.2.2 Library Design and Selection 
3.2.2.1 Initial selection 
To evolve TEM-1 variants dependent on NCAA incorporation for activity, we 
designed random codon (NNS) libraries that spanned the six residues that had side chains 
in closest proximity to the suppressed position (Table 3-2, Figure 3-2). Libraries were 
selected in the presence of 3nY or 3iY on solid media supplemented with carbenicillin. 
Selection plates revealed a survival rate of ~0.1%, with a total surviving population of 
105 cells for each library. One hundred colonies from each selection were assayed in the 
presence of carbenicillin with or without the corresponding NCAA. Most clones (>99%) 
from the F66 and T189 libraries did not require the NCAA for survival on carbenicillin, 
and sequencing indicated a high rate of mutation of the original UAG codon. However, in 
the L162 library greater than 95% of clones required the NCAA for survival and the 
UAG codon was retained.  
3.2.2.2 Counter-selection with tyrosine 
In order to limit pathways for reversion to a natural genetic code, we attempted to 
eliminate 3nY- and 3iY-dependent β-lactamase variants that would also be active with 
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the structurally similar canonical amino acid tyrosine at position 162, which is available 
in the genetic code via a single mutation of the amber codon. To accomplish this, 96 
NCAA-dependent clones from each of the L162 libraries (3nY and 3iY) were 
transformed with a plasmid encoding an OTS for the incorporation of tyrosine at UAG 
codons. This preliminary screen revealed a total of 24 clones (14 from the 3nY library 
and 10 from the 3iY library) with minimal carbenicillin resistance with tyrosine 
incorporation, suggesting that replacing the NCAA with tyrosine strongly impaired β-
lactamase activity. These 24 clones were sequenced and were found to comprise 23 
unique sequences, with a single duplicate (Table 3-3, Table 3-4). In these clones, 
significant enrichment was observed for M68F (17/24) and F72G (11/24) mutations, 
while sequencing of NCAA active β-lactamases before the tyrosine counter-screen saw 
no convergence at these positions. The F72G mutation appears to make space for the 
larger aromatic side chains of the NCAA residues (Figure 3-3). M68F was frequently 
found in combination with F72G (10 out of 24). There were no obvious differences 
between variants selected on 3nY and those selected on 3iY. 
3.2.3 Characterization of selected β-lactamase variants 
3.2.3.1 Enzyme activity with probable canonical amino acid replacements 
It was also possible that reversion might occur via the wild-type amino acid at 
position 162, leucine, which is also available via a single mutational step from the amber 
codon. We chose to evaluate the activity of the 23 unique β-lactamases with leucine and 
tyrosine codons replacing the UAG codon in each clone. These cognate codons are read 
at higher efficacy by E. coli translational machinery than OTS incorporation of amino 
acids, and by eliminating leucine and tyrosine active clones, we reduced the number of 
clones dependent on NCAAs to four variants (Table 3-5). Two of these variants showed 
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reduced enzymatic activity with either L or Y (MIC <1000 µg ml-1 carbenicillin; Fig. 1a, 
TEM-1.B9 and TEM-1.F2), one variant showed reduced activity with L, and one showed 
reduced activity with Y (Figure 3-4, TEM-1.G3 and TEM-1.D1 respectively).  
Interestingly, all four variants were active with both 3nY and 3iY, as might have 
been expected given the similarity of sequenced variants selected on these two tyrosine 
analogues. All four variants also had higher activity with 3nY than with 3iY (Figure 3-
4). Additionally, during the course of this experiment we observed higher carbenicillin 
resistance for colonies containing the 3iY OTS on plates containing 3nY than those 
containing the 3nY OTS, suggesting the synthetase originally evolved for 3iY 
incorporation was in fact better at incorporating 3nY than the synthetase evolved for 3nY 
incorporation. This was subsequently confirmed by UAG suppression assays using a GFP 
reporter (Figure 3-5), and the 3iY OTS was used for both 3nY and 3iY incorporation in 
all subsequent experiments.  
3.2.3.2 Selecting and testing enzyme function with other canonical amino acids 
Having eliminated tyrosine and leucine from the pool of amino acids that could 
replace the NCAA in the β-lactamase, we wanted to determine if any other canonical 
amino acids could substitute. Thus, NNS codon libraries at position 162 were constructed 
for the four selected TEM-1 variants. Libraries were selected on carbenicillin and TEM-1 
genes from 15 random colonies were sequenced from each library. Canonical amino 
acids that could support activity were identified for all TEM-1 variants (Table 3-6), with 
phenylalanine being the most abundant. Variant TEM-1.B9 was observed to have the 
fewest canonical solutions, with all 15 clones returning TTC codons corresponding to 
phenylalanine. To confirm this reduced set of canonical solutions for TEM-1.B9, 20 
individual variants were constructed corresponding to all 20 canonical amino acids at 
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position 162, and the MICs determined for each (Figure 3-6). This experiment confirmed 
that phenylalanine was the only canonical amino acid capable of rescuing NCAA 
dependence. We also explored stability and activity of TEM-1.B9, and control variants.  
3.2.3.3 Long Term OTS Addiction 
Since the codons for phenylalanine (TTT and TTC) cannot be accessed by a 
single point mutation from a TAG codon, and cannot be suppressed by a single mutation 
in either of the genes encoding E. coli tRNAPhe (pheU and pheV), we hypothesized that 
NCAA dependence and concomitant OTS functionality might be maintained during 
prolonged serial culture experiments with this β-lactamase. We therefore serially cultured 
E. coli cells containing either TEM-1.B9 or a control TEM-1 variant with an amber 
codon replacing residue D254 (TEM-1.D254tag) and the 3iY OTS, in triplicate. TEM-
1.D254tag is located on a solvent exposed surface loop (Figure 3-7) and substitutions at 
this location with either canonical or NCAAs retain wild-type activity. Cells were 
cultured for over 250 generations, and despite screening >5*1011 cells for carbenicillin 
resistance in the absence of 3nY in both solid and liquid media, no escaped cells were 
detected for cultures containing TEM-1.B9 (Figure 3-8, Figure 3-9). Control cultures 
containing the TEM-1.D254tag variant escaped NCAA dependence within 10 generations 
(one passage to confluence), and occurrences of NCAA independent β-lactam resistance 
increased in subsequent generations. The lack of escape mutants observed for cells 
containing TEM-1.B9 indicates that the combination of reducing the pool of canonical 
solutions, and eliminating solutions accessible by single point mutations is an effective 
strategy for enforcing NCAA dependence and OTS functionality. 
We also investigated the frequency of escape for the other variants that, based on 
our substitution analyses, should have more paths to the use of a canonical code for 
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survival. Each of the other three variants was cultured in triplicate for 50 generations and 
3*109 cells screened from each line every 10 generations to determine the escape 
frequency. These variants had significantly fewer escape events than the TEM-1.D254tag 
control, but all had at least one escape event over the 50 generations (Figure 3-8). 
Screening cells in liquid cultures after 50 generations produced a similar result (Figure 3-
9), confirming that eliminating canonical solutions at the NCAA position is important for 
preventing escape events. Additional serial culturing experiments at lower carbenicillin 
concentrations (0.25 ml−1 and 1 mg ml−1; Figure 3-10) or in mutation-prone E. coli 
strains (Baba et al., 2006) (Figure 3-11) further confirmed the stability of the TEM-1.B9 
allele. The lack of escape mutants observed for cells containing TEM-1.B9 indicates that 
both reducing the pool of canonical solutions and eliminating solutions accessible by 
single point mutations is an effective strategy for enforcing NCAA dependence and OTS 
functionality. 
3.2.3.4 Transferring addiction to different bacterial hosts 
Given β-lactams have a broad spectrum of activity, and that the tRNA and aaRS 
of the 3iY OTS might be orthogonal in species other than E. coli, we hypothesized that 
other bacterial species could be addicted to an NCAA using our evolved TEM-1.B9 β-
lactamase. We used a single plasmid containing both OTS and TEM-1.B9 to test this 
hypothesis in E. coli strains TOP10, XL1-Blue, BL21 and RTΔA (derived from 
C321.ΔA) (Lajoie et al., 2013; Thyer et al., 2015) the Enterobacteriaceae species; 
Shigella flexneri; Salmonella enterica; Yersinia ruckeri; and Acinetobacter baylyi, which 
is from the order Pseudomonadales and is genetically distant from the Enterobacteriales. 
All strains and species became dependent upon 3nY for growth in the presence of 
ampicillin (Figure 3-12, Figure 3-13). To our knowledge, this was the first 
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demonstration of NCAA incorporation with M. jannaschii tyrosyl-tRNA synthetase in 
any Shigella, Salmonella, Yersinia or Acinetobacter and suggests broad compatibility of 
the archaeal translation machinery in bacteria. Serial culturing of all tested species 
showed continuous dependence on 3nY for ampicillin resistance. (Figure 3-14 and 
Figure 3-15). 
3.3 DISCUSSION 
By evolving TEM-1 β-lactamase to function selectively upon incorporation of the 
NCAAs 3nY or 3iY at the amber stop codon, we could maintain an OTS in diverse 
bacterial species for a hundred generations without any detected escape of NCAA 
dependence. This strategy should prove successful with other enzymes and other amino 
acids. In general, it should be possible to reconfigure internal pockets within proteins to 
accommodate an unnatural amino acid selectively, with little chance of accessing 
canonical solutions. More importantly, the ability to addict a range of bacterial species to 
NCAAs through engineered β-lactamases should provide a much more facile means of 
introducing new amino acids into the genetic codes of many organisms, including 
industrially relevant bioprocess strains. 
3.4 MATERIALS AND METHODS 
3.4.1 Strains and reagents 
TOP10 E. coli (Life Technologies) was used for routine cloning, screening of the 
libraries, and MIC measurements. Salmonella enterica (ATCC #9270), Shigella flexneri 
(ATCC #12022), and Yersinia ruckeri (ATCC #29473) were obtained through VWR 
international. Amberless E. coli strain RTΔA (derived from C321.ΔA) was described 
previously (Thyer et al., 2015), Acinetobacter baylyi ADP1 was a gift from Dr. Jeffery 
Barrick, University of Texas at Austin. 
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Restriction enzymes XhoI, HindIII, and DpnI, and Antarctic Phosphatase were 
obtained from New England Biolabs (NEB). All PCRs were performed using Phusion 
polymerase (NEB), 200 µM dNTPs and 0.5 µM of each oligonucleotide primer (IDT). 
Gibson assembly was used for site specific mutagenesis and assembly of the single 
plasmid systems (Gibson, 2009). Antibiotics required for plasmid maintenance were used 
at the concentrations listed unless otherwise indicated; chloramphenicol (34 µg ml-1), 
gentamycin (10 µg ml-1), kanamycin (50 µg ml-1) and spectinomycin (100 µg ml-1). 
3.4.2 Plasmid construction 
The OTSs were used in pNCAA (Genbank KU055485) and pAA (KU055484). 
Briefly, these plasmids contain an orthogonal translation cassette consisting of the 
Methanocaldococcus jannaschii tyrosyl-tRNA synthetase (MjYRS) expressed from the E. 
coli tyrS promoter and the Nap3 UAG suppressor tRNA under the control of the E. coli 
lpp promoter. The pNCAA-3nY variant was constructed by replacing the 3iY-RS gene 
with a codon optimized MjYRS evolved for incorporation of 3nY (Cooley et al., 2014), 
pNCAA contained gentamycin resistance cassette, and pAA contained spectinomycin 
resistance cassette.  
The TEM-1 expression plasmid (pBla, Genbank KU055483) was derived from 
plasmid pBR322 (GenBank J01749.1). An XhoI restriction site was added immediately 
downstream of the blaTEM-1 coding sequence, and a HindIII site added immediately 5′ of 
the start codon. The tetA(C) gene was replaced with the cat gene encoding 
chloramphenicol acetyl-transferase, which conferred chloramphenicol resistance from the 
plasmid pACYC184 (GenBank X06403.1). The blaTEM-1 variant TEM-1.D254tag control 
was generated using Gibson assembly. 
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The single plasmid expression system was derived from plasmid pTH18kr 
(GenBank AB019603.1) which contains the low copy, medium host range SC101 origin 
(Hashimoto-Gotoh, 2000). The region containing Plac, the MCS, and lacZα was replaced 
with a bicistronic insert encoding a codon optimized (for E. coli) 3iY synthetase and 
TEM-1 variants under the control of the constitutive EM7 promoter (Genbank 
KU055486). Oligos DT.15 and DT.16 (Table 3-7) were used to amplify pTH18kr 
backbone, for Gibson assembly. The Nap3 tRNA cassette was cloned from the pNCAA-
3iY plasmid located 3’ of synthetase and TEM-1 variants. TEM-1 variants were swapped 
into plasmid through amplification from pBla plasmid with oligos DT.17 and DT.18, 
with backbone application using DT.19, and DT.20. The plasmid was maintained in E. 
coli strains in LB media (Fisher BioReagents) supplemented with 25 µg ml-1 kanamycin, 
50 µg ml-1 carbenicillin, and 1 mM 3nY (Sigma). The IncQ plasmid was created by 
replacing the TEM-1 β-lactamase on plasmid pMMB66EH (GenBank X15234) with 
TEM-1 variants, tRNA, and 3iY synthetase, using primers DT.21 and DT.22 to amplify 
pMMB66EH, and primers DT.23 and DT.24 to amplify machinery from the SC101 based 
plasmids.  
3.4.3 Residue selection and characterization 
TEM-1 β-lactamase libraries were designed by manual inspection of the TEM-1 
structure (PDB: 1XPB) (Fonze, 1995) using the molecular visualization program pymol 
(v1.3). Individual variants with amber codons replacing F66, L162, or T189 were 
generated by Gibson assembly. The MICs of these variants with ampicillin were 
determined by plating 5*107 cells (TOP10 E. coli) containing TEM-1 variants, and either 
pAA-Y, pNCAA-3nY, or pNCAA-3iY on solid media supplemented with 1 mM 3nY or 
3iY as appropriate. MIC E-test strips (Biomerieux) were added to each plate, followed by 
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incubation for 16 hours at 37°C. MICs were recorded as the lowest concentration of 
ampicillin with no cellular growth following the manufacturer’s instructions. 
3.4.4 Library design and construction 
For the L162 library, the six residues with side chains in closest proximity to the 
leucine side chain were selected for site-saturation (NNS) mutagenesis. These 
corresponded to residues M68, F72, L139, L148, L152, and L169 (Figure 3-2). 
Degenerate oligonucleotides (IDT) were used to amplify the blaTEM-1 gene in three 
segments. The N-terminal fragment was amplified using primers DT.1 and DT.3, the C-
terminal fragment with DT.2 and DT.6, and the central fragment with DT.4 and DT.5. 
Library fragments were purified by gel extraction (Promega) and were assembled by 
overlap PCR using an equimolar ratio with primers DT.1 and DT.2. The assembled 
product was digested with XhoI and HindIII and ligated into a watermarked pBla 
backbone (E166 and P167 codons replaced with TAA stop codons). The blaTEM-1 library 
and backbone were mixed in a 2:1 molar ratio and ligated with T4 DNA ligase (NEB) at 
16°C for 16 hours. Ligated DNA was desalted by column purification (Zymo) and 
transformed into MegaX DH10B T1R Electrocompetent cells (Invitrogen, C6400-03). 
Library diversity was calculated by dilution plating and was determined to exceed 3*108. 
Supercoiled library DNA was recovered by plasmid minipreps (Qiagen). 
3.4.5 Primary β-lactamase selections and tyrosine counter-screening 
Electrocompetent cells (E. coli TOP10 containing either pNCAA-3nY or 
pNCAA-3iY) were prepared by culture in SOB medium at 37°C to mid log phase (~ 
OD600=0.6), incubation on ice for 20 minutes, centrifugation at 2500g for 10 minutes, 
and two washes with equal volumes of chilled 10% glycerol. Cells were then resuspended 
in half culture volumes of chilled 10% glycerol along with 5 µg of TEM-1 library DNA. 
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Cells were electroporated using a Biorad micropulser and library diversity measured by 
dilution plating. Each library was plated on LB-agar supplemented with 250 µg ml-1 
carbenicillin and either 1mM of 3nY or 3iY, as appropriate, and incubated at 37°C for 16 
hours. Both libraries had ~105 colonies after selection, with calculated transformation 
efficiencies exceeding 3*108. Two-hundred colonies from each library were picked from 
the selection plates and streaked on three plates: the first containing 1 mM of NCAA and 
carbenicillin (250 µg ml-1), the second without the NCAA, and a third without NCAA or 
carbenicillin. 
Following incubation, clones which did not survive on the second plate (lacking 
NCAA) were picked and cultured in LB at 37°C for 16 hours, and then used to inoculate 
fresh 2 ml LB cultures. After incubation for 3.5 hours, cultures were chilled on ice for 20 
minutes, centrifuged at 2500g for 10 minutes and resuspended in 200 µL of TSS buffer 
(Lajoie et al., 2013) with plasmid pAA-Y, and incubated for one hour on ice. LB medium 
was added to a final volume of 2 ml and cultures were recovered at 37°C for 2 hours. An 
aliquot of 200 µL was plated on LB-agar supplemented with chloramphenicol and 
spectinomycin, and incubated at 37°C for 16 hours. Colonies from these plates were used 
to determine MICs of individual clones as described above. Clones which appeared to be 
inactive with tyrosine incorporation were analyzed by Sanger sequencing (Table 3-3, 
Table 3-4). 
3.4.5 Rephenotyping β-lactamase variants 
The TAG codon at position 162 in all unique blaTEM-1 genes isolated from the 
primary selection and screening was replaced with either leucine (TTG) or tyrosine 
(TAT) codons using Gibson assembly (oligo DT.9 with DT.10 and DT.11 respectively). 
Leucine and tyrosine variants were sequence verified, and MICs were determined by 
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plating 3 µL of mid-log cultures on LB-agar supplemented with chloramphenicol and a 
range of carbenicillin concentrations (0, 25, 50, 100, 250, 375, 500, 750, and 1000 µg ml-
1). Clones selected for further characterization (TEM-1.B9, TEM-1.D1, TEM-1.F2, TEM-
1.G3) were transformed into cells containing either pNCAA-3nY or pNCAA-3iY, to 
determine NCAA dependent MICs. Each was plated on three series of plates covering a 
range of carbenicillin concentrations; one lacking NCAAs, one with 1 mM 3nY, and one 
with 1 mM 3iY. Carbenicillin concentrations used were 0, 50, 100, 250, 375, 500, 750, 
1000, 1500, 2000, 2500, 3000, 3500, 4000, 5000, 6000, 8000 and 12000 µg ml-1. 
3.4.6 Characterization of TEM-1.B9 
TEM-1.B9 and TEM-1.D253tag were transformed into RTΔA containing the 3iY-
OTS plasmid, and grown in 1000 µg ml-1 carbenicillin with 10 mM 3nY at 30°C for 20 
hours. Wild-type TEM-1 was transformed into TOP10 E. coli, and grown in LB at 30°C 
for 20 hours. Samples were purified via periplasmic osmotic release (Stec et al., 2005). 
Cells were rinsed twice in 30 mM tris at pH 7.2, then resuspended in 20% sucrose with 5 
mM EDTA on ice for 30 minutes. Cells were centrifuged and resuspended in ice cold 
water. Samples were concentrated with cellulose based centrifugation concentrators with 
10 kDa MWCO. Samples were further purified with FPLC HiTrap Q column (GE) with 
10 mM tris buffer at pH 7, and eluted with a 0 to 100 mM NaCl gradient. Kinetic analysis 
was conducted using 1 nM β-lactamase while monitoring the conversion of nitrocefin 
(EMD chemicals) at a range of concentrations (0, 10, 20, 30, 50, 75, 100, 150, 200, 250, 
300, 350 µM) by measurement of absorbance at 486 nm in 100 mM phosphate buffer at 
pH 7 using a Tecan Infinite M200 Pro, technical duplicates were averaged, and error bars 
represent standard deviation (Figure 3-16). Kinetic values were calculated with 
Michaelis-Menten kinetics. Melting curves were calculated by monitoring fluorescence 
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with Texas Red, using excitation and emission wavelengths of 577 and 620 nm 
respectively, (Figure 3-17) with technical duplicates, using a Roche LightCycler 96, and 
data analysis was performed with LightCycler 96 SW 1.1 software. 
3.4.7 Identifying additional canonical solutions 
The TAG codon at position 162 of selected clones was randomized using a 
degenerate codon library (NNS), representing all 20 canonical amino acids. Gibson 
assembly was used for library construction with primers DT.9 and DT.14. Libraries were 
prepared as described above, and 12 naïve clones from each were sequenced to ensure a 
good codon distribution, and acceptable bias. Libraries were transformed into TOP10 
cells and plated on LB-agar supplemented with 2000 µg ml-1 carbenicillin, above normal 
lab culture condition, but below the NCAA dependent MICs of the selected clones, which 
allowed us to identify amino acids that resulted in high enzyme activity. Fifteen random 
colonies from each library selection were recovered in liquid media and blaTEM-1 genes 
analyzed by Sanger sequencing. Additionally, a sample of library was grown in liquid 
media at several carbenicillin concentrations, plasmids from each was purified and 
sequenced with Sanger sequencing. Chromatogram analysis shows a convergence at 
higher carbenicillin concentrations to phenylalanine codons (Figure 3-18). To further 
characterize the TEM-1.B9 variant, 16 individual variants were pulled from NNS library 
corresponding to all 20 canonical amino acids at position 162 (tyrosine and leucine were 
cloned previously at this location, methionine and tryptophan were constructed with DT.9 
paired with DT.12 and DT.13 respectively). Each was sequence verified and MICs 
determined as described previously. Biological triplicates of each codon were measured 
to ensure reproducibility, with all triplicates in close agreement. 
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3.4.8 Serial Culture Experiments 
pBla containing our identified TEM-1 variants, including TEM-1.D254tag, were 
transformed into E. coli cells containing the pNCAA-3iY plasmid and plated on LB-agar 
supplemented with gentamycin and chloramphenicol. Colonies were picked in triplicate 
and cultured in liquid medium overnight. Overnight cultures were diluted 1:1,000 to start 
new 5-ml cultures of LB medium supplemented with 1 mM 3nY and carbenicillin (2,500 
μg ml−1 for all clones except TEM-1.G3, which was grown at 1,500 μg ml−1). Cultures 
containing TEM-1.B9 and TEM-1.D254tag were serially grown to confluence (~10 
doublings) for 25 d. TEM-1.B9 and TEM-1.D254tag were additionally cultured in 
TOP10 and JW0105-1 E. coli knockout strains (Baba et al., 2006) at 1,000 μg ml−1 for 10 
d, and TOP10 cells were additionally cultured at 250 μg ml−1 for 10 d using the same 
protocol. Cells containing other blaTEM-1 variants were cultured to confluence for 5 d. 
3.4.9 Characterization of Single Plasmid System in Bacterial Species 
All bacterial species and strains described above were made electrocompetent 
through serial glycerol washes during mid-log phase growth, as described above. Yersinia 
ruckeri was grown and maintained at 26°C. Transformed cells were grown on LB-agar 
plates with kanamycin and 10 µg ml-1 ampicillin with 1 mM 3nY. Colonies were picked 
from plates in triplicate or greater to ensure reproducibility and grown in LB medium. At 
mid-log, an aliquot of 5*107 cells was plated on LB-agar with and without 1 mM 3nY. 
MIC Etest strips were then added to each plate. MICs were recorded after 16 h of 
incubation (Figure 3-12). Data reported as mean of biological replicates ± s.e.m. Sample 
sizes (n) for each species reported were as follows: TOP10, 12; XL1-Blue, 3; BL21, 3; 
RTΔA, 6; S. enterica, 6; S. flexneri, 6; Y. ruckeri, 3; A. baylyi, 3. Strains with n>3 were 
used as internal controls to ensure consistency over multiple Etest strip packages. 
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For serial growth experiments, strains were cultured in LB medium with 1 mM 
3nY and carbenicillin for 10 d, with daily 1,000-fold dilutions. After the tenth day, 
cultures were tested for reversions by plating on LB-agar with carbenicillin in the 
absence of 3nY. 
3.4.10 Reversion Assays 
Escape frequencies were determined for cultures containing TEM-1 variants 
following each of the first five passages to confluence, and additionally following the 
10th and 25th passages for TEM-1.B9 and TEM-1.D254tag cultures. Aliquots of ~3*109 
cells from overnight cultures were centrifuged at 2500g for 10 minutes and resuspended 
in 5 ml of LB medium supplemented with chloramphenicol and gentamycin, and 
incubated at 37°C for five hours to minimize transfer of 3nY. Following incubation, 
cultures were centrifuged and resuspended in 5 ml of fresh LB and ~3*109 cells were 
plated on solid media containing 2500 µg ml-1 carbenicillin (1500 µg ml-1 carbenicillin 
for TEM-1.G3). Colony counts on plates were used to determine escape frequencies. 
All cultures were challenged by liquid reversion assays at day 5, and TEM-1.B9 
again at day 25. Approximately 3*1010 cells were recovered by centrifugation and 
resuspended in 20 ml fresh LB with chloramphenicol and gentamycin, and incubated at 
37°C for five hours. Cells were then centrifuged and resuspended again, and used to 
inoculate 200 ml of LB supplemented with 2500 µg ml-1 carbenicillin (1500 µg ml-1 
carbenicillin for TEM-1.G3). Cell growth was monitored by OD600 readings taken at 0, 
1, 2, 3, 4, 8, 20, 32, and 48 hours post dilution.  
 Single plasmid reversion assays were conducted in triplicate by passaging E. coli 
strains and other bacterial species in LB supplemented with 1 mM 3nY and 50 µg ml-1 
ampicillin for all strains except RTΔA (100 µg ml-1) and Y. ruckeri (conditioned to grow 
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at 50 µg ml-1 after 3 days, Y. ruckeri was passaged at 26°C). A 1:1000 dilution was used 
daily to allow for ~10 doublings per passages. After 10 passages, 3*109 cells were 
centrifuged and resuspended in fresh LB without NCAA, and grown for 4 hours, then 
centrifuged and resuspended, and plated on LB-agar plates with the ampicillin 
concentrations as used during serial culture. Colony counts at a range of dilutions were 
used to determine reversion rates. 
3.4.11 Molecular Modeling of TEM1 Library Variants 
The wild-type structure of TEM1 (PDB: 1XPB) (Fonze, 1995) was prepared for 
mutational analyses using the Molecular Operating Environment (MOE.09.2014) 
software package from Chemical Computing Group. The structure was inspected for 
anomalies and protonated/charged with the Protonate3D subroutine (310K, pH 7.4, 0.1 M 
salt)21. The protonated structure was then lightly tethered to reduce significant deviation 
from the empirically determined coordinates and minimized using the Amber10:EHT 
forcefield with R-field treatment of electrostatics to an RMS gradient of 0.1 kcal mol-1 
Å-1. Next, we created rotamer libraries for each non-canonical amino acid using a low-
mode molecular dynamics (LowModeMD) methodology. Library positions of 
representative variants from the selection were mutated and repacked within the local 
environment. Conformational analysis of the loop was evaluated with LowModeMD22. 
Mutated structures were then solvated with water and counterions in a 6 Å sphere and 
minimized to an RMS gradient of 0.001 kcal mol-1 Å-1. 2-D contact maps of the non-
canonical solutions were inspected with Ligand Interactions23 after arbitrarily setting the 
non-canonical amino acid to the ligand position. Measurements of stability and potential 
energy were scored within MOE. 
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3.5 DEPOSITED ACCESSION CODES 
Sequencing data generated from this work are deposited under accession codes 









3.6 TABLES AND FIGURES 
 
Tyr 3nY 3iY 
F66tag 256 4 4 
L162tag 24 4 4 
T189tag 8 4 3 
Table 3-1: MICs of UAG TEM-1 variants  
MICs of TEM-1.tag variants with tyrosine, 3-nitrotyrosine, or 3-iodotyrosine 























Arg43 Met68 Leu75 
Arg61 Phe72 Leu152 
Glu64 Leu139 Met155 
Pro67 Leu148 Asp157 
Tyr264 Leu152 Thr160 
Thr266 Leu169 Met186 
  
Table 3-2: Library positions 








TEM-1 Met68 Phe72 Leu139 Leu148 Leu152 Leu162 Leu169 
A5 Ser Gly Met Met Leu Amb Leu 
B8 Phe Gly Thr Leu Met Amb Leu 
B9 Phe Gly Thr Leu Met Amb Leu 
C3 Tyr Gly Ile Ile Leu Amb Leu 
C8 Met Trp Ser Leu Leu Amb Ser 
C10 Leu Phe Ile Leu Leu Amb Cys 
D1 Phe Gly Leu Leu Ala Amb Leu 
D2 Phe Gly Thr Met Leu Amb Leu 
D3 Phe Gly Phe Leu Val Amb Leu 
E1 Phe Ile Met Val Leu Amb Ile 
E3 Phe Gly Ala Leu Ala Amb Leu 
E6 Val Arg Leu Met Leu Amb Cys 
E9 Met Phe Ala Ile Ile Amb Cys 
E10 Thr Gly Met Leu Leu Amb Leu 
F2 Phe Gly Leu Leu Thr Amb Leu 
F3 Met Gly Leu Ile Met Amb Leu 
F4 Leu Gly Met Leu Ala Amb Leu 
F9 Phe Gly Ala Ile Leu Amb Leu 
G3 Met Ala Ala Leu Val Amb Cys 
G7 Ile Gly Phe Met Met Amb Leu 
G9 Phe Gly Ile Val Ala Amb Leu 
H1 Met Gly Thr Leu Leu Amb Val 
H3 Met Ala His His Leu Amb Cys 
H8 Phe Gly Ile Leu Leu Amb Val 
 
Table 3-3: Amino acid sequences of TEM-1 variants  
Sequences of the 24 clones isolated after tyrosine OTS characterization. Gray indicates 







TEM-1 Met68 Phe72 Leu139 Leu148 Leu152 Leu162 Leu169 
A5 AGC GGC ATG ATG CTG TAG TTG 
B8 TTC GGG ACC CTC ATG TAG TTG 
B9 TTC GGG ACC CTC ATG TAG TTG 
C3 TAC GGG ATC ATC TTG TAG TTG 
C8 ATG TGG TCG CTC TTG TAG TCG 
C10 TTG TTC ATC CTG TTG TAG TGC 
D1 TTC GGG CTG TTG GCG TAG TTG 
D2 TTC GGC ACC ATG TTG TAG CTC 
D3 TTC GGC TTC CTC GTG TAG CTG 
E1 TTC ATC ATG GTC TTG TAG ATC 
E3 TTC GGG GCC TTG GCC TAG CTG 
E6 CTG CGG CTG ATG CTG TAG TGC 
E9 ATG TTC GCG ATC ATC TAG TGC 
E10 ACG GGC ATG TTG CTC TAG CTG 
F2 TTC GGC CTC CTC ACC TAG CTG 
F3 ATG GGC CTG ATC ATG TAG TTG 
F4 TTG GGC ATG CTC GCC TAG CTG 
F9 TTC GGG GCC ATC CTG TAG TTG 
G3 ATG GCC GCG CTC GTC TAG TGC 
G7 ATC GGG TTC ATG ATG TAG TTG 
G9 TTC GGC ATC GTC GCG TAG TTG 
H1 ATG GGG ACC CTC TTG TAG GTC 
H3 ATG GCG CAC TTG CTC TAG TGC 
H8 TTC GGC ATC TTG CTC TAG GTC 
Table 3-4: Codon sequences of TEM-1 variants  
Sequences of the 24 clones isolated after tyrosine OTS characterization. Gray indicates 
selection on 3nY, blue indicates selection on 3iY. Bolded and underlined identifiers 








TEM-1 Met68 Phe72 Leu139 Leu148 Leu152 Leu162 Leu169 
TEM-1.B9 Phe Gly Thr Leu Met Amb Leu 
TEM-1.D2 Phe Gly Thr Met Leu Amb Leu 
TEM-1.F2 Phe Gly Leu Leu Thr Amb Leu 
TEM-1.G3 Met Ala Ala Leu Val Amb Cys 
 
Table 3-5: Sequences of four potential addicted TEM-1 variants  
Mutations of the β-lactamases identified with reduced canonical functionality, and 













TTC 15 Phe 
TEM1.D1 
TTC 9 Phe 
TGG 4 Trp 
TAC 2 Tyr 
TEM1.F2 
TTC 11 Phe 
TGG 4 Trp 
TEM1.G3 
TTC 6 Phe 
ATC 5 Ile 
ATG 1 Met 
GTG 1 Val 
GTC 1 Val 
CTG 1 Leu 
Table 3-6: Canonical amino acid solutions 
Sequencing results from Amb162NNS libraries of the four TEM-1 variants fully 
characterized. Results indicate that each selected clone has at least one canonical amino 














































-1) kcat st. dev. KM (µM) KM st. dev. 
TEM-1 195.9 16.5 23.3 9.1 
TEM-1.D254tag 189.1 13.8 32.7 9.6 
TEM-1.B9 154.2 5.2 33.2 4.6 
 
Table 3-8:  TEM-1 β-lactamase kinetics 
Kinetic parameters for wild-type TEM-1, TEM-1.B9, and TEM-1.D254tag, as 








Figure 3-1: NCAA structures 
The structure of the amino acids used in UAG-suppression OTSs throughout this study; 
the canonical amino acid L-tyrosine (Tyr, left), and the NCAAs 3-nitro-L-tyrosine (3nY, 




Figure 3-2: TEM-1 L162 Structure 
Structure of wild-type TEM-1 β-lactamase (PDBID: 1XPB) at position L162 (red) with 
the amino acids randomized in the L162tag library (blue).  
 
 
Figure 3-3: MOE modeled image of TEM-1.B9 




Figure 3-4: MIC characterization  
Carbenicillin MIC values of four selected TEM-1 β-lactamase variants with 3iY, 3nY, 
leucine and tyrosine at position 162. 3nY and 3iY were incorporated at an encoded TAG 
codon. Tyrosine and leucine were coded for with cognate E. coli codons TAT and TTG 




Figure 3-5: 3nY and 3iY incorporation efficiencies 
Activities of engineered MjYRSs previously evolved to incorporate 3nY or 3iY. Each 
was characterized using 3iY and 3nY OTS in the presence of 1mM 3nY or 1mM 3iY. 
NCAA incorporation was quantified by measuring fluorescence of GFP-Y39tag. Values 


































Figure 3-6: MICs of TEM-1.B9 
MICs of TEM-1.B9 with each canonical amino acid and the NCAAs 3iY and 3nY at 
position 162. Data represent mean ± s.e.m. of biological triplicates. 
 
 
Figure 3-7: Structure of TEM-1.D254X 
TEM-1 β-lactamase with solvent exposed loop amino acid D254 (red), used as a control 
throughout chapter three. 
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Figure 3-8: Monitoring NCAA dependence over time 
(Left) Escape events of four selected clones and TEM-1.D254tag monitored through 50 
generations. A sample of cells were screened for escape events every 10 generations, in 
triplicate.  
Figure 3-9: Liquid culture assays for loss of addiction after 50 generations 
(Right) After 50 generations of growth, a liquid media assay was used to screen large a 
larger E. coli population. Cultures containing carbenicillin were inoculated and growth in 




Figure 3-10: Bacterial escape at low antibiotic concentrations 
Escaped cells of TOP10 E. coli at lower carbenicillin concentrations. Samples were 
passaged in triplicate for 100 doublings in 250 μg ml-1 and 1000 μg ml-1, and plated on 
solid media without 3nY to determine escape occurrences. TEM-1.B9 had no escape 





Figure 3-11: Escape occurances of mutation-prone E. coli 
Strains from the Keio knockout collection (Baba et al., 2006) were passaged in triplicate 
for 100 doublings, and plated on solid media without 3nY to determine escape 
occurrences. Data reported as mean of biological triplicates ± s.d. The parental strain 
(BW25113), and a knockout of dnaQ, responsible for 3’ to 5’ proofreading of DNA 
polymerase III (Echols et al., 1983). 
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Figure 3-12: MICs of different bacterial species 
MIC values of E. coli strains and different bacterial species in the presence and absence 
of 1 mM 3nY. (1) TOP10 E. coli; (2) XL1-Blue E. coli; (3) BL21 E. coli; (4) RTΔA E. 
coli; (5) S. enterica; (6) S. flexneri; (7) Y. ruckeri; (8) A. baylyi. Asterisk denotes that the 
value for RTΔA does not represent the MIC as the strain grew at the maximal ampicillin 
concentration tested; this is expected as 3nY incorporation does not compete with RF1-




Figure 3-13: MIC plates of different bacterial species 
MIC results for TEM-1.B9 in bacteria using MIC strip testing on LB-agar with 1 mM 
3nY (top row) and without NCAA (bottom row). From left to right: Top10 E. coli, XL1-







Figure 3-14: Escaped cells in different bacterial species 
Escape frequency of E. coli strains and bacterial species after 100 generations. (1) TOP10 E. 
coli; (2) XL1-Blue E. coli; (3) BL21 E. coli; (4) RTΔA E. coli; (5) S. enterica; (6) S. flexneri; 
(7) Y. ruckeri. Notably, XL1-Blue cells contain the supE suppressor tRNA and are 
intrinsically ampicillin resistant with TEM-1.D254tag. Data represent mean ± s.e.m. of three 
or more biological triplicates. 
 
 
Figure 3-15:  Acinetobactor baylyi escaped cells 
Rates of 3nY independent ampicillin resistance development in A. baylyi ADP1 with and 
without plasmid encoded TEM-1 variants. TEM-1.B9 and TEM-1.D254tag were serially 
passaged to 50 doublings, and then a sample of 108 cells were plated onto LB-agar 
supplemented with 25 µg ml-1 ampicillin without 3nY. To determine the background rate of 
ampicillin resistance development in A. baylyi ADP1, wild type bacteria with no plasmids 
were grown to confluence and plated on 25 µg ml-1 ampicillin. Data reported as mean of 
biological triplicates ± s.d. 
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Figure 3-16: β-lactamase kinetics 
Kinetics data from wild-type TEM-1, TEM-1.B9, and TEM-1.D254tag. Data points are 




Figure 3-17: Melting curves of TEM-1 variants  
Melting curves of wild-type TEM-1, TEM-1.B9, and TEM-1.D254tag. Melting 
temperatures were determined to be 52.1±1°C for wild-type TEM-1, 51.5±2°C for TEM-




Figure 3-18: Sequencing reads of the TEM-1.B9 tag162NNS library  
The single codon library was grown in liquid media at a gradient of carbenicillin 
concentrations. Sequencing results indicated phenylalanine was the only amino acid that 
provided enzyme activity at carbenicillin concentrations greater than 500 µg ml-1. This 
was reaffirmed through solid media selections, and a comprehensive analysis of TEM-





Figure 3-19:  NCAA concentration dependent ampicillin resistance  
Ampicillin MIC in Top10 E. coli as correlated to NCAA concentration. The MIC is 
directly correlated to 3nY concentration in the solid media. Data represent mean of 
biological triplicates ± s.d.  
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Chapter 4: Progress Towards NCAA-Chemistry Dependence 
4.1 INTRODUCTION 
4.1.1 Previous work on generating NCAA dependent enzymes 
By evolving TEM-1 β-lactamase to function selectively upon site specific 
incorporation of the NCAAs 3nY or 3iY at the amber stop codon, we could maintain 
OTS activity in several bacterial species for at least one hundred generations without 
escape of NCAA dependence. The selected TEM-1 variant, TEM-1.B9, was structurally 
dependent on the physiochemical properties of 3nY or 3iY, and could not be 
compensated for with any amino acid within a single nucleotide polymorphism of the 
UAG stop codon. Despite this, the unique chemistry of the NCAAs was not used in any 
enzymatic role, but in a passive role for structural integrity of TEM-1. Additionally, 
while TEM-1.B9 successfully addicted several bacterial species, β-lactam antibiotics are 
entirely limited in use to prokaryotes, and largely Gram-negative eubacteria. NCAAs 
have been added to the genome of many organisms besides bacteria, including yeast and 
mammalian cells, and a more generalizable approach to NCAA addiction would have 
greater utility. Additionally, a lack of 3nY or 3iY was not inherently detrimental to a 
bacterium addicted to 3nY with TEM-1.B9, but required a supplemented β-lactam to be 
effective. An addiction system based on essential cellular function, which would become 
inactive in the absence of an NCAA could be used for OTS rentention, as well as 
biocontainment. Previous efforts to this end required significant reworking of a large 
number of genes throughout a genome (Mandell, 2015; Rovner, 2015). A more succinct 
effort, based on a single engineered enzyme would greatly facilitate trans-species NCAA 
addiction.  
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4.1.2 T7 RNA Polymerase 
The RNA polymerase from T7 bacteriophage (T7 RNAP) is single protein 
capable of transcription without any additional proteins or cofactors (Schenborn and 
Mierendorf, 1985). T7 RNAP recognizes a small 17 base-pair promoter that is orthogonal 
to and functions well in prokaryotic and eukaryotic hosts (Conrad et al.; Lieber et al., 
1989; Peretz et al., 2007; Studier and Moffatt, 1986). T7 RNAP has been used for in vitro 
RNA synthesis (Schenborn and Mierendorf, 1985), and in vivo RNA synthesis and 
protein overexpression (Studier and Moffatt, 1986). It is well-studied, with a 
comprehensive understanding of promoter recognition, and high resolution structural data 
in various conformations available (Cheetham et al., 1999; Temiakov et al., 2004; Yin 
and Steitz, 2004). T7 RNAP is amenable to engineering, and variants have been selected 
which recognize new promoter sequences while losing specificity for the native promoter 
(Meyer et al., 2015; Temme et al., 2012). These qualities make T7 RNAP an attractive 
target for engineering NCAA dependence.  
Having previously demonstrated that a protein can be engineered to be 
structurally dependent on NCAA incorporation, while having no role in enzymatic 
function, we wished to use the unique physiochemical properties bestowed by NCAAs 
for an active site chemistry. Several previous studies have shown that T7 RNAP could be 
engineered to recognize a panel of orthogonal promoter sequences, and that these could 
be used simultaneously in vivo without cross reactivity (Meyer et al., 2015; Temme et al., 
2012). While the T7 RNAP specificity loop is responsible for promoter recognition, the 
primary specificity-determining contacts are made through DNA promoter interactions 
with residues R746, N748, R756, and Q758 (Figure 4-1), and mutations in these amino 
acids often results in complete loss of T7 RNAP functionality (Imburgio et al., 2000). 
Indeed, the promoter specificity of T7 RNAP can be shifted for preference towards 
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unfavorable promoter sequences with just single amino acid substitutions in the promoter 
recognition loop (Imburgio et al., 2000; Raskin et al., 1993; Rong et al., 1998). As such, 
we desired to find promoters that were specifically recognized by NCAAs encoded at 
promoter interacting residues within T7 RNAP. 
4.2 APPROACH 
Since it is possible to change the promoter specificity of T7 RNAP with single 
amino acid substitutions at the promoter-interacting residues R746, N748, R756, and 
Q758 (Imburgio et al., 2000; Raskin et al., 1993; Rong et al., 1998), we chose to use 
these site for NCAA incorporation. We generated T7 RNAP variants with a UAG codon 
replacing one of each of the selected amino acids, and thus created four T7 RNAP 
variants; R746 (T7RNAP-R746X), N748 (T7RNAP-N748X), R756 (T7RNAP-R756X), 
or Q758X (T7RNAP-Q758X). Additionally, we created a control T7 RNAP with a UAG 
codon replacing the codon coding for D10 (T7RNAP-D10X), which is near the N-
terminus of T7 RNAP, is not structurally important, and does not significantly affect T7 
RNAP functionality (Figure 4-2). We used these constructs to search for promoters 
which were sequence specifically recognized by 3nY or 3iY at these positions.  
4.2.1 T7 Promoter Recognition with NCAAs 
We first needed to determine the activity of each T7 RNAP variant with the wild-
type T7 promoter (PT7). T7 RNAP expression was placed under the tetracycline 
expression system (Lutz and Bujard, 1997), which is tightly regulated, with minimal 
background, on the plasmid pRNAP. We used the Methanocaldococcus jannaschii 
tyrosyl-tRNA synthetase and corresponding tRNA that had previously been engineered to 
incoported 3iY, and has been shown to incorporate 3nY. We used a GFP reporter with 
the T7 promoter (PT7) under control of the lacO operator system as an indicator of T7 
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RNAP transcriptional activity. Since mutations with canonical amino acids at positions 
R746, N748, R756, or Q758 disrupt promoter recognition and largely deactivate T7 
based transcription, we expected that 3iY or 3nY replacing these positions would result in 
significantly reduced transcription, which in turn could be monitored with the GFP 
reporter under PT7. We used E. coli strain RTΔA (Thyer et al., 2015) to test T7 RNAP 
variant activities, and determine background expression of GFP under different 
expression conditions; in the presence and absence of anhydrous tetracycline (aTc), to 
induce T7 RNAP expression, and the presence and absence of IPTG to induce GFP 
expression. We tested each in media lacking NCAA, and with .5 mM of NCAA (either 
3nY or 3iY). The results (Figure 4-3) demonstrate that GFP expression, and thus T7 
transcription, is dependent on IPTG, aTc, and NCAA supplementation. Additionally, 
these results confirmed that T7RNAP-D10X is functional when incorporating either 3nY 
or 3iY, and thus makes an appropriate positive control. Finally, and most importantly, 
these results confirm that T7 RNAP is largely deactivated with 3nY and 3iY substitutions 
at every tested position used for promoter recognition. These results confirm that R746, 
N748, R756, and Q758 are acceptable T7 RNAP variants to select promoters to 
complement, as T7 RNAP with NCAAs at any of these positions is unable to recognize 
its natural promoter. 
4.2.2 GFP Selection 
We designed a simple screen to select for promoters which would be recognized 
by T7 RNAP variants with 3nY or 3iY at each position. Since the four tested positions 
recognize a small region of the promoter consisting of five nucleotides, (positions -7 to -
11 in PT7) (Figure 4-2), it was reasonable to create a promoter library randomizing all 
five of these positions that could be selected with all four T7 RNAP variants. There exist 
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1024 possible promoters in this randomized space (4 nucleotide possibilities at each of 
the 5 randomized nucleotides, 45=1024). The library was generated in front of GFP, and 
exceeded 10-fold coverage of the theoretical library size. A subsampling of 10 randomly 
selected colonies showed good sequence variation at the randomized positions. The 
library was transformed into RTΔA harboring each of the T7 RNAP variants and 
pSC101-NCAA, and plated on LB-agar with aTc and IPTG and either 1 mM 3nY, or 1 
mM 3iY. The following day, green colonies were selected for sequencing under blue 
light, (Figure 4-4), a similar ratio of fluorescent colonies was seen. To sample promoter 
diversity, we selected colonies with a range of fluorescent intensity from each T7 RNAP 
variant and each NCAA. A total of 96 were picked, 12 from each selection condition. 
Plasmids from each were subsequently purified and sequenced. Sequencing revealed an 
artifact in the promoter region of all 96 selected clones (Figure 4-5 and Figure 4-6) 
which resulted in a predicted strong prokaryotic promoter, as determined by Neural 
Network Promoter Prediction (Reese, 2001).   
4.2.3 CPR Selection of Active Promoters 
The GFP selection failed to identify T7 promoters that were selectively 
recognized by T7 RNAP variants in an NCAA dependent matter, instead enriching 
artifacts that encoded cryptic consensus sequence E. coli promoters. As such, we 
determined the best way to proceed would be a methodology that allowed for sequential 
positive and negative selections. The positive selection would enrich for promoters that 
are active with a T7 RNAP variant, while the negative selection would eliminate any 
consensus sequence E. coli promoters that might arise, from artifacts or the N5 sequence. 
T7 RNAP is an excellent enzyme for selections, as any gene (protein or RNA) can be 
expressed with a simple T7 promoter. As such, we elected to go with compartmentalized 
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partnered replication (CPR), an emulsion based positive selection system which has been 
successfully used to engineer T7 RNAP previously (Ellefson et al., 2014; Meyer et al., 
2015). 
4.2.3.1 Positive Selection 
CPR (Figure 3-7) uses the cellular production of Taq DNA polymerase as a 
selection criteria. Cellularly produced Taq DNA polymerase is then used for PCR 
amplification of the DNA sequence under selection. Cells are emulsified during PCR to 
ensure that Taq only amplifies the DNA from the host cell, and sequential rounds enrich 
for more active Taq producing sequences. We generated a T7 promoter library identical 
to that of the GFP screen, to drive the expression of Taq DNA polymerase. We conducted 
two rounds of CPR positive selection on each of the T7 RNAP variants with both 3nY 
and 3iY. We used a negative selection between the two positive rounds to eliminate any 
cryptic promoters which may have arisen during library assembly.  
4.2.3.2 Negative Selection 
For a negative selection, we used a plasmid encoded E. coli phenylalanyl-tRNA 
synthetase (pheS) containing the mutation A294G (mpheS). This mutation relaxes amino 
acid specificity, allowing for the incorporation of several aromatic NCAAs into the 
genome at phenylalanine codons (see Chapter 1). When growth media is supplemented 
with p-chloro-L-phenylalanine (PCPA) and mpheS is expressed, PCPA is incorporated 
throughout the genome and host fitness is affected, or the host become nonviable (Ibba 
and Hennecke, 1995). This negative selection has been used as a negative selection with 
CPR previously (Maranhao and Ellington, 2016). After the first round of positive 
selection with CPR, the library was cloned into the mpheS negative selection plasmid 
backbone, and transformed into TOP10 E. coli. Transformant cultures were grown 
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overnight in 5 mM PCPA and 100 µM IPTG. After overnight growth, the plasmid was 
purified from the culture and the promoter sequences were amplified using PCR, and 
cloned into the Taq expression vector for a second round of CPR.  
4.2.3.3 GFP Characterization 
After a second round of CPR positive selection, the selected promoters were 
cloned into in front of a GFP expression cassette, and transformed into RTΔA E. coli 
containing pSC101-NCAA and the proper T7 RNAP variant. Transformants were plated 
and grown overnight and then individual colonies from each condition were picked and 
tested for GFP expression. We tested each selected promoter with the T7 RNAP variant 
and NCAA with which it had been selected. We tested 16 from each condition, for a total 
of 160 promoters (D10X, R746X, N748X, R756X, and Q758X). We identified two 
potential promoters from this characterization, one which showed a 10-fold increase over 
background fluorescence (promoter D3, PD3) and one which showed a 2-fold increase 
(promoter A2, PA2). Both of these promoters were selected for activation with 3nY 
incorporated into the promoter recognizing region, PA2 was selected with T7RNAP-
R746X, and PD3 was selected with T7RNAP-N748X. We sequenced both promoters, PD3 
was a single nucleotide away from the wild-type cognate T7 promoter, (GACTC to 
GCCTC), and PA2 had three mutations from the wild-type promoter (GACTC to 
GGTTG).  
We cloned the two identified promoters, PD3 and PA2 into another GFP construct 
and retested to verify promoter activity with the corresponding T7 RNAP variants. We 
also wanted to explore possible cross-reactivity with T7RNAP-D10X, to determine 
orthogonality to wild-type T7 RNAP (Figure 4-8). Our results verified PD3 activity with 
3nY incorporated into T7RNAP-748X, but also showed that PD3 was recognized by 
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T7RNAP-D10X with near cognate efficiency, suggesting that our promoter was not 
specific for 3nY. Upon recharacterization, we saw no increase in GFP expression with 
PA2. Additional characterizations of PA2 showed no increase in GFP expression with any 
T7 RNAP variants.  
4.3 DISCUSSION 
T7 RNAP is an attractive target for NCAA addiction. It is functional in a wide 
range of organisms, can be used to drive positive and negative selections, and can be 
incorporated into genomes to drive essential pathways. Utilization of an NCAA in 
promoter recognition is possible, as was demonstrated here with PD3. While PD3 was not 
orthogonal to wild-type T7 RNAP recognition, this work demonstrates that promoters can 
be made to accommodate NCAAs in the promoter recognition domain of T7RNAP. The 
theoretical library size of the promoter selected here (~1000 variations) is relatively 
small, and while R746, N748, R756, and Q758 only recognize these nucleotides, 
upstream or downstream effects in the promoter, or other T7 RNAP promoter recognition 
domain may play some role in recognition, as seems apparent in previous studies (Meyer 
et al., 2015), and a larger library could increase the chances of finding NCAA specific 
promoters. Alternatively, accommodation of 3nY or 3iY in the positions selected could 
have significant structural effects on T7RNAP, which could inactivate some T7 RNAP 
variants entirely. Additionally, selection with NCAAs capable of unique interactions 
would likely be beneficial, amino acids such as DOPA, which can readily form multiple 
hydrogen bonds, or metal chelating amino acids might provide unique interactions which 
could aid in nucleic acid recognition in a way that may not be compensated with the 
canonical genetic code.  
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4.4 MATERIALS AND METHODS 
4.4.1 Strains and Reagents 
TOP10 E. coli (Life Technologies) was used for routine cloning of plasmids and 
the mpheS negative selection. Amberless E. coli strain RTΔA (derived from C321.ΔA) 
was described previously (Thyer et al., 2015) was used for positive selection with CPR. 
NCAAs 3-nitro-L-tyrosine, 3-iodo-L-tyrosine, as well as PCPA were purchased from 
Sigma-Aldrich. LB media (Fisher BioReagents) was used for culturing all E. coli in all 
conditions, and LB-agar (Fisher BioReagents) was used for plating of cultures and cells 
for screens and cloning. Antibiotics were used at concentrations of 50 μg ml-1 kanamycin, 
100 μg ml-1 ampicillin or carbenicillin, and 150 μg ml-1 spectinomycin. Libraries and 
plasmids were constructed with oligos purchase from Integrated DNA Technology. 
Plasmids were sequence verified with Sanger sequencing at the University of Texas at 
Austin Core Facilities.  
4.4.2 Plasmid Construction 
Plasmid pSC101-NCAA was constructed using the pNCAA plasmid (Ellefson et 
al., 2016) as a template for OTS, and inserted into the pTH18kr backbone (GenBank 
AB019603.1) which contains the low copy SC101 origin (Hashimoto-Gotoh, 2000) and 
kanamycin resistance marker, using Gibson cloning (Gibson, 2009). T7 RNAP plasmid 
was provided by Shaunak Kar at the University of Texas at Austin. Briefly, it was built 
upon the TetR/O regulatory system (Lutz and Bujard, 1997) with the P15A origin of 
replication, and a weak RBS (BioBricks Part Number BBa_J61101). In-frame UAG 
codons were added using the Gibson method for site directed mutagenesis (Gibson, 
2009). GFP, Taq DNA polymerase, and mpheS were encoded in the pCDF-duet 
backbone (Novagen), with the CloDF origin and spectinomycin resistance marker. DNA 
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sequencing surrounding encoded T7 promoter were reduced to a minimal sequence to 
eliminate cryptic prokaryotic promoter formation.  
4.4.3 Library Construction 
DNA oligos with 5 randomized positions were used to amplify pCDF-GFP or 
pCDF-Taq. PCR products were purified with agarose gel electrophoresis, and 
reassembled with Gibson method (Gibson, 2009). Individual clones, as well as library 
mixture, were sequenced to verify random promoter sequences with no detected biases.  
4.4.4 GFP Screen 
Plasmids pSC101-NCAA and pTET-T7 for each T7 RNAP variant were 
transformed into RTΔA E. coli and plated on plates supplemented with kan and amp. A 
single colony from each was selected and grown to midlog phase (OD600 approximately 
0.6), and made electro-competent using serial glycerol washes, followed by 
electroporation as described above with purified promoter library plasmid. Transformants 
were recovered in LB media for 1 hour at 37°C and plated at various dilutions on agar 
plates supplemented with spec, kan, amp, 100 μM IPTG and 100 ng ml-1 aTc, as well as 
.5 mM 3nY or 3iY. Plates were incubated overnight at 37°C, and imaged under blue 
light. Green colonies of various fluorescent intensities were selected for sequencing. 
Sequences were analyzed for prokaryotic promoters using Neural Network Promoter 
Prediction (Reese, 2001). 
4.4.5 CPR Positive Selection 
pSC101-NCAA plasmid and pTET-T7 plasmid, containing each T7 RNAP 
variant, were transformed into RTΔA E. coli and plated on plates supplemented with kan 
and spec. A single colony from each transformation was selected and made 
electrocompotent as described above, and transformed with pTaq plasmid with promoter 
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library. Cultures were recovered at 37°C in LB for 1 hour, then established overnight in 
LB supplemented with spec, kan, and amp.  
A 100 µL aliquot from each overnight culture was used to inoculate 5 ml of fresh 
LB with .5 mM 3ny or 3iY, and kan, spec, and amp. Cultures were grown at 37°C for 1 
hr then induced with 50 ng ml-1 of aTc and 100 µM IPTG, and incubated for 3 more 
hours at 37°C. After the 3 h expression, cells (300 μl) were spun down (15 min, 1500g, 4 
°C) and washed twice with Taq buffer (50 mM KCl, 10 mM Tris-HCl pH 8, 1.5 mM 
MgCl2). Washed cells were resuspended in 300 μl CPR buffer (50 mM KCl, 10 mM Tris-
HCl pH 8, 1.5 mM MgCl2, 200 μM dNTP, 0.3 nM each CPR1 primer, 100 μM). 
Resuspended cells were added to a 2 ml microtube containing: 876 μl Tegosoft 
(Evonik), 240 μl mineral oil (Sigma), 84 μl AbilEW09 (Evonik), and the rubber tip from 
a 1 ml syringe. This mixture was chilled at 4°C while rotating for 5 minutes. The mixture 
was emulsified using a TissueLyser LT (Qiagen), which was operated at 42 Hz for 4 min 
at 4°C. Emulsified cells were dispersed in 100 µL aliquots and thermal cycled [95°C:3 
min, 20 cycles of (95°C:30s, 59°C:30s, 72°C:10s), 72°C:5 min]. Post PCR emulsions 
were pooled and centrifuged (10 min at 12000g), and the top layer of oil was removed. 
The remaining emulsion was broken by applying an equal volume of phenol:chloroform 
mixture (1:1) (Sigma) and vortexing. The broken emulsion was then applied to a 
PhaseLock tube (5 Prime) and centrifuged for 2 minutes at 16000g. The top aqueous 
fraction (upper layer) was transferred to a microtube and an equal volume of chloroform 
(Sigma) was added, vortexed and placed in a new PhaseLock tube and centrifuged for 2 
minutes at 16000g. The aqueous layer from this second extraction was collected and 
column purified (Zymo Research Corp). The elution from column purifications was used 
as template for the secondary recovery PCR using Pfusion polymerase (Invitrogen) and 
CPR2 primers specific to the overhang regions of CPR1 primers. These secondary PCR 
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products were run on a 1.5% agarose gel. The band corresponding to the desired PCR 
amplicon was excised from the agarose gel and extracted (Promega). This purified 
secondary amplicon was used as template for the third PCR, which generated sufficient 
product for Gibson cloning into the pCDF-mpheS plasmid and transformed into TOP10 
E. coli. 
4.4.6 PCPA Negative Selection 
Transformation efficiencies for the Gibson cloning after CPR positive selection 
exceeded 103 on each selection condition, as determined by dilution plating. The 
promoter libraries in pCDF-mpheS were recovered in LB at 37°C for 1 hour, then added 
to LB supplemented with spec, 1 mM IPTG, and 5 mM PCPA and incubated overnight 
for no more than 12 hours. After 12 hours, plasmids from cultures were purified and used 
as a template for PCR with CPR3 primers. PCR product was run on 1.5% agarose gel and 
band extracted as described above. Purified product was used to Gibson clone into pTaq 
backbone, which were then used for a second round of positive CPR selection.  
4.4.7 GFP Characterization 
After the second round of CPR positive selection, gel purified PCR product 
containing the selected promoter library was cloned into pCDF-GFP plasmid. The 
purified promoter library was transformed into RTΔA containing pSC101-NCAA and 
appropriate T7 RNAP variant as described above, and plated on kan, amp, and spec 
supplemented LB-agar and incubated at 37°C for 12 hours. Individual colonies were 
selected and grown overnight in LB with kan, amp, and spec, and incubated for 16 hours 
overnight. Saturated overnight cultures were diluted 1:1000 to inoculate 1 ml of fresh LB 
supplemented with .5 mM 3nY or 3iY as appropriate, kan, amp, and spec at half normal 
concentration, after 1.5 hours, 50 ng ml-1 of aTc and 100 µM IPTG were used to induce 
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cultures, and incubator an additional 5 hours. After induction period, cultures were 
serially centrifuged at 2000g for 10 minutes and washed with PBS. Fluorescence was 
measured in Tecan M200 pro, using 475 nm excitation and reading at 525 nm wavelength 
for emission, and normalized to OD600 measurement. D10 with PT7 and three samples 
from PLIB were used as controls on each plate. The same protocol was followed for 
















CPR1 f GCAAAACCGATCAGGCGCCCTTCCCGGCTCTCCCTTATGCGACTCCTGCATTAGGAAATTAATAC 
CPR1 r CGGATCTCAGCACTGCAGCGGTGGTCTCCCCATGGTATATCTCCTTAACAATTGTTATCCGCTCACAATTCCCCTATAGT 
CPR2 f GCAAAACCGATCAGGCGCCCTTCCCGG 
CPR2 r CGGATCTCAGCACTGCAGCGGTGGTCTCCC 
CPR3 f CTCTCCCTTATGCGACTCCTGCATTAGGAAATTAATAC 









Table 4-1: Primer sequences 




Figure 4-1: T7 RNAP promoter recognition 
 Structural basis of T7 RNAP promoter recognition. T7 RNAP specificity loop (pale 
green) interacts with the DNA promoter sequence. Residues R746 (green), N748 (blue), 
R756 (yellow), and Q758 (teal) recognize nucleotide positions -7 to -11 within the T7 
promoter seqeunce (pink/red nucleotides). Pink and red nucleotides were randomized in 
the T7 promoter library, and screened against T7 RNAP variants with 3nY or 3iY 




Figure 4-2: T7 D10X Control  
Structure of the D10X positive control used throughout this work. D10 (bottom, red), 







Figure 4-3: T7 RNAP functionality assays  
T7 RNAP functionality assays as determined by a GFP reporter. T7 RNAP activity was 
tested in media without aTc or IPTG (black bars), in media with 100 ng ml-1 aTc (yellow 
bars), in media with 500 µM IPTG (green bars), and media supplemented with aTc and 
IPTG (blue bars). All were tested without NCAA supplementation (no border), and with 
500 µM of NCAA (red borders), using both 3nY (top), 3iY (bottom). Wildtype T7 RNAP 
was active with aTc and IPTG, while control D10X required NCAA supplementation to 
be fully active. R746X, N748X, R756X, and Q758X were largely inactive under all 
conditions, except for Q758X, which has some activity without the NCAA added, 
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Figure 4-4: GFP screen result  
Imaging of promotor library driving GFP from a library selection plate. Green colonies 






Figure 4-5: GFP screen T7 promoter sequences  
Sequencing of promoters selected from Plib GFP selection plates. Green colonies were 
selected for sequencing and all selected clones revealed a promoter artifact that expressed 
GFP in a T7 independent manner using a predicted E. coli promoter.  
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Figure 4-6: GFP cryptic promoter sequences  
Imaging of promotor library GFP selection plate. Green colonies were picked for 







Figure 4-7: CPR Selection Scheme  
The PLib library was built to drive the expression of Taq DNA polymerase. Cells 
containing promoters which were read by the T7 RNAP variant they contained would 
express and build up Taq DNA polymerase. Cells were emulsified with primers to 
amplify the promoter sequence, and if Taq was present, PCR would successfully amplify 
the active promoters. Active promoters were then cloned into a negative selection vector, 
to remove cryptic promoters, as seen in the GFP selection attempt. A second round of 




Figure 4-8: NCAA recognized promoter characterization 
GFP assays to determine the activity of promotors identified after two CPR rounds of 
positive selection and a PCFA negative selection against T7 RNAP variants. The 
promoter PD3 is recognized by the T7 RNAP variant T7-N748X with 3nY incorporation. 




















Chapter 5: Evolution with an Expanded Genetic Code 
Evolution has been limited to the 22 proteinogenic amino acids of the natural 
genetic code. While several theories on the evolutionary origin of the code have been 
proposed, experimental exploration of these theories is largely restricted to computational 
modeling and phylogenetic evaluation. Advances in genetic code expansion, through the 
addition of noncanonical amino acids (NCAAs), provide tools to explore proposed 
mechanisms of genetic code evolution. Several recent reports demonstrate that expanded 
genetic codes can provide fitness advantages through the unique physiochemical 
properties of NCAAs or by creating new mutational routes for evolution. Here we report 
the first long-term bacterial evolution of a genetically unaltered wild-type bacteria with 
an ambiguously translated amber (UAG) stop codon. Our results reveal several adaptive 
mutations in the addiction cassette and across evolved genomes. Evolved cells also 
decreased amber suppression efficiency, and increased fitness as measured by growth 
rates. 
5.1 INTRODUCTION 
Terrestrial evolution has been confined to the natural genetic code comprising the 
20 canonical amino acids as well as selenocysteine and pyrrolysine, two rare, naturally 
occurring amino acids. These amino acids are encoded by nucleotide codons, which are 
decoded in the ribosome using transfer RNAs (tRNAs).  In total, 64 codons are available, 
of which 61 signal for codon-specific amino acids and three signal translational 
termination. The genetic code was established early in evolutionary history, and is largely 
shared among all life. While several theories exist for the evolution of the genetic code, 
experimental evaluation of proposed theories has largely been limited to computational 
modeling and genomic analysis. Proposed processes in the evolution of codon 
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arrangement and assignment include codon capture (Osawa and Jukes; Osawa et al., 
1992), ambiguous intermediate codons (Schultz and Yarus, 1994), and genome 
streamlining (Andersson and Kurland, 1998). None of these evolutionary processes are 
yet observed in controlled laboratory conditions. Despite the lack of direct observation, 
the existence of alternative codes (e.g. mitochondrial genomes), which likely evolved 
from the standard codon table, provides evidence that the genetic code is not frozen in its 
current state (Knight et al., 2001).  
Orthogonal translation systems (OTSs) comprising aminoacyl tRNA synthetase 
(aaRS)/tRNA pairs independent of the hosts translational machinery enable addition of 
new chemistries to the genetic code in vivo. These OTSs are typically engineered to 
incorporate noncanonical amino acids (NCAAs) at the amber (UAG) stop codon, thereby 
expanding the set of proteinogenic amino acids available to the host organism. The use of 
UAG as the NCAA codon results in an ambiguously read codon throughout the genome; 
during translation, amber codons can be read by release factor 1 and signal translational 
termination or be read as a cognate codon by the orthogonal tRNA and incorporate an 
NCAA into the translating protein. In bacteria, UAG codon ambiguity has significant 
fitness effects, and without a functional dependence on NCAA incorporation E. coli 
populations rapidly deactivated the encoded OTS (Tack et al., 2016; Wang et al., 2014). 
These fitness effects are due in part to the elongation of cellular proteins which naturally 
terminate with the UAG codon (Mukai et al., 2011). When UAG is read as a cognate 
codon with near 100% efficiency, E. coli is severely compromised or nonviable (Johnson 
et al., 2012; Mukai et al., 2011). The fitness cost of OTSs can be mitigated by reassigning 
a number or all genomic TAG codons to alternative stop codons (Isaacs et al., 2011; 
Mukai et al., 2015).  
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Evolutionary studies have revealed a number of adaptive approaches bacteria take 
to increase fitness over short evolutionary time periods (Gayán et al., 2016; Horinouchi et 
al., 2015; Lenski et al., 1991). Engineered OTSs can incorporate chemistries not typically 
available with canonical amino acids including covalent crosslinking, metal chelation, 
and redox chemistry. These new chemistries can enable functions previously inaccessible 
through adaptation and evolution. Pyrrolysine and selenocysteine are chemically unique 
proteinogenic amino acids which are irreplaceable in their natural context, demonstrating 
that expanded codes have evolved and become essential in nature. It was recently shown 
that T7 bacteriophage with access to an expanded genetic code would evolve to use 3-
iodotyrosine in its genome to reach new fitness peaks (Hammerling et al., 2014). More 
recently, it was demonstrated that NCAAs assigned to UAG codons can provide new 
evolutionary paths to rifampicin resistance (Hammerling et al., 2016). These studies used 
engineered E. coli lacking release factor 1, which eliminates competition for the UAG 
codon, allowing for nearly cognate UAG translation in the ribosome. Evolutionary 
exploration of ambiguous codons in wild-type E. coli has not been demonstrated, likely 
due to the inactivation of OTSs during short evolutionary time periods (Tack et al., 2016; 
Wang et al., 2014). 
5.2 APPROACH 
5.2.1 Experimental Design 
We wished to examine the long-term adaptation and evolution of E. coli strains 
addicted to an unnatural amino acid, 3-nitrotyrosine (3nY). As a chassis for evolution, we 
chose to use E. coli strain MG1655 because it is well-characterized, with a sequenced and 
annotated genome (Blattner et al., 1997). MG1655 is autotrophic for all 20 canonical 
amino acids allowing for robust growth in amino acid knockout media.  
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MG1655 transformed with a plasmid encoding a non-reverting β-lactamase 
(TEM-1.B9) previously selected to be dependent on 3nY was used as a starting point for 
selection6. However, since TEM-1.B9 with 3nY already conferred resistance to high 
levels of ampicillin this would have prevented progressive selections for improved 
accommodation and incorporation. We therefore further engineered TEM-1.B9 to use 
ceftazidime (CAZ) as a substrate. We altered the Ω-loop of TEM-1.B9 to include 
mutations W165Y, E166Y, and P1657G (Figure 5-1), which are known to change TEM-
1 from a penicillinase to a cephalosporinase (Palzkill et al., 1994; Stojanoski et al., 2015).  
This new β-lactamase, TEM-1.B9YYG-3nY, conferred moderate resistance to CAZ in a 
3nY-dependent manner (Fig. 1) at much lower concentrations commonly used in 
bacterial cultures (3-10 μg ml-1, Figure 5-2).  In addition to the β-lactamase the plasmid 
contained an Methanocaldococcus jannaschii tyrosyl-tRNA synthetase (aaRS) previously 
engineered to be specific for 3-iodo-L-tyrosine (3iY) (Sakamoto et al., 2009), but which 
has also been demonstrated to be highly compatible with 3nY (Tack et al., 2016) (Figure 
3-5), and the corresponding M. jannaschii tyrosyl-tRNA with the anticodon engineered to 
be complementary to the UAG amber stop codon.    
Finally, we also created a control using TEM-1.B9YYG with phenylalanine 
(TTT) at position 162 (TEM-1.B9YYG-Phe).  Phenylalanine is the only canonical amino 
acid that produces a functional TEM-1.B9 β-lactamase when replacing 3nY162.  TEM-
1.B9YYG-Phe conferred CAZ resistance in a 3nY-indepednent manner. 
Strains were passaged in three different mixtures of amino acids in MOPS-EZ 
Rich Defined Medium (RDM). The first mixture contained all 20 standard amino acids 
(condition 1, RDM-20), the second mixture lacked tyrosine (condition 2, RDM-19), and 
the third mixture lacked serine, leucine, tryptophan, glutamine, tyrosine, lysine, and 
glutamate (condition 3, RDM-13) (Figure 5-3). These seven amino acids represent all 
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amino acids coded by codons accessible through single nucleotide mutations from the 
UAG stop codon, and thus represented the most stringent selection condition, where any 
single mutation would not necessarily acquire a ready source for suppression. Each media 
condition was supplemented with 10 mM 3nY, matching the concentration of L-serine, 
the most abundant amino acid in RDM. 
5.3 DESIGN AND RESULTS 
5.3.1 Conditions 
We selected three clones with 3nY suppression dependence (TEM-1.B9YYG-
3nY), and three clones that did not require suppression for growth (TEM-1.B9YYG-Phe). 
These strains were denoted as 3nY-A, 3nY-B, and 3nY-C, and Phe-A, Phe-B, and Phe-C. 
Each clone was passaged in each of the three different amino acid environments 
described above (e.g. 3nY-A1, 3nY-A2, 3nY-A3).  
The cultures were passaged daily by inoculating 5 ml of RDM with 1 µL of 
overnight growth. This resulted in approximately 12.5 generations per daily passage. 
During the course of passaging, CAZ concentration was increased at a rate of 1 µg ml-1 
per 100 generations to a final concentration of 22 µg ml-1 to provide evolutionary 
pressure and ensure enforcement of 3nY dependence. Progenitor clones proved largely 
incapable of growth in RDM-13 when supplemented with 3nY, even in the absence of 
CAZ (Table 5-1 and Table 5-2), so for the first 10 passages in RDM-13 the media was 
supplemented with 25% RDM-19. After these initial 10 passages, all lines were capable 
of growth in RDM-13.  
At the conclusion of 80 passages, corresponding to 2000 generations, we selected 
a single clone from each evolved line and condition and sequenced the bacterial genomes 
of the single clone as well as then entire bacterial culture using HiSeq4000 Illumina 
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platform. Selected cells were, in general, genotypically representative of the average 
bacterial population. We further characterized phenotypic parameters of the selected 
evolved and progenitor cells. 
5.3.2 Growth Rates 
We measured the growth rates of progenitor strains in all three media conditions 
and the growth rates of the evolved strains in the media in which they were evolved. 
Growth rates were measured with and without 3nY, and with and without 2 or 22 µg ml-1 
CAZ, doubling times were calculated based on growth rates in the absence of CAZ and 
with or without 3nY (Table 5-2).  
The growth rate of the wild-type MG1655 was slowed by differing amino acid 
supplements, as well as by the addition of 3nY to the media (Table 5-1). Cells containing 
the 3nY OTS had similar growth rates to wild-type MG1655 in RDM-20, irrespective of 
whether 3nY was added to the media.  However, in RDM-19 and RDM-13 the addition 
of the 3nY in the presence of its OTS further suppressed growth rates. It appears as 
though both amino acid limitation and the presence of the unnatural amino acid impact 
metabolism, and this impact is enhanced if the unnatural amino acid can be incorporated. 
In other words, there are multiple components to cellular fitness in the presence of the 
unnatural amino acid, some of which depend on translation, and some of which do not. 
Over the course of evolution, the growth rates of all lines increased in all 
conditions, with the exception of Phe-B3, which showed no growth in media lacking 3nY 
(discussed in 5.3.5.5). The relative fitness effects associated with media conditions 
remained consistent even after evolution; growth rates were highest in RDM-20 without 
NCAA, and greater metabolic stresses with decreasing numbers of amino acid 
supplements resulted in decreases in growth rates. Surprisingly, though, large growth 
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deficits that were seen with RDM-13 could be largely overcome during evolution. As was 
the case with the wild-type strains, it appears that some growth deficits were due to 
incorporation of 3nY, and some not (compare the initial growth deficits and evolutionary 
recoveries of strains with and without the OTS under RDM-13 growth conditions), but 
both types could be largely repaired over the course of evolution.  
Since the OTS used is capable of incorporation the NCAA 3-iodo-tyrosine (3iY) 
as well as 3nY, we also tested growth rates of all lines with 3iY. Growth rates of 
progenitor cells were less affected by 10 mM of 3iY than by 3nY (Table 5-1 and Table 
5-2), but trends were similar. Interestingly, lines evolved to accommodate 3nY appeared 
to equally well accommodate 3iY, indicating that many of the evolutionary adaptations 
are not amino acid specific (Table 5-2). 
5.3.3 Retention of the OTS 
Given the experimental set-up, the primary question we were addressing was 
whether strains that were addicted to the orthogonal translation system would retain it 
and utilize it differently or better than strains that were not addicted to the OTS. To 
evaluate the functionality of the OTS we measured UAG suppression efficiency with a 
GFP reporter system that contained a tyrosine (TAT), amber (TAG), or ochre (TAA) at 
position Y39 of GFPmut2. We tested the GFP reporters in each selected evolved clone, as 
well as the progenitor clones. All of the addicted cell lines remained capable of efficient 
amber suppression (>25% 3nY incorporation at UAG codons) (Figure 5-4, top). In 
contrast, three of the nine non-addicted cell lines (Phe-A1, Phe-B2, and Phe-C2) had lost 
UAG suppression capability (<1% 3nY incorporation) (Figure 5-4, bottom). 
Surprisingly, UAG suppression efficiency dropped in both 3nY addicted and 3nY 
independent lines, relative to parental controls. 
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Of the 3nY addicted lines, only 3nY-A2 acquired any mutations in the OTS, 
acquiring a T->G mutation in the tRNA processing region at position T(-28).  In contrast, 
in the nonaddicted lines OTS mutations occurred in the Phe-A1, A2, B2, and C2 lines. 
Line Phe-A1 and Phe-B2 have 3nY-aaRS mutations. In line Phe-A1, a single nucleotide 
deletion creates a frameshift in the 3nY-aaRS and resulted in a TGA ochre stop codon at 
position 123 in the 3nY-aaRS, resulting in complete loss of UAG suppression (Fig 3). 
Line Phe-B2 contains an IS-1 mediated insertion, a mechanism that has previously been 
observed to inactive OTS machinery (Wang et al., 2014). Lines Phe-A2 and Phe-C2 had 
mutations in the tRNA. The Phe-A2 plasmid contained a G26C substitution in the hinge 
between D-stem and C-stem (Figure 5-5, blue), while the Phe-C2 plasmid has a G42A 
substitution in the C-stem of the tRNA. The latter mutation is predicted to compromise 
tRNA structure, as determined using mfold (Zuker, 2003) and tRNA prediction software 
(Schattner et al., 2005) (Fig 5-5, red). This tRNA mutation potentially explains the 
complete loss of UAG suppression in the Phe-C2 line (Fig 3).  
Overall, either the presence of a suppressor tRNA or more specifically the 
incorporation of 3nY puts cells at a fitness disadvantage, and in the absence of addiction 
to the unnatural amino acid this trait can be readily lost. Given that strains that 
incorporate 3iY grow as well as strains that incorporate 3nY, the fitness disadvantage can 
be attributed more to suppression itself rather than a particular NCAA. 
5.3.4 Evolution of antibiotic resistance 
During the course of passaging the cultures, CAZ concentrations were increased 
to levels beyond the MIC of the progenitor strains (the initial MIC of lines was 
approximately 2-6 µg ml-1, while the final CAZ concentration challenge was 22 µg ml-1). 
Increased bacterial survival at increasingly higher CAZ concentrations indicated that 
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CAZ resistance was evolving in the lines. We measured the MIC of each evolved clone 
with and without 3nY (Figure 5-2). The 3nY addicted lines remained dependent on 3nY 
for improved ceftazidime resistance, while the MICs of TEM-1.B9YYG-Phe lines 
increased in a 3nY-independent manner.  
All nine of the addicted cell lines acquired at least a single mutation in TEM-
1.B9YYG-3nY during evolution, (Table 5-3). Many of these mutations are known or 
expected to be stabilizing mutations of TEM-1 β-lactamase (Bershtein et al., 2008; 
Jacquier et al., 2013; Kather et al., 2008; Perilli et al., 2005; Salverda et al., 2010).  Some 
mutations are specific to TEM-1.B9, which originally included a number of substitutions 
relative to the wild-type enzyme that addicted it to 3nY. The new substitution T139I is 
more similar to the original wild-type residue, leucine, but does not reduce the 3nY 
dependence of the enzyme.  Of the non-addicted lines β-lactamase genes from Phe-A1, 
B1, C1, A2, and C2 acquired β-lactamase mutations, while β-lactamase genes from Phe-
B2, A3, B3, and C3 were unchanged during evolution.  The higher rate of mutation for 
TEM-1.B9YYG-3nY relative to the wild-type β-lactamase gene indicates that the enzyme 
dependent upon the unnatural amino acid was not initially as fit as its wild-type 
counterpart, especially in the presence of increasing antibiotic concentrations. 
The phenotypic impact of the β-lactamase mutations was further examined by 
taking plasmids purified from the evolved lines and transforming them into native 
MG1655 (Figure 5-6).  Notably, plasmids from 3nY-B1, A2, B2, C2, and A3 yielded 
increases in MIC greater than 2-fold the original MIC. These plasmids all contained the 
β-lactamase mutations known or suggested to have stabilizing effects (Table-5-3). 
However, β-lactamase mutations cannot fully explain MIC changes, as plasmids 3nY-C2 
and 3nY-C3 have the identical mutation (T138K) yet confer different MICs when 
transformed into MG1655.  
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Beyond mutations in the β-lactamase gene itself, increases in MIC may have also 
been the result of other plasmid or genomic mutations that altered antibiotic resistance 
through other mechanisms. For example, plasmid 3nY-C3 has a mutation in repC, which 
can affect copy number (Haring et al., 1985).  In addition, several genomic genes 
accumulated mutations that are known to have a role in antibiotic tolerance. Four lines 
had mutations in envZ, a histidine kinase that regulates ompF and ompC expression, 
which in turn alter membrane porosity and have been tied to β-lactam resistance (Jaffe et 
al., 1982). In the same vein, line 3nY-C3 has an ompF mutation. Mutations to cyaA or 
crp, two related proteins directly or indirectly involved in transcriptional regulation, 
occurred in eight evolved lines (3nY-B1, B2, C2, A3, C3 and Phe-A2, C2, C3); 
inactivation of these genes has been shown to produce resistance to β-lactams (Jaffé et 
al., 1983; Ruiz and Levy, 2011). The opgG gene was mutated in 3nY-C1,A2 and Phe-B1, 
and is involved in conferring resistance to antibiotics (Hanoulle et al., 2004). Finally, 
lipopolysaccharide (LPS) expression has been tied ceftazidime treatments, especially at 
or near MIC levels, and several lines had mutations in LPS biosynthetic genes (Leying et 
al., 1992; Pagani et al., 1990).  
Beyond the stabilization of TEM-1.B9YYG-3nY there were few changes specific 
for lines that were addicted to 3nY relative to those that were not addicted to 3nY.  None 
of the lines appear to use an expanded genetic code to increase fitness through 
ceftazidime resistance. 
5.3.5 Genomic adaptations 
As anticipated, the number of mutations acquired by a strain scaled with the 
stringency of selection. Full genome sequencing and analysis revealed that the lines 
addicted to 3nY acquired more mutations than those not addicted (there were a total of 
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forty-nine ORF-affecting mutations in the nine TEM-1.B9YYG-3nY strains, and a total 
of forty mutations in the nine TEM-1.B9YYG-Phe strains). Additionally, mutations 
increased in knockout media, with 3nY and Phe totaling twenty-two mutations in RDM-
20, thirty-one mutations in RDM-19, and thirty-six mutations in RDM-13 (Table 5-4, 
and Table 5-5).  Several trends were seen among evolution conditions and genes affected 
during evolution. There were seven mutations that appeared across multiple lines, 
summarized in (Table 5-6).  
5.3.5.1 Tyrosine transporter tyrP 
The tyrP gene, a tyrosine specific permease (Andrews et al., 1991), was deleted or 
otherwise inactivated in ten of the eighteen evolved lines, including all six lines (with and 
without the addicted β-lactamase) evolved in RDM-13 and all three TEM-1.B9YYG-Phe 
lines evolved in RDM-19, as well as 3nY-C2. Inactivation of the tyrP gene in lines 3nY-
C2, A3, B3, C3, Phe-A2, B2, A3, B3, and C3 involved IS-mediated knockouts of varying 
lengths, while line Phe-C2 contained a SNP that generated a stop codon (W357tag). In 
contrast, the tyrP gene remained unaffected in all six lines evolved in media 
supplemented with tyrosine (RDM-20). Since 3nY is structurally similar to tyrosine, it is 
possible that 3nY was using tyrP for cell entry, and thus deactivating tyrP increased 
fitness in media lacking tyrosine (RDM-19 and RDM-13). To test this hypothesis, we 
used the Keio knockout collection (Baba et al., 2006) to examine the fitness effects of a 
tyrP deficiency in RDM with and without 3nY. The results (Figure 5-7) show tyrP 
knockout has no effect on growth compared to wild-type E. coli in RDM-20 and RDM-
19, but significantly delays growth in RDM-13, both with and without 3nY. Thus, tyrP 
does not appear to mediate 3nY toxicity, at least as measured by growth conditions.   
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5.3.5.2 Methionine transporter mtr 
Another transporter (mtr, specific for typtophan) (Brown, 1970) was the third 
most mutated gene amongst evolved lines. Mutations of mtr occurred in five of the six 
lines evolved in RDM-13, including all expect Phe-B3. Again, in contrast the mtr gene 
remained intact in all lines evolved in tryptophan rich media (RDM-20 and RDM-19). 
We used the mtr knockout from the Keio knockout collection (Baba et al., 2006) to 
explore the possibility that mtr involved in 3nY-induced fitness effects. Growth curves 
again show mtr knockouts did not increase cellular fitness in RDM-13 with 3nY (Figure 
5-7).  
5.3.5.3 cyaA/crp mutations 
The second most common mutational target during evolution was adenylate 
cyclase cyaA, which activates the transcriptional regulator crp, which was also mutated in 
one evolved line. The cyaA/crp regulation system activates catabolic pathways for While 
in total eight lines had mutations to these genes associated with transcriptional regulation 
of pathways involved in lactose, galactose, and citrate catabolism. Seven of the eight 
mutations to these genes were single nucleotide substitutions resulting in amino acid 
substitutions, and one was a 78-nucleotide deletion at the c-terminus of the protein, 
involved in regulation. Using the Keio knockout ΔcyaA strain, we saw similar growth in 
all evolutionary conditions, with perhaps the exception of RDM-13, where the ΔcyaA 
strain grew slightly quicker than other knockout strains or the wild-type E. coli (Figure 
5-7). This is likely not representative of the actual effects of the cyaA mutations seen 
during evolution, since single mutations often reduce enzyme kinetics, but the enzyme 
remains active. Additionally, cyaA mutations were not restricted to lines evolved in 
RDM-13, but seen in all growth conditions, and so is likely not the mechanism by which 
RDM-13 lines evolved to grow in RDM-13.  
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5.3.5.4 A large genomic fragment knockout 
Besides the single gene mutations described above, there was a significant 
deletion from the genome of ten evolved lines, including all lines grown in RDM-13, and 
four lines evolved in RDM-19. This fragment is mediated by IS-1, the fragment varies in 
length, exact deletion sites, and the total number of genes either entirely or partially 
removed, though all 10 began at the uspC gene. Seven of the 10 genome excisions ended 
in the tyrP gene (3nY-A3, B3, and C3, and Phe-A2, B2, B3, and C3) and was responsible 
for many of the tyrP mutations as discussed above. One ends at yecH, leaving tyrP intact 
(3nY-B2), and two end in yecA, entirely removing tyrP from the genome (3nY-C2, and 
Phe-A3). This genome modification may be responsible for the growth rate 
improvements seen in RDM-13 evolved lines, as it is shared amongst all six of them. 
Efforts to remove this segment from wild-type MG1655 are underway, and growth 
curves in RDM-13 will be used to determine the possible phenotypic advantages this 
genome excision may confer. Here are a list of the genes removed by this excision, and 
their function (if known). In summary, there is no known function for these proteins that 
would clearly bestow a phenotypic advantage when removed from the genome of bacteria 
evolved in RDM-13.  
Universal stress protein C (uspC) is involved in UV tolerance and the transition to 
stationary phase during growth in rich media (Gustavsson et al., 2002; Siegele, 2005). 
Trehalose-6-phosphate synthase (otsA) and trehalose-6-phosphate phosphatase (otsB) are 
involved osmorgulation, and contribute to antibiotic tolerance and oxidative stress 
prevention (Kuczyńska-Wiśnik et al., 2015). The arabinose transporter subunits (araH, 
araG, and araF) are responsible for the cross-membrane transport of the sugar L-
arabinose (Kolodrubetz and Schleif, 1981). Ferritin iron-storage complex (ftnB) and 
related protein (ftnA) are involved, or predicted to be involved, in iron storage (Hudson et 
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al., 1993). The predicted proteins yecJ, yecH and yecR have unknown function, but may 
play a role in cell envelope or flagellar formation (Paradis-Bleau et al., 2014; Stafford et 
al., 2005). Additionally, yecA has predicted metal binding properties (Serres et al., 2001). 
The small membrane protein (azuC) has been identified as a stress response protein, and 
is regulated by crp (Fontaine et al., 2011; Hemm et al., 2010). The tyrosine transporter 
(tyrP) and its impact in growth effects was described above.  
5.3.5.5 An in-frame TAG codon in an essential gene 
A single clone, Phe-B3, evolved in RDM-13 and initially not dependent on 3nY 
for growth, acquired an in-frame genomic TAG codon in the gene lptD, which is 
involved in LPS biosynthesis. This was initially apparent when plate-base MIC assays of 
Phe-B3 showed no growth. Repeated attempts resulted in no growth as well, and no MIC 
is reported for Phe-B3 in the absence of 3nY (Figure 5-2). Growth curve analysis 
showed that Phe-B3 grew only in the presence of 3nY (Figure 5-8). Phe-B3 was not 
addicted to 3nY when the experiment began, and could have deactivated the OTS. It has 
acquired a mutation that, for the moment, requires UAG suppression with 3nY. Full 
genome sequencing of the mixed population of the PheB3 strain revealed that this 
mutation was not common in the evolving culture, and is thus likely a permissive, 
transient mutation in the population.  
 5.4 DISCUSSION 
We present here the genomic and phenotypic analysis of the wild-type E. coli 
strain MG1655 which was evolved for 2000 generations with an expanded genetic code. 
Our results indicate that a functional addiction to the NCAA, as conferred by encoding 
with TEM-1.B9YYG-3nY, is required to ensure the OTS remains functional throughout 
evolution. Even after 2000 generations of evolution, that adoption of the NCAA 
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throughout the genome is limited. Despite a pressure to evolve with the NCAA, bacteria 
preferred to downregulate NCAA incorporation and UAG suppression, and use the 
natural genome to overcome evolutionary pressures. 
5.5 METHODS AND MATERIALS 
5.5.1 Evolutionary Set Up 
5.5.1.1 Addiction Plasmid 
The plasmid used for ceftazidime resistance was derived from pMMB67EH. The 
TEM-1 β-lactamase was replaced with the 3nY addiction operon as described previously 
(Tack et al., 2016). The substrate specificity was changed from penicillins to 
cephalosporins by replacing residues 165-167 with a YYG sequence, using primers 
B9YYGf and B9YYGr for 3nY cassette, and B9YYGFf and B9YYGFr (Table 5-7)for 
Phe control plasmid, and assembled using the Gibson protocol(Gibson, 2009). Plasmids 
were cloned into TOP10 E. coli and plating on LB-agar with 10 mM 3nY and 2 μg ml-1 
CAZ. Samples were sequenced verified at University of Texas core facilities using 
Sanger sequencing. 
5.5.1.2 Media 
MOPS-EZ Rich Defined Media (RDM, purchased from TEKnova) with the full 
complement of amino acids, as well as the knockout medias, were prepared according the 
manufacturers specifications. Ultrapure water was autoclaved and then 3nY was added to 
a concentration of 17.24 mM while hot, to facilitate dissolving. Once cooled, the 3nY 
supplemented water was used to complete RDM, and the entire preparation was filter 
sterilized with Nalgene Rapid-Flow SFCA filtration units. Media was stored at 4°C 
before use, and moved to 20°C one day before use. 
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5.5.1.3 Passaging 
Wild-type E. coli MG1655 was made electrocompotent with serial 10% glycerol 
washes, and electroporated with the addiction plasmid or control plasmid, and plated on 
LB-agar with 2 μg ml-1 CAZ. Three colonies from each transformation were picked and 
grown in RDM+3nY with 2 μg ml-1 CAZ, overnight. Each culture was then used to 
inoculate three subcultures: one in RDM containing the full complement of 20 amino 
acids, one in RDM lacking tyrosine, and one in RDM lacking tyrosine, glutamine, lysine, 
glutamate, tryptophan, serine, and leucine. Cultures lacking the seven amino acids were 
incapable of growth in 3nY initially, but were capable when 25% of media was replaced 
with RDM lacking tyrosine, this growth condition was used for the first 100 generations, 
and then cultures were capable of growth in experimental conditions lacking the seven 
amino acids. Cultures were passaged every 16-24 hours by transferring 1 μl into 5 ml of 
media, and grown shaking at 37°C.   
5.5.2 Genome Sequencing and Assembly 
After the 2000 generations, 1 μl from each line was streaked on MOPS-EZ rich 
defined media with agar and 10 mM 3nY. Single colonies were selected and grown in 3 
ml MOPS-EZ RDM with 10 mM 3nY with 22 μg ml-1 CAZ. Simultaneously, samples 
from the progenitor strains were grown in similar conditions but with 2 μg ml-1 CAZ. 
After overnight growth, genomic DNA purified using bacteria genome miniprep kit 
(purchased from Sigma-Aldrich). Bacterial genomic DNA were prepped and sequenced 
with 150 bp paired ends on a HiSeq 4000, achieving greater than 100x coverage across 
all samples. Raw reads were processed through trimming and adapter removal using 
trimmomatic (v0.32) (Bolger et al., 2014). Alignment of sequencing reads and variant 
calling was performed through the breseq workflow (v0.27.2) (Deatherage and Barrick, 
2014). 
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5.5.3 Growth Curves 
Culture were inoculated from glycerol stocks and grown in respective appropriate 
media. After overnight growth to full OD, 1 µl from overnight cultures were used to 
inoculate 200 µL of media with appropriate concentrations of CAZ and 3nY. A Tecan 
Infinite M200 pro microplate reader set to 37°C monitored absorbance at 600 nm for 
approximately 24 hours. Data for each well were trimmed from .1 to .2 OD600 after which 
the rate of logarithmic change in OD was calculated for each line. Keio collection strains 
were BW25113 as the wild-type E. coli, JW3778 (ΔcyaA), JW1895 (ΔtyrP), and JW3130 
(Δmtr), and were a gracious gift from the Jeffrey Barrick Lab at the University of Texas 
at Austin. 
5.5.4 MICs 
The 6 progenitor bacteria and the 18 selected clones from the evolved lines were 
grown overnight in 3nY enriched MOPS-EZ growth media supplemented with 2 μg ml-1 
or 22 μg ml-1 of CAZ respectively.  Overnight cultures were used to inoculate fresh 
MOPS-EZ rich defined media lacking 3nY and without CAZ, and were grown for five 
hours at 37°C in shaking incubator. Aliquots of 25 uL from each line (corresponding to 
~107 cfu) were plated on LB-agar, with or without 10 mM 3nY, in triplicate. Plates were 
allowed a period to dry for 5 minutes, and ceftazidime E-test MIC strips (Biomerieux) 
were added to each plate. Plates were incubated for 16 hours at 37°C. MIC values are 
reported as the lowest MIC concentration on E-test strip, in which no bacterial growth 
occurred. 
5.5.5 GFP Assays 
The codon for Tyr39 in GFPmut2, under control of the tacI promoter with a lacO 
operator, was mutated to amber codon (TAG), tyrosine codon (TAT), or ochre nonsense 
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codon (TAA) using primers TAGf, TATf, TAAf, along with N39r for PCR amplification. 
Amplicons were concentrated and desalted using QIAquick PCR purification kit, and 
resultant PCR product was circularized using the isothermal Gibson protocol, followed 
by the addition of DpnI to digest original PCR template. Gibson product was 
electroporated into TOP10 E. coli, and plated on LB-agar supplemented with kanamycin. 
Clones were grown, and plasmid DNA isolated using QIAprep Spin Miniprep Kit. Each 
sequence was confirmed by DNA Sanger sequencing at the University of Texas Core 
Facility.  
Glycerol stocks of the eighteen evolved clones, as well as the six progenitor 
clones, were used to inoculate 2 ml of LB media, supplemented with 10 mM 3nY, as well 
as .02% glucose, in 2 μg ml-1 CAZ, and grown to saturation overnight.  A 5 μl aliquot 
from each was used to inoculate 5 ml of LB, 10 mM 3nY, and 2 μg ml-1 CAZ, and grown 
at 37°C for 3 hours, and made electrocompetent with serial washes of 10% glycerol. 
Samples were transformed with GFP (N39X) variants, recovered with LB media, and 
plated on LB-agar with 10 mM 3nY, .02% glucose, 50 μg ml-1 KAN, and 2 μg ml-1 CAZ, 
and grown overnight at 37°C.  
Four samples from each plate were picked and grown overnight at 37°C in 500 μl 
LB with 10 mM 3nY, .02% glucose, 50 μg ml-1 KAN, and 2 μg ml-1 CAZ. A 2 μl aliquot 
of each overnight culture was used to inoculate 1 ml LB media supplemented with 50 μg 
ml-1 KAN, and containing either 1 mM 3nY, 1 mM 3-iodotyrosine, or with no 
supplemented NCAA. Cultures were grown at 37°C for 3 hours, then induced with 1 mM 
IPTG, and grown for another 5 hours at 37°C. Final cultures were centrifuged and 
washed twice at 2000g with 4°C PBS (50 mM phosphate, 300 mM NaCl, pH 8), and a 
150 μl aliquot of washed culture were used to measure absorbance at 600 nm wavelength, 
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was well as GFP fluorescence, with measured emission of 525 nm wavelength, upon 






5.6 TABLES AND FIGURES 
 
Figure 5-1: TEM-1YYG structure 
Alignment of TEM-1 β-lactamase (green, PDB: 1XPB) that was used to engineered 
TEM-1.B9, and the TEM-1 Ω-loop mutant (salmon, PDB: 4rx3) that changes substrate 
specificity from lactams to cephalosporins. These mutations affect the loop structure and 
the pocket surrounding 3nY incorporation site L162 (red sticks).The engineered pocket 
(blue and black sticks) is mostly affected at L169 (black sticks). Despite this, the TEM-






Figure 5-2: MICs of MG1655 
Minimum inhibitory concentration (MICs) of ceftazidime determinations of all 
progenitor and evolved lines (A0, B0, and C0) with and without 3nY (orange and blue, 
respectively). Lines evolved with 3nY addiction (Top) increased MICs with 3nY while 
background in the absence of 3nY remained near zero. Nonaddicted lines saw higher 












































Figure 5-3: Evolutionary conditions 
The addiction cassette included 3nY-aaRS, TEM-1.B9 variant, and tRNA. Three colonies 
containing TEM-1.B9YYG-3nY and three colonies containing TEM-1.B9YYG-Phe (A, 
B, and C for each) were selected, and each was grown in RDM-20, RDM-19, and RDM-
13 with 10 mM 3nY and ceftazidime for 2000 generations. During the course of 
passaging, the ceftazidime concentration was gradually increased, beginning at 2 µg ml-1 





Figure 5-4: UAG suppression efficiency of evolved lines 
GFPmut2 with a TAG codon replacing Tyr39 was expressed in all progenitor lines, as 
well all evolved lines to determine UAG suppression activity relative to a tyrosine (TAT) 
codon. All lines evolved with 3nY addiction maintained a functional level of UAG 
suppression (3nY-A1-C3). Three lines (Phe-A1, B2, and C2) from the nonaddicted 
evolved lines eliminated UAG suppression activity (<1% of TAT39 GFPmut2 












































Figure 5-5: Structure of tRNAs 
Computational predictions of the tRNAs used and found in this study. Left is the 
generation zero tRNA, center is the structure of the Phe-A2 tRNA substitution G27C 
(blue) which is predicted not to affect tRNA structure. Right is the predicted structural 





Figure 5-6: MICs of plasmid encoded resistance 
MICs of MG1655 transformed with plasmid purified from each of the evolved line, as 
well as the progenitor cells. Reported values are average of biological triplicates, error 
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Figure 5-7: Keio knockout growth curves 
Strains from the Keio knockout collection (Baba et al., 2006) were used to analyze the 
growth rates of lines with common knockouts in each media grown. Neither cyaA 
(purple), mtr (green), nor tyrP (red) knockouts significantly increased growth in RDM-13 
















Figure 5-8: Phe-B3 growth rates 
Evolved line Phe-B3 acquired a mutation resulting in an in-frame TAG codon in the 
essential gene lptD, which is involved in LPS biosynthesis. After 2000 generations, Phe-
B3 became dependent on 3nY incorporation for growth, and had no growth in the 















MG1655 Doubling Rate 
 Wild-Type 3nY-OTS 
 0 mM 10 mM 3nY 10 mM 3iY 0 mM 10 mM 3nY 10 mM 3iY 
RDM-20 1.64 1.43 1.46 1.65 1.42 1.50 
RDM-19 1.53 1.28 1.46 1.42 1.28 1.23 
RDM-13 1.31 0.46 1.25 1.00 0.05 1.09 
 
Table 5-1: Doubling rates of MG1655 wild-type 
Calculated growth rates (hr-1) of MG1655 in the amino acid environments used during 
evolution. MG1655 doubling rates decrease with the removal of amino acids and with the 
addition of 10 mM of 3nY, but are less affected by 10 mM 3iY. The impact on growth 
rates is increased in MG1655 encoding the 3nY addiction cassette used during evolution. 




  Progenitor Evolved 
  0 mM 10 mM 3nY 10 mM 3iY 0 mM 10 mM 3nY 10 mM 3iY 
3nY 
RDM-20 1.65 1.42 1.50 1.77 1.69 1.67 
RDM-19 1.42 1.28 1.23 1.69 1.53 1.48 
RDM-13 1.00 0.05 1.09 1.35 1.26 1.40 
Phe 
RDM-20 1.41 1.27 1.34 1.82 1.64 1.78 
RDM-19 1.30 1.19 1.17 1.71 1.60 1.66 
RDM-13 0.94 0.14 1.14 1.40 1.38 1.41 
 
Table 5-2: Doubling rates of progenitor and evolved clones 
Doubling rates (hr-1) of MG1655 with addiction plasmid both before and after evolution. 











Mutation Lines Effect 
V33I 3nY-B3  
Q39K Phe-B1 CAZ specific 








H153R 3nY-B1 Stabilizing 
M155I Phe-C1  
M182T 3nY-A2 Stabilizing 
A184V 3nY-A3  
T200P 3nY-A1  
A224V Phe-A2 Stabilizing 
 
Table 5-3: Evolved TEM-1.B9YYG mutations 
Listing of the TEM-1.B9YYG mutations and the lines they appeared in during evolution, 
as well as published effects of the mutation, if known. Every line of the 3nY addicted 







Table 5-4: Genomic mutations in 3nY lines 
List of the mutations found in each of the TEM-1.B9YYG-3nY evolved lines 
Gene mutation Location












opgG +9 insert IS-1 385-393/1536
ycjO d87 250-336/882























sanA +9 IS-1 165-173/720
mtr -6 391-396/1245
ompR M57L
yibA +9 IS-1 15-23/843
yaiT A>C 682/1458






































































Table 5-5: Genomic mutations in Phe lines 










sdaC +9 insert IS-1 1192-1200/1290
waaQ +9 insert IS-1 581-589/1035
ybbP A580E
opgG +9 IS-1 738-746/1656
sdaC W18tag
waaO +4  IS-5 925-928/1020
sdaC +1 798/1290
envZ S87Y









waaB +4 IS-5 226-229/1080
caiC I449S














tnaA +5 IS-2 303-304/1416




































































Gene Lines Discription Identifier 
tyrP 
3nY-C2,A3,B3,C3 

























histidine kinase:osmotic regulation P0AEJ4 
Phe-C1 
galU Phe-B2,A3,C3 UTP:glucose-1-phosphate uridylyltransferase P0AEP3 
opgG 





Table 5-6: Genes with mutations in more than one evolved line 
A list of the nine mutational hotspots during evolution, and the evolutionary lines in 




























Table 5-7: Primer sequences 
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